id	sid	tid	token	lemma	pos
cord-283340-ksyd5l56	1	1	key	key	NN
cord-283340-ksyd5l56	1	2	:	:	:
cord-283340-ksyd5l56	2	1	cord-283340-ksyd5l56	cord-283340-ksyd5l56	JJ
cord-283340-ksyd5l56	2	2	authors	author	NNS
cord-283340-ksyd5l56	2	3	:	:	:
cord-283340-ksyd5l56	2	4	Choi	Choi	NNP
cord-283340-ksyd5l56	2	5	,	,	,
cord-283340-ksyd5l56	2	6	Geun	Geun	NNP
cord-283340-ksyd5l56	2	7	Joo	Joo	NNP
cord-283340-ksyd5l56	2	8	;	;	:
cord-283340-ksyd5l56	2	9	Kim	Kim	NNP
cord-283340-ksyd5l56	2	10	,	,	,
cord-283340-ksyd5l56	2	11	Hyun	Hyun	NNP
cord-283340-ksyd5l56	2	12	Min	Min	NNP
cord-283340-ksyd5l56	2	13	;	;	:
cord-283340-ksyd5l56	2	14	Kang	Kang	NNP
cord-283340-ksyd5l56	2	15	,	,	,
cord-283340-ksyd5l56	3	1	Hyun	Hyun	NNP
cord-283340-ksyd5l56	3	2	title	title	NN
cord-283340-ksyd5l56	3	3	:	:	:
cord-283340-ksyd5l56	3	4	The	the	DT
cord-283340-ksyd5l56	3	5	Potential	potential	JJ
cord-283340-ksyd5l56	3	6	Role	role	NN
cord-283340-ksyd5l56	3	7	of	of	IN
cord-283340-ksyd5l56	3	8	Dyslipidemia	Dyslipidemia	NNP
cord-283340-ksyd5l56	3	9	in	in	IN
cord-283340-ksyd5l56	3	10	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	3	11	Severity	Severity	NNP
cord-283340-ksyd5l56	3	12	:	:	:
cord-283340-ksyd5l56	3	13	an	an	DT
cord-283340-ksyd5l56	3	14	Umbrella	Umbrella	NNP
cord-283340-ksyd5l56	3	15	Review	Review	NNP
cord-283340-ksyd5l56	3	16	of	of	IN
cord-283340-ksyd5l56	3	17	Systematic	Systematic	NNP
cord-283340-ksyd5l56	3	18	Reviews	Reviews	NNP
cord-283340-ksyd5l56	3	19	date	date	NN
cord-283340-ksyd5l56	3	20	:	:	:
cord-283340-ksyd5l56	3	21	2020	2020	CD
cord-283340-ksyd5l56	3	22	-	-	HYPH
cord-283340-ksyd5l56	3	23	09	09	CD
cord-283340-ksyd5l56	3	24	-	-	SYM
cord-283340-ksyd5l56	3	25	21	21	CD
cord-283340-ksyd5l56	3	26	journal	journal	NN
cord-283340-ksyd5l56	3	27	:	:	:
cord-283340-ksyd5l56	3	28	J	J	NNP
cord-283340-ksyd5l56	3	29	Lipid	Lipid	NNP
cord-283340-ksyd5l56	3	30	Atheroscler	Atheroscler	NNP
cord-283340-ksyd5l56	3	31	DOI	DOI	NNP
cord-283340-ksyd5l56	3	32	:	:	:
cord-283340-ksyd5l56	3	33	10.12997	10.12997	CD
cord-283340-ksyd5l56	3	34	/	/	SYM
cord-283340-ksyd5l56	3	35	jla.2020.9.3.435	jla.2020.9.3.435	NNP
cord-283340-ksyd5l56	3	36	sha	sha	NNP
cord-283340-ksyd5l56	3	37	:	:	:
cord-283340-ksyd5l56	3	38	ebd3560062c23900ae0067b48f0723f422f57ffb	ebd3560062c23900ae0067b48f0723f422f57ffb	NNP
cord-283340-ksyd5l56	4	1	doc_id	doc_id	CD
cord-283340-ksyd5l56	4	2	:	:	:
cord-283340-ksyd5l56	4	3	283340	283340	CD
cord-283340-ksyd5l56	4	4	cord_uid	cord_uid	NNS
cord-283340-ksyd5l56	4	5	:	:	:
cord-283340-ksyd5l56	5	1	ksyd5l56	ksyd5l56	CD
cord-283340-ksyd5l56	5	2	OBJECTIVE	objective	NN
cord-283340-ksyd5l56	5	3	:	:	:
cord-283340-ksyd5l56	6	1	The	the	DT
cord-283340-ksyd5l56	6	2	aim	aim	NN
cord-283340-ksyd5l56	6	3	of	of	IN
cord-283340-ksyd5l56	6	4	this	this	DT
cord-283340-ksyd5l56	6	5	study	study	NN
cord-283340-ksyd5l56	6	6	was	be	VBD
cord-283340-ksyd5l56	6	7	to	to	TO
cord-283340-ksyd5l56	6	8	analyze	analyze	VB
cord-283340-ksyd5l56	6	9	the	the	DT
cord-283340-ksyd5l56	6	10	available	available	JJ
cord-283340-ksyd5l56	6	11	knowledge	knowledge	NN
cord-283340-ksyd5l56	6	12	about	about	IN
cord-283340-ksyd5l56	6	13	the	the	DT
cord-283340-ksyd5l56	6	14	potential	potential	JJ
cord-283340-ksyd5l56	6	15	association	association	NN
cord-283340-ksyd5l56	6	16	between	between	IN
cord-283340-ksyd5l56	6	17	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	6	18	and	and	CC
cord-283340-ksyd5l56	6	19	the	the	DT
cord-283340-ksyd5l56	6	20	severity	severity	NN
cord-283340-ksyd5l56	6	21	of	of	IN
cord-283340-ksyd5l56	6	22	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	6	23	disease	disease	NN
cord-283340-ksyd5l56	6	24	2019	2019	CD
cord-283340-ksyd5l56	6	25	(	(	-LRB-
cord-283340-ksyd5l56	6	26	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	6	27	)	)	-RRB-
cord-283340-ksyd5l56	6	28	as	as	IN
cord-283340-ksyd5l56	6	29	reported	report	VBN
cord-283340-ksyd5l56	6	30	in	in	IN
cord-283340-ksyd5l56	6	31	previous	previous	JJ
cord-283340-ksyd5l56	6	32	published	publish	VBN
cord-283340-ksyd5l56	6	33	systematic	systematic	JJ
cord-283340-ksyd5l56	6	34	reviews	review	NNS
cord-283340-ksyd5l56	6	35	.	.	.
cord-283340-ksyd5l56	7	1	METHODS	methods	NN
cord-283340-ksyd5l56	7	2	:	:	:
cord-283340-ksyd5l56	8	1	In	in	IN
cord-283340-ksyd5l56	8	2	this	this	DT
cord-283340-ksyd5l56	8	3	umbrella	umbrella	NN
cord-283340-ksyd5l56	8	4	review	review	NN
cord-283340-ksyd5l56	8	5	(	(	-LRB-
cord-283340-ksyd5l56	8	6	an	an	DT
cord-283340-ksyd5l56	8	7	overview	overview	NN
cord-283340-ksyd5l56	8	8	of	of	IN
cord-283340-ksyd5l56	8	9	systematic	systematic	JJ
cord-283340-ksyd5l56	8	10	reviews	review	NNS
cord-283340-ksyd5l56	8	11	)	)	-RRB-
cord-283340-ksyd5l56	8	12	,	,	,
cord-283340-ksyd5l56	8	13	we	-PRON-	PRP
cord-283340-ksyd5l56	8	14	investigated	investigate	VBD
cord-283340-ksyd5l56	8	15	the	the	DT
cord-283340-ksyd5l56	8	16	association	association	NN
cord-283340-ksyd5l56	8	17	between	between	IN
cord-283340-ksyd5l56	8	18	dyslipidemia	dyslipidemia	NNP
cord-283340-ksyd5l56	8	19	and	and	CC
cord-283340-ksyd5l56	8	20	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	8	21	severity	severity	NN
cord-283340-ksyd5l56	8	22	.	.	.
cord-283340-ksyd5l56	9	1	A	a	DT
cord-283340-ksyd5l56	9	2	systematic	systematic	JJ
cord-283340-ksyd5l56	9	3	search	search	NN
cord-283340-ksyd5l56	9	4	was	be	VBD
cord-283340-ksyd5l56	9	5	performed	perform	VBN
cord-283340-ksyd5l56	9	6	of	of	IN
cord-283340-ksyd5l56	9	7	4	4	CD
cord-283340-ksyd5l56	9	8	main	main	JJ
cord-283340-ksyd5l56	9	9	electronic	electronic	JJ
cord-283340-ksyd5l56	9	10	databases	database	NNS
cord-283340-ksyd5l56	9	11	(	(	-LRB-
cord-283340-ksyd5l56	9	12	MEDLINE	MEDLINE	NNP
cord-283340-ksyd5l56	9	13	,	,	,
cord-283340-ksyd5l56	9	14	Embase	Embase	NNP
cord-283340-ksyd5l56	9	15	,	,	,
cord-283340-ksyd5l56	9	16	Scopus	Scopus	NNP
cord-283340-ksyd5l56	9	17	,	,	,
cord-283340-ksyd5l56	9	18	and	and	CC
cord-283340-ksyd5l56	9	19	the	the	DT
cord-283340-ksyd5l56	9	20	Cochrane	Cochrane	NNP
cord-283340-ksyd5l56	9	21	Library	Library	NNP
cord-283340-ksyd5l56	9	22	databases	database	NNS
cord-283340-ksyd5l56	9	23	)	)	-RRB-
cord-283340-ksyd5l56	9	24	from	from	IN
cord-283340-ksyd5l56	9	25	inception	inception	NN
cord-283340-ksyd5l56	9	26	until	until	IN
cord-283340-ksyd5l56	9	27	August	August	NNP
cord-283340-ksyd5l56	9	28	2020	2020	CD
cord-283340-ksyd5l56	9	29	.	.	.
cord-283340-ksyd5l56	10	1	We	-PRON-	PRP
cord-283340-ksyd5l56	10	2	evaluated	evaluate	VBD
cord-283340-ksyd5l56	10	3	the	the	DT
cord-283340-ksyd5l56	10	4	methodological	methodological	JJ
cord-283340-ksyd5l56	10	5	quality	quality	NN
cord-283340-ksyd5l56	10	6	of	of	IN
cord-283340-ksyd5l56	10	7	the	the	DT
cord-283340-ksyd5l56	10	8	included	include	VBN
cord-283340-ksyd5l56	10	9	studies	study	NNS
cord-283340-ksyd5l56	10	10	using	use	VBG
cord-283340-ksyd5l56	10	11	the	the	DT
cord-283340-ksyd5l56	10	12	A	a	DT
cord-283340-ksyd5l56	10	13	MeaSurement	MeaSurement	NNP
cord-283340-ksyd5l56	10	14	Tool	tool	NN
cord-283340-ksyd5l56	10	15	to	to	TO
cord-283340-ksyd5l56	10	16	Assess	assess	VB
cord-283340-ksyd5l56	10	17	systematic	systematic	JJ
cord-283340-ksyd5l56	10	18	Reviews	review	NNS
cord-283340-ksyd5l56	10	19	(	(	-LRB-
cord-283340-ksyd5l56	10	20	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	10	21	)	)	-RRB-
cord-283340-ksyd5l56	10	22	2	2	CD
cord-283340-ksyd5l56	10	23	tool	tool	NN
cord-283340-ksyd5l56	10	24	and	and	CC
cord-283340-ksyd5l56	10	25	used	use	VBD
cord-283340-ksyd5l56	10	26	the	the	DT
cord-283340-ksyd5l56	10	27	Grading	grading	NN
cord-283340-ksyd5l56	10	28	of	of	IN
cord-283340-ksyd5l56	10	29	Recommendations	Recommendations	NNPS
cord-283340-ksyd5l56	10	30	,	,	,
cord-283340-ksyd5l56	10	31	Assessment	Assessment	NNP
cord-283340-ksyd5l56	10	32	,	,	,
cord-283340-ksyd5l56	10	33	Development	Development	NNP
cord-283340-ksyd5l56	10	34	,	,	,
cord-283340-ksyd5l56	10	35	and	and	CC
cord-283340-ksyd5l56	10	36	Evaluation	Evaluation	NNP
cord-283340-ksyd5l56	10	37	(	(	-LRB-
cord-283340-ksyd5l56	10	38	GRADE	grade	NN
cord-283340-ksyd5l56	10	39	)	)	-RRB-
cord-283340-ksyd5l56	10	40	system	system	NN
cord-283340-ksyd5l56	10	41	to	to	TO
cord-283340-ksyd5l56	10	42	assess	assess	VB
cord-283340-ksyd5l56	10	43	the	the	DT
cord-283340-ksyd5l56	10	44	quality	quality	NN
cord-283340-ksyd5l56	10	45	of	of	IN
cord-283340-ksyd5l56	10	46	evidence	evidence	NN
cord-283340-ksyd5l56	10	47	for	for	IN
cord-283340-ksyd5l56	10	48	the	the	DT
cord-283340-ksyd5l56	10	49	outcome	outcome	NN
cord-283340-ksyd5l56	10	50	.	.	.
cord-283340-ksyd5l56	11	1	In	in	IN
cord-283340-ksyd5l56	11	2	addition	addition	NN
cord-283340-ksyd5l56	11	3	,	,	,
cord-283340-ksyd5l56	11	4	we	-PRON-	PRP
cord-283340-ksyd5l56	11	5	evaluated	evaluate	VBD
cord-283340-ksyd5l56	11	6	the	the	DT
cord-283340-ksyd5l56	11	7	strengths	strength	NNS
cord-283340-ksyd5l56	11	8	and	and	CC
cord-283340-ksyd5l56	11	9	limitations	limitation	NNS
cord-283340-ksyd5l56	11	10	of	of	IN
cord-283340-ksyd5l56	11	11	the	the	DT
cord-283340-ksyd5l56	11	12	evidence	evidence	NN
cord-283340-ksyd5l56	11	13	and	and	CC
cord-283340-ksyd5l56	11	14	the	the	DT
cord-283340-ksyd5l56	11	15	methodological	methodological	JJ
cord-283340-ksyd5l56	11	16	quality	quality	NN
cord-283340-ksyd5l56	11	17	of	of	IN
cord-283340-ksyd5l56	11	18	the	the	DT
cord-283340-ksyd5l56	11	19	available	available	JJ
cord-283340-ksyd5l56	11	20	studies	study	NNS
cord-283340-ksyd5l56	11	21	.	.	.
cord-283340-ksyd5l56	12	1	RESULTS	result	NNS
cord-283340-ksyd5l56	12	2	:	:	:
cord-283340-ksyd5l56	13	1	Out	out	IN
cord-283340-ksyd5l56	13	2	of	of	IN
cord-283340-ksyd5l56	13	3	35	35	CD
cord-283340-ksyd5l56	13	4	articles	article	NNS
cord-283340-ksyd5l56	13	5	identified	identify	VBN
cord-283340-ksyd5l56	13	6	,	,	,
cord-283340-ksyd5l56	13	7	2	2	CD
cord-283340-ksyd5l56	13	8	systematic	systematic	JJ
cord-283340-ksyd5l56	13	9	reviews	review	NNS
cord-283340-ksyd5l56	13	10	were	be	VBD
cord-283340-ksyd5l56	13	11	included	include	VBN
cord-283340-ksyd5l56	13	12	in	in	IN
cord-283340-ksyd5l56	13	13	the	the	DT
cord-283340-ksyd5l56	13	14	umbrella	umbrella	NN
cord-283340-ksyd5l56	13	15	review	review	NN
cord-283340-ksyd5l56	13	16	.	.	.
cord-283340-ksyd5l56	14	1	A	a	DT
cord-283340-ksyd5l56	14	2	total	total	NN
cord-283340-ksyd5l56	14	3	of	of	IN
cord-283340-ksyd5l56	14	4	7,951	7,951	CD
cord-283340-ksyd5l56	14	5	COVID-19-positive	covid-19-positive	JJ
cord-283340-ksyd5l56	14	6	patients	patient	NNS
cord-283340-ksyd5l56	14	7	were	be	VBD
cord-283340-ksyd5l56	14	8	included	include	VBN
cord-283340-ksyd5l56	14	9	.	.	.
cord-283340-ksyd5l56	15	1	According	accord	VBG
cord-283340-ksyd5l56	15	2	to	to	IN
cord-283340-ksyd5l56	15	3	the	the	DT
cord-283340-ksyd5l56	15	4	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	15	5	2	2	CD
cord-283340-ksyd5l56	15	6	criteria	criterion	NNS
cord-283340-ksyd5l56	15	7	and	and	CC
cord-283340-ksyd5l56	15	8	GRADE	grade	NN
cord-283340-ksyd5l56	15	9	system	system	NN
cord-283340-ksyd5l56	15	10	,	,	,
cord-283340-ksyd5l56	15	11	the	the	DT
cord-283340-ksyd5l56	15	12	quality	quality	NN
cord-283340-ksyd5l56	15	13	of	of	IN
cord-283340-ksyd5l56	15	14	the	the	DT
cord-283340-ksyd5l56	15	15	included	include	VBN
cord-283340-ksyd5l56	15	16	studies	study	NNS
cord-283340-ksyd5l56	15	17	was	be	VBD
cord-283340-ksyd5l56	15	18	not	not	RB
cord-283340-ksyd5l56	15	19	high	high	JJ
cord-283340-ksyd5l56	15	20	.	.	.
cord-283340-ksyd5l56	16	1	A	a	DT
cord-283340-ksyd5l56	16	2	history	history	NN
cord-283340-ksyd5l56	16	3	of	of	IN
cord-283340-ksyd5l56	16	4	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	16	5	is	be	VBZ
cord-283340-ksyd5l56	16	6	likely	likely	JJ
cord-283340-ksyd5l56	16	7	to	to	TO
cord-283340-ksyd5l56	16	8	be	be	VB
cord-283340-ksyd5l56	16	9	associated	associate	VBN
cord-283340-ksyd5l56	16	10	with	with	IN
cord-283340-ksyd5l56	16	11	the	the	DT
cord-283340-ksyd5l56	16	12	severity	severity	NN
cord-283340-ksyd5l56	16	13	of	of	IN
cord-283340-ksyd5l56	16	14	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	16	15	infection	infection	NN
cord-283340-ksyd5l56	16	16	,	,	,
cord-283340-ksyd5l56	16	17	but	but	CC
cord-283340-ksyd5l56	16	18	the	the	DT
cord-283340-ksyd5l56	16	19	contrary	contrary	NN
cord-283340-ksyd5l56	16	20	is	be	VBZ
cord-283340-ksyd5l56	16	21	the	the	DT
cord-283340-ksyd5l56	16	22	case	case	NN
cord-283340-ksyd5l56	16	23	for	for	IN
cord-283340-ksyd5l56	16	24	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	16	25	levels	level	NNS
cord-283340-ksyd5l56	16	26	at	at	IN
cord-283340-ksyd5l56	16	27	hospitalization	hospitalization	NN
cord-283340-ksyd5l56	16	28	.	.	.
cord-283340-ksyd5l56	17	1	CONCLUSIONS	conclusion	NNS
cord-283340-ksyd5l56	17	2	:	:	:
cord-283340-ksyd5l56	18	1	Although	although	IN
cord-283340-ksyd5l56	18	2	existing	exist	VBG
cord-283340-ksyd5l56	18	3	research	research	NN
cord-283340-ksyd5l56	18	4	on	on	IN
cord-283340-ksyd5l56	18	5	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	18	6	and	and	CC
cord-283340-ksyd5l56	18	7	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	18	8	is	be	VBZ
cord-283340-ksyd5l56	18	9	limited	limit	VBN
cord-283340-ksyd5l56	18	10	,	,	,
cord-283340-ksyd5l56	18	11	our	-PRON-	PRP$
cord-283340-ksyd5l56	18	12	findings	finding	NNS
cord-283340-ksyd5l56	18	13	suggest	suggest	VBP
cord-283340-ksyd5l56	18	14	that	that	IN
cord-283340-ksyd5l56	18	15	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	18	16	may	may	MD
cord-283340-ksyd5l56	18	17	play	play	VB
cord-283340-ksyd5l56	18	18	a	a	DT
cord-283340-ksyd5l56	18	19	role	role	NN
cord-283340-ksyd5l56	18	20	in	in	IN
cord-283340-ksyd5l56	18	21	the	the	DT
cord-283340-ksyd5l56	18	22	severity	severity	NN
cord-283340-ksyd5l56	18	23	of	of	IN
cord-283340-ksyd5l56	18	24	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	18	25	infection	infection	NN
cord-283340-ksyd5l56	18	26	.	.	.
cord-283340-ksyd5l56	19	1	More	more	RBR
cord-283340-ksyd5l56	19	2	adequately	adequately	RB
cord-283340-ksyd5l56	19	3	powered	powered	JJ
cord-283340-ksyd5l56	19	4	studies	study	NNS
cord-283340-ksyd5l56	19	5	are	be	VBP
cord-283340-ksyd5l56	19	6	needed	need	VBN
cord-283340-ksyd5l56	19	7	.	.	.
cord-283340-ksyd5l56	20	1	TRIAL	trial	NN
cord-283340-ksyd5l56	20	2	REGISTRATION	registration	NN
cord-283340-ksyd5l56	20	3	:	:	:
cord-283340-ksyd5l56	20	4	PROSPERO	PROSPERO	NNP
cord-283340-ksyd5l56	20	5	Identifier	identifier	NN
cord-283340-ksyd5l56	20	6	:	:	:
cord-283340-ksyd5l56	21	1	CRD42020205979	CRD42020205979	NNP
cord-283340-ksyd5l56	22	1	The	the	DT
cord-283340-ksyd5l56	22	2	recent	recent	JJ
cord-283340-ksyd5l56	22	3	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	22	4	disease	disease	NN
cord-283340-ksyd5l56	22	5	2019	2019	CD
cord-283340-ksyd5l56	22	6	(	(	-LRB-
cord-283340-ksyd5l56	22	7	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	22	8	)	)	-RRB-
cord-283340-ksyd5l56	22	9	outbreak	outbreak	NN
cord-283340-ksyd5l56	22	10	has	have	VBZ
cord-283340-ksyd5l56	22	11	spread	spread	VBN
cord-283340-ksyd5l56	22	12	rapidly	rapidly	RB
cord-283340-ksyd5l56	22	13	and	and	CC
cord-283340-ksyd5l56	22	14	has	have	VBZ
cord-283340-ksyd5l56	22	15	affected	affect	VBN
cord-283340-ksyd5l56	22	16	the	the	DT
cord-283340-ksyd5l56	22	17	world	world	NN
cord-283340-ksyd5l56	22	18	for	for	IN
cord-283340-ksyd5l56	22	19	almost	almost	RB
cord-283340-ksyd5l56	22	20	a	a	DT
cord-283340-ksyd5l56	22	21	year	year	NN
cord-283340-ksyd5l56	22	22	,	,	,
cord-283340-ksyd5l56	22	23	causing	cause	VBG
cord-283340-ksyd5l56	22	24	immense	immense	JJ
cord-283340-ksyd5l56	22	25	economic	economic	JJ
cord-283340-ksyd5l56	22	26	and	and	CC
cord-283340-ksyd5l56	22	27	social	social	JJ
cord-283340-ksyd5l56	22	28	difficulties	difficulty	NNS
cord-283340-ksyd5l56	22	29	.	.	.
cord-283340-ksyd5l56	23	1	Despite	despite	IN
cord-283340-ksyd5l56	23	2	efforts	effort	NNS
cord-283340-ksyd5l56	23	3	to	to	TO
cord-283340-ksyd5l56	23	4	develop	develop	VB
cord-283340-ksyd5l56	23	5	vaccines	vaccine	NNS
cord-283340-ksyd5l56	23	6	and	and	CC
cord-283340-ksyd5l56	23	7	new	new	JJ
cord-283340-ksyd5l56	23	8	treatments	treatment	NNS
cord-283340-ksyd5l56	23	9	,	,	,
cord-283340-ksyd5l56	23	10	preventing	prevent	VBG
cord-283340-ksyd5l56	23	11	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	23	12	remains	remain	VBZ
cord-283340-ksyd5l56	23	13	challenging	challenging	JJ
cord-283340-ksyd5l56	23	14	and	and	CC
cord-283340-ksyd5l56	23	15	no	no	DT
cord-283340-ksyd5l56	23	16	clear	clear	JJ
cord-283340-ksyd5l56	23	17	treatment	treatment	NN
cord-283340-ksyd5l56	23	18	options	option	NNS
cord-283340-ksyd5l56	23	19	exist	exist	VBP
cord-283340-ksyd5l56	23	20	.	.	.
cord-283340-ksyd5l56	24	1	As	as	IN
cord-283340-ksyd5l56	24	2	of	of	IN
cord-283340-ksyd5l56	24	3	September	September	NNP
cord-283340-ksyd5l56	24	4	11	11	CD
cord-283340-ksyd5l56	24	5	,	,	,
cord-283340-ksyd5l56	24	6	2020	2020	CD
cord-283340-ksyd5l56	24	7	,	,	,
cord-283340-ksyd5l56	24	8	roughly	roughly	RB
cord-283340-ksyd5l56	24	9	28	28	CD
cord-283340-ksyd5l56	24	10	million	million	CD
cord-283340-ksyd5l56	24	11	people	people	NNS
cord-283340-ksyd5l56	24	12	worldwide	worldwide	RB
cord-283340-ksyd5l56	24	13	have	have	VBP
cord-283340-ksyd5l56	24	14	been	be	VBN
cord-283340-ksyd5l56	24	15	infected	infect	VBN
cord-283340-ksyd5l56	24	16	with	with	IN
cord-283340-ksyd5l56	24	17	severe	severe	JJ
cord-283340-ksyd5l56	24	18	acute	acute	JJ
cord-283340-ksyd5l56	24	19	respiratory	respiratory	JJ
cord-283340-ksyd5l56	24	20	syndrome	syndrome	NN
cord-283340-ksyd5l56	24	21	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	24	22	2	2	CD
cord-283340-ksyd5l56	25	1	(	(	-LRB-
cord-283340-ksyd5l56	25	2	SARS	SARS	NNP
cord-283340-ksyd5l56	25	3	-	-	HYPH
cord-283340-ksyd5l56	25	4	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	25	5	)	)	-RRB-
cord-283340-ksyd5l56	25	6	,	,	,
cord-283340-ksyd5l56	25	7	the	the	DT
cord-283340-ksyd5l56	25	8	virus	virus	NN
cord-283340-ksyd5l56	25	9	that	that	WDT
cord-283340-ksyd5l56	25	10	causes	cause	VBZ
cord-283340-ksyd5l56	25	11	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	25	12	,	,	,
cord-283340-ksyd5l56	25	13	and	and	CC
cord-283340-ksyd5l56	25	14	more	more	JJR
cord-283340-ksyd5l56	25	15	than	than	IN
cord-283340-ksyd5l56	25	16	900,000	900,000	CD
cord-283340-ksyd5l56	25	17	people	people	NNS
cord-283340-ksyd5l56	25	18	have	have	VBP
cord-283340-ksyd5l56	25	19	died	die	VBN
cord-283340-ksyd5l56	25	20	.	.	.
cord-283340-ksyd5l56	26	1	With	with	IN
cord-283340-ksyd5l56	26	2	some	some	DT
cord-283340-ksyd5l56	26	3	exceptions	exception	NNS
cord-283340-ksyd5l56	26	4	,	,	,
cord-283340-ksyd5l56	26	5	most	most	JJS
cord-283340-ksyd5l56	26	6	deaths	death	NNS
cord-283340-ksyd5l56	26	7	are	be	VBP
cord-283340-ksyd5l56	26	8	thought	think	VBN
cord-283340-ksyd5l56	26	9	to	to	TO
cord-283340-ksyd5l56	26	10	be	be	VB
cord-283340-ksyd5l56	26	11	related	relate	VBN
cord-283340-ksyd5l56	26	12	to	to	IN
cord-283340-ksyd5l56	26	13	underlying	underlying	JJ
cord-283340-ksyd5l56	26	14	comorbidities	comorbiditie	NNS
cord-283340-ksyd5l56	26	15	.	.	.
cord-283340-ksyd5l56	27	1	1	1	LS
cord-283340-ksyd5l56	28	1	Therefore	therefore	RB
cord-283340-ksyd5l56	28	2	,	,	,
cord-283340-ksyd5l56	28	3	identifying	identify	VBG
cord-283340-ksyd5l56	28	4	the	the	DT
cord-283340-ksyd5l56	28	5	risk	risk	NN
cord-283340-ksyd5l56	28	6	factors	factor	NNS
cord-283340-ksyd5l56	28	7	related	relate	VBN
cord-283340-ksyd5l56	28	8	to	to	IN
cord-283340-ksyd5l56	28	9	severe	severe	JJ
cord-283340-ksyd5l56	28	10	COVID-19	covid-19	NN
cord-283340-ksyd5l56	28	11	is	be	VBZ
cord-283340-ksyd5l56	28	12	important	important	JJ
cord-283340-ksyd5l56	28	13	to	to	TO
cord-283340-ksyd5l56	28	14	enable	enable	VB
cord-283340-ksyd5l56	28	15	stratification	stratification	NN
cord-283340-ksyd5l56	28	16	of	of	IN
cord-283340-ksyd5l56	28	17	risk	risk	NN
cord-283340-ksyd5l56	28	18	in	in	IN
cord-283340-ksyd5l56	28	19	advance	advance	NN
cord-283340-ksyd5l56	28	20	,	,	,
cord-283340-ksyd5l56	28	21	to	to	TO
cord-283340-ksyd5l56	28	22	optimize	optimize	VB
cord-283340-ksyd5l56	28	23	the	the	DT
cord-283340-ksyd5l56	28	24	reallocation	reallocation	NN
cord-283340-ksyd5l56	28	25	of	of	IN
cord-283340-ksyd5l56	28	26	medical	medical	JJ
cord-283340-ksyd5l56	28	27	resources	resource	NNS
cord-283340-ksyd5l56	28	28	,	,	,
cord-283340-ksyd5l56	28	29	and	and	CC
cord-283340-ksyd5l56	28	30	to	to	TO
cord-283340-ksyd5l56	28	31	improve	improve	VB
cord-283340-ksyd5l56	28	32	patients	patient	NNS
cord-283340-ksyd5l56	28	33	'	'	POS
cord-283340-ksyd5l56	28	34	overall	overall	JJ
cord-283340-ksyd5l56	28	35	prognoses	prognosis	NNS
cord-283340-ksyd5l56	28	36	.	.	.
cord-283340-ksyd5l56	29	1	As	as	IN
cord-283340-ksyd5l56	29	2	SARS	SARS	NNP
cord-283340-ksyd5l56	29	3	-	-	:
cord-283340-ksyd5l56	29	4	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	29	5	primarily	primarily	RB
cord-283340-ksyd5l56	29	6	attacks	attack	VBZ
cord-283340-ksyd5l56	29	7	the	the	DT
cord-283340-ksyd5l56	29	8	respiratory	respiratory	JJ
cord-283340-ksyd5l56	29	9	tract	tract	NN
cord-283340-ksyd5l56	29	10	,	,	,
cord-283340-ksyd5l56	29	11	several	several	JJ
cord-283340-ksyd5l56	29	12	studies	study	NNS
cord-283340-ksyd5l56	29	13	have	have	VBP
cord-283340-ksyd5l56	29	14	investigated	investigate	VBN
cord-283340-ksyd5l56	29	15	the	the	DT
cord-283340-ksyd5l56	29	16	relationship	relationship	NN
cord-283340-ksyd5l56	29	17	between	between	IN
cord-283340-ksyd5l56	29	18	chronic	chronic	JJ
cord-283340-ksyd5l56	29	19	obstructive	obstructive	JJ
cord-283340-ksyd5l56	29	20	pulmonary	pulmonary	JJ
cord-283340-ksyd5l56	29	21	disease	disease	NN
cord-283340-ksyd5l56	29	22	,	,	,
cord-283340-ksyd5l56	29	23	2	2	CD
cord-283340-ksyd5l56	29	24	asthma	asthma	NN
cord-283340-ksyd5l56	29	25	,	,	,
cord-283340-ksyd5l56	29	26	3	3	CD
cord-283340-ksyd5l56	29	27	or	or	CC
cord-283340-ksyd5l56	29	28	smoking	smoking	NN
cord-283340-ksyd5l56	29	29	,	,	,
cord-283340-ksyd5l56	29	30	4	4	CD
cord-283340-ksyd5l56	29	31	and	and	CC
cord-283340-ksyd5l56	29	32	the	the	DT
cord-283340-ksyd5l56	29	33	severity	severity	NN
cord-283340-ksyd5l56	29	34	of	of	IN
cord-283340-ksyd5l56	29	35	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	29	36	.	.	.
cord-283340-ksyd5l56	30	1	However	however	RB
cord-283340-ksyd5l56	30	2	,	,	,
cord-283340-ksyd5l56	30	3	it	-PRON-	PRP
cord-283340-ksyd5l56	30	4	has	have	VBZ
cord-283340-ksyd5l56	30	5	also	also	RB
cord-283340-ksyd5l56	30	6	been	be	VBN
cord-283340-ksyd5l56	30	7	found	find	VBN
cord-283340-ksyd5l56	30	8	that	that	IN
cord-283340-ksyd5l56	30	9	patients	patient	NNS
cord-283340-ksyd5l56	30	10	with	with	IN
cord-283340-ksyd5l56	30	11	underlying	underlie	VBG
cord-283340-ksyd5l56	30	12	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	30	13	disease	disease	NN
cord-283340-ksyd5l56	30	14	or	or	CC
cord-283340-ksyd5l56	30	15	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	30	16	disease	disease	NN
cord-283340-ksyd5l56	30	17	risk	risk	NN
cord-283340-ksyd5l56	30	18	factors	factor	NNS
cord-283340-ksyd5l56	30	19	have	have	VBP
cord-283340-ksyd5l56	30	20	a	a	DT
cord-283340-ksyd5l56	30	21	high	high	JJ
cord-283340-ksyd5l56	30	22	risk	risk	NN
cord-283340-ksyd5l56	30	23	of	of	IN
cord-283340-ksyd5l56	30	24	a	a	DT
cord-283340-ksyd5l56	30	25	severe	severe	JJ
cord-283340-ksyd5l56	30	26	course	course	NN
cord-283340-ksyd5l56	30	27	of	of	IN
cord-283340-ksyd5l56	30	28	illness	illness	NN
cord-283340-ksyd5l56	30	29	or	or	CC
cord-283340-ksyd5l56	30	30	mortality	mortality	NN
cord-283340-ksyd5l56	30	31	due	due	IN
cord-283340-ksyd5l56	30	32	to	to	IN
cord-283340-ksyd5l56	30	33	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	30	34	.	.	.
cord-283340-ksyd5l56	31	1	5	5	LS
cord-283340-ksyd5l56	31	2	-	-	SYM
cord-283340-ksyd5l56	31	3	7	7	CD
cord-283340-ksyd5l56	31	4	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	31	5	can	can	MD
cord-283340-ksyd5l56	31	6	also	also	RB
cord-283340-ksyd5l56	31	7	have	have	VB
cord-283340-ksyd5l56	31	8	various	various	JJ
cord-283340-ksyd5l56	31	9	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	31	10	manifestations	manifestation	NNS
cord-283340-ksyd5l56	31	11	such	such	JJ
cord-283340-ksyd5l56	31	12	as	as	IN
cord-283340-ksyd5l56	31	13	myocardial	myocardial	JJ
cord-283340-ksyd5l56	31	14	injury	injury	NN
cord-283340-ksyd5l56	31	15	,	,	,
cord-283340-ksyd5l56	31	16	arrhythmias	arrhythmias	RB
cord-283340-ksyd5l56	31	17	,	,	,
cord-283340-ksyd5l56	31	18	acute	acute	JJ
cord-283340-ksyd5l56	31	19	coronary	coronary	JJ
cord-283340-ksyd5l56	31	20	syndrome	syndrome	NN
cord-283340-ksyd5l56	31	21	,	,	,
cord-283340-ksyd5l56	31	22	and	and	CC
cord-283340-ksyd5l56	31	23	venous	venous	JJ
cord-283340-ksyd5l56	31	24	thromboembolism	thromboembolism	NN
cord-283340-ksyd5l56	31	25	.	.	.
cord-283340-ksyd5l56	32	1	8	8	CD
cord-283340-ksyd5l56	33	1	Several	several	JJ
cord-283340-ksyd5l56	33	2	observational	observational	JJ
cord-283340-ksyd5l56	33	3	studies	study	NNS
cord-283340-ksyd5l56	33	4	and	and	CC
cord-283340-ksyd5l56	33	5	meta	meta	NNP
cord-283340-ksyd5l56	33	6	-	-	HYPH
cord-283340-ksyd5l56	33	7	analyses	analysis	NNS
cord-283340-ksyd5l56	33	8	have	have	VBP
cord-283340-ksyd5l56	33	9	shown	show	VBN
cord-283340-ksyd5l56	33	10	that	that	IN
cord-283340-ksyd5l56	33	11	underlying	underlying	JJ
cord-283340-ksyd5l56	33	12	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	33	13	disease	disease	NN
cord-283340-ksyd5l56	33	14	,	,	,
cord-283340-ksyd5l56	33	15	diabetes	diabetes	NN
cord-283340-ksyd5l56	33	16	mellitus	mellitus	NN
cord-283340-ksyd5l56	33	17	,	,	,
cord-283340-ksyd5l56	33	18	and	and	CC
cord-283340-ksyd5l56	33	19	hypertension	hypertension	NN
cord-283340-ksyd5l56	33	20	clearly	clearly	RB
cord-283340-ksyd5l56	33	21	increase	increase	VBP
cord-283340-ksyd5l56	33	22	the	the	DT
cord-283340-ksyd5l56	33	23	severity	severity	NN
cord-283340-ksyd5l56	33	24	and	and	CC
cord-283340-ksyd5l56	33	25	mortality	mortality	NN
cord-283340-ksyd5l56	33	26	of	of	IN
cord-283340-ksyd5l56	33	27	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	33	28	.	.	.
cord-283340-ksyd5l56	34	1	[	[	-LRB-
cord-283340-ksyd5l56	34	2	9	9	CD
cord-283340-ksyd5l56	34	3	]	]	-RRB-
cord-283340-ksyd5l56	34	4	[	[	-LRB-
cord-283340-ksyd5l56	34	5	10	10	CD
cord-283340-ksyd5l56	34	6	]	]	-RRB-
cord-283340-ksyd5l56	35	1	[	[	-LRB-
cord-283340-ksyd5l56	35	2	11	11	CD
cord-283340-ksyd5l56	35	3	]	]	-RRB-
cord-283340-ksyd5l56	36	1	However	however	RB
cord-283340-ksyd5l56	36	2	,	,	,
cord-283340-ksyd5l56	36	3	unlike	unlike	IN
cord-283340-ksyd5l56	36	4	diabetes	diabetes	NN
cord-283340-ksyd5l56	36	5	and	and	CC
cord-283340-ksyd5l56	36	6	hypertension	hypertension	NN
cord-283340-ksyd5l56	36	7	,	,	,
cord-283340-ksyd5l56	36	8	relatively	relatively	RB
cord-283340-ksyd5l56	36	9	few	few	JJ
cord-283340-ksyd5l56	36	10	studies	study	NNS
cord-283340-ksyd5l56	36	11	have	have	VBP
cord-283340-ksyd5l56	36	12	been	be	VBN
cord-283340-ksyd5l56	36	13	conducted	conduct	VBN
cord-283340-ksyd5l56	36	14	on	on	IN
cord-283340-ksyd5l56	36	15	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	36	16	,	,	,
cord-283340-ksyd5l56	36	17	one	one	CD
cord-283340-ksyd5l56	36	18	of	of	IN
cord-283340-ksyd5l56	36	19	the	the	DT
cord-283340-ksyd5l56	36	20	most	most	RBS
cord-283340-ksyd5l56	36	21	important	important	JJ
cord-283340-ksyd5l56	36	22	risk	risk	NN
cord-283340-ksyd5l56	36	23	factors	factor	NNS
cord-283340-ksyd5l56	36	24	of	of	IN
cord-283340-ksyd5l56	36	25	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	36	26	disease	disease	NN
cord-283340-ksyd5l56	36	27	.	.	.
cord-283340-ksyd5l56	37	1	Several	several	JJ
cord-283340-ksyd5l56	37	2	observational	observational	JJ
cord-283340-ksyd5l56	37	3	studies	study	NNS
cord-283340-ksyd5l56	37	4	have	have	VBP
cord-283340-ksyd5l56	37	5	reported	report	VBN
cord-283340-ksyd5l56	37	6	an	an	DT
cord-283340-ksyd5l56	37	7	association	association	NN
cord-283340-ksyd5l56	37	8	between	between	IN
cord-283340-ksyd5l56	37	9	high	high	JJ
cord-283340-ksyd5l56	37	10	-	-	HYPH
cord-283340-ksyd5l56	37	11	density	density	NN
cord-283340-ksyd5l56	37	12	lipoprotein	lipoprotein	NN
cord-283340-ksyd5l56	37	13	(	(	-LRB-
cord-283340-ksyd5l56	37	14	HDL	HDL	NNP
cord-283340-ksyd5l56	37	15	)	)	-RRB-
cord-283340-ksyd5l56	37	16	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	37	17	levels	level	NNS
cord-283340-ksyd5l56	37	18	and	and	CC
cord-283340-ksyd5l56	37	19	the	the	DT
cord-283340-ksyd5l56	37	20	severity	severity	NN
cord-283340-ksyd5l56	37	21	of	of	IN
cord-283340-ksyd5l56	37	22	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	37	23	12	12	CD
cord-283340-ksyd5l56	37	24	,	,	,
cord-283340-ksyd5l56	37	25	13	13	CD
cord-283340-ksyd5l56	37	26	;	;	:
cord-283340-ksyd5l56	37	27	however	however	RB
cord-283340-ksyd5l56	37	28	,	,	,
cord-283340-ksyd5l56	37	29	the	the	DT
cord-283340-ksyd5l56	37	30	results	result	NNS
cord-283340-ksyd5l56	37	31	are	be	VBP
cord-283340-ksyd5l56	37	32	inconsistent	inconsistent	JJ
cord-283340-ksyd5l56	37	33	.	.	.
cord-283340-ksyd5l56	38	1	To	to	IN
cord-283340-ksyd5l56	38	2	date	date	NN
cord-283340-ksyd5l56	38	3	,	,	,
cord-283340-ksyd5l56	38	4	multiple	multiple	JJ
cord-283340-ksyd5l56	38	5	systematic	systematic	JJ
cord-283340-ksyd5l56	38	6	reviews	review	NNS
cord-283340-ksyd5l56	38	7	and	and	CC
cord-283340-ksyd5l56	38	8	meta	meta	NNP
cord-283340-ksyd5l56	38	9	-	-	HYPH
cord-283340-ksyd5l56	38	10	analyses	analysis	NNS
cord-283340-ksyd5l56	38	11	have	have	VBP
cord-283340-ksyd5l56	38	12	been	be	VBN
cord-283340-ksyd5l56	38	13	published	publish	VBN
cord-283340-ksyd5l56	38	14	analyzing	analyze	VBG
cord-283340-ksyd5l56	38	15	the	the	DT
cord-283340-ksyd5l56	38	16	potential	potential	JJ
cord-283340-ksyd5l56	38	17	link	link	NN
cord-283340-ksyd5l56	38	18	between	between	IN
cord-283340-ksyd5l56	38	19	presence	presence	NN
cord-283340-ksyd5l56	38	20	of	of	IN
cord-283340-ksyd5l56	38	21	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	38	22	and	and	CC
cord-283340-ksyd5l56	38	23	the	the	DT
cord-283340-ksyd5l56	38	24	severity	severity	NN
cord-283340-ksyd5l56	38	25	of	of	IN
cord-283340-ksyd5l56	38	26	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	38	27	.	.	.
cord-283340-ksyd5l56	39	1	However	however	RB
cord-283340-ksyd5l56	39	2	,	,	,
cord-283340-ksyd5l56	39	3	to	to	IN
cord-283340-ksyd5l56	39	4	our	-PRON-	PRP$
cord-283340-ksyd5l56	39	5	knowledge	knowledge	NN
cord-283340-ksyd5l56	39	6	,	,	,
cord-283340-ksyd5l56	39	7	no	no	DT
cord-283340-ksyd5l56	39	8	attempt	attempt	NN
cord-283340-ksyd5l56	39	9	has	have	VBZ
cord-283340-ksyd5l56	39	10	been	be	VBN
cord-283340-ksyd5l56	39	11	made	make	VBN
cord-283340-ksyd5l56	39	12	to	to	TO
cord-283340-ksyd5l56	39	13	summarize	summarize	VB
cord-283340-ksyd5l56	39	14	the	the	DT
cord-283340-ksyd5l56	39	15	evidence	evidence	NN
cord-283340-ksyd5l56	39	16	from	from	IN
cord-283340-ksyd5l56	39	17	these	these	DT
cord-283340-ksyd5l56	39	18	systematic	systematic	JJ
cord-283340-ksyd5l56	39	19	reviews	review	NNS
cord-283340-ksyd5l56	39	20	.	.	.
cord-283340-ksyd5l56	40	1	Therefore	therefore	RB
cord-283340-ksyd5l56	40	2	,	,	,
cord-283340-ksyd5l56	40	3	systematically	systematically	RB
cord-283340-ksyd5l56	40	4	and	and	CC
cord-283340-ksyd5l56	40	5	comprehensively	comprehensively	RB
cord-283340-ksyd5l56	40	6	re	re	VB
cord-283340-ksyd5l56	40	7	-	-	VBN
cord-283340-ksyd5l56	40	8	evaluated	evaluate	VBD
cord-283340-ksyd5l56	40	9	the	the	DT
cord-283340-ksyd5l56	40	10	evidence	evidence	NN
cord-283340-ksyd5l56	40	11	to	to	TO
cord-283340-ksyd5l56	40	12	provide	provide	VB
cord-283340-ksyd5l56	40	13	an	an	DT
cord-283340-ksyd5l56	40	14	overview	overview	NN
cord-283340-ksyd5l56	40	15	of	of	IN
cord-283340-ksyd5l56	40	16	the	the	DT
cord-283340-ksyd5l56	40	17	association	association	NN
cord-283340-ksyd5l56	40	18	between	between	IN
cord-283340-ksyd5l56	40	19	dyslipidemia	dyslipidemia	NNP
cord-283340-ksyd5l56	40	20	and	and	CC
cord-283340-ksyd5l56	40	21	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	40	22	severity	severity	NN
cord-283340-ksyd5l56	40	23	.	.	.
cord-283340-ksyd5l56	41	1	Specifically	specifically	RB
cord-283340-ksyd5l56	41	2	,	,	,
cord-283340-ksyd5l56	41	3	we	-PRON-	PRP
cord-283340-ksyd5l56	41	4	conducted	conduct	VBD
cord-283340-ksyd5l56	41	5	an	an	DT
cord-283340-ksyd5l56	41	6	umbrella	umbrella	NN
cord-283340-ksyd5l56	41	7	review	review	NN
cord-283340-ksyd5l56	41	8	to	to	TO
cord-283340-ksyd5l56	41	9	evaluate	evaluate	VB
cord-283340-ksyd5l56	41	10	the	the	DT
cord-283340-ksyd5l56	41	11	findings	finding	NNS
cord-283340-ksyd5l56	41	12	of	of	IN
cord-283340-ksyd5l56	41	13	systematic	systematic	JJ
cord-283340-ksyd5l56	41	14	reviews	review	NNS
cord-283340-ksyd5l56	42	1	and/or	and/or	CC
cord-283340-ksyd5l56	42	2	metaanalyses	metaanalyse	NNS
cord-283340-ksyd5l56	42	3	that	that	WDT
cord-283340-ksyd5l56	42	4	investigated	investigate	VBD
cord-283340-ksyd5l56	42	5	the	the	DT
cord-283340-ksyd5l56	42	6	relationship	relationship	NN
cord-283340-ksyd5l56	42	7	of	of	IN
cord-283340-ksyd5l56	42	8	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	42	9	and	and	CC
cord-283340-ksyd5l56	42	10	severity	severity	NN
cord-283340-ksyd5l56	42	11	of	of	IN
cord-283340-ksyd5l56	42	12	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	42	13	infection	infection	NN
cord-283340-ksyd5l56	42	14	and	and	CC
cord-283340-ksyd5l56	42	15	to	to	TO
cord-283340-ksyd5l56	42	16	assess	assess	VB
cord-283340-ksyd5l56	42	17	the	the	DT
cord-283340-ksyd5l56	42	18	evidence	evidence	NN
cord-283340-ksyd5l56	42	19	regarding	regard	VBG
cord-283340-ksyd5l56	42	20	potential	potential	JJ
cord-283340-ksyd5l56	42	21	limitations	limitation	NNS
cord-283340-ksyd5l56	42	22	and	and	CC
cord-283340-ksyd5l56	42	23	the	the	DT
cord-283340-ksyd5l56	42	24	consistency	consistency	NN
cord-283340-ksyd5l56	42	25	of	of	IN
cord-283340-ksyd5l56	42	26	findings	finding	NNS
cord-283340-ksyd5l56	42	27	.	.	.
cord-283340-ksyd5l56	43	1	An	an	DT
cord-283340-ksyd5l56	43	2	umbrella	umbrella	NN
cord-283340-ksyd5l56	43	3	review	review	NN
cord-283340-ksyd5l56	43	4	was	be	VBD
cord-283340-ksyd5l56	43	5	performed	perform	VBN
cord-283340-ksyd5l56	43	6	in	in	IN
cord-283340-ksyd5l56	43	7	this	this	DT
cord-283340-ksyd5l56	43	8	study	study	NN
cord-283340-ksyd5l56	43	9	.	.	.
cord-283340-ksyd5l56	44	1	An	an	DT
cord-283340-ksyd5l56	44	2	umbrella	umbrella	NN
cord-283340-ksyd5l56	44	3	review	review	NN
cord-283340-ksyd5l56	44	4	provides	provide	VBZ
cord-283340-ksyd5l56	44	5	a	a	DT
cord-283340-ksyd5l56	44	6	summary	summary	NN
cord-283340-ksyd5l56	44	7	of	of	IN
cord-283340-ksyd5l56	44	8	existing	exist	VBG
cord-283340-ksyd5l56	44	9	published	publish	VBN
cord-283340-ksyd5l56	44	10	meta	meta	NNP
cord-283340-ksyd5l56	44	11	-	-	HYPH
cord-283340-ksyd5l56	44	12	analyses	analysis	NNS
cord-283340-ksyd5l56	44	13	and	and	CC
cord-283340-ksyd5l56	44	14	systematic	systematic	JJ
cord-283340-ksyd5l56	44	15	reviews	review	NNS
cord-283340-ksyd5l56	44	16	and	and	CC
cord-283340-ksyd5l56	44	17	determines	determine	VBZ
cord-283340-ksyd5l56	44	18	whether	whether	IN
cord-283340-ksyd5l56	44	19	authors	author	NNS
cord-283340-ksyd5l56	44	20	addressing	address	VBG
cord-283340-ksyd5l56	44	21	similar	similar	JJ
cord-283340-ksyd5l56	44	22	review	review	NN
cord-283340-ksyd5l56	44	23	questions	question	NNS
cord-283340-ksyd5l56	44	24	have	have	VBP
cord-283340-ksyd5l56	44	25	independently	independently	RB
cord-283340-ksyd5l56	44	26	reported	report	VBN
cord-283340-ksyd5l56	44	27	similar	similar	JJ
cord-283340-ksyd5l56	44	28	results	result	NNS
cord-283340-ksyd5l56	44	29	and	and	CC
cord-283340-ksyd5l56	44	30	arrived	arrive	VBD
cord-283340-ksyd5l56	44	31	at	at	IN
cord-283340-ksyd5l56	44	32	similar	similar	JJ
cord-283340-ksyd5l56	44	33	conclusions	conclusion	NNS
cord-283340-ksyd5l56	44	34	.	.	.
cord-283340-ksyd5l56	45	1	14	14	CD
cord-283340-ksyd5l56	46	1	We	-PRON-	PRP
cord-283340-ksyd5l56	46	2	applied	apply	VBD
cord-283340-ksyd5l56	46	3	the	the	DT
cord-283340-ksyd5l56	46	4	Cochrane	Cochrane	NNP
cord-283340-ksyd5l56	46	5	Collaboration	Collaboration	NNP
cord-283340-ksyd5l56	46	6	methodology	methodology	NN
cord-283340-ksyd5l56	46	7	15	15	CD
cord-283340-ksyd5l56	46	8	and	and	CC
cord-283340-ksyd5l56	46	9	available	available	JJ
cord-283340-ksyd5l56	46	10	methodological	methodological	JJ
cord-283340-ksyd5l56	46	11	guidelines	guideline	NNS
cord-283340-ksyd5l56	46	12	for	for	IN
cord-283340-ksyd5l56	46	13	overviews	overview	NNS
cord-283340-ksyd5l56	46	14	of	of	IN
cord-283340-ksyd5l56	46	15	reviews	review	NNS
cord-283340-ksyd5l56	46	16	.	.	.
cord-283340-ksyd5l56	47	1	16	16	CD
cord-283340-ksyd5l56	47	2	,	,	,
cord-283340-ksyd5l56	47	3	17	17	CD
cord-283340-ksyd5l56	48	1	The	the	DT
cord-283340-ksyd5l56	48	2	study	study	NN
cord-283340-ksyd5l56	48	3	protocol	protocol	NN
cord-283340-ksyd5l56	48	4	was	be	VBD
cord-283340-ksyd5l56	48	5	prospectively	prospectively	RB
cord-283340-ksyd5l56	48	6	registered	register	VBN
cord-283340-ksyd5l56	48	7	in	in	IN
cord-283340-ksyd5l56	48	8	the	the	DT
cord-283340-ksyd5l56	48	9	International	International	NNP
cord-283340-ksyd5l56	48	10	Prospective	Prospective	NNP
cord-283340-ksyd5l56	48	11	Register	Register	NNP
cord-283340-ksyd5l56	48	12	of	of	IN
cord-283340-ksyd5l56	48	13	Systematic	Systematic	NNP
cord-283340-ksyd5l56	48	14	Reviews	review	NNS
cord-283340-ksyd5l56	49	1	(	(	-LRB-
cord-283340-ksyd5l56	49	2	PROSPERO	PROSPERO	NNP
cord-283340-ksyd5l56	49	3	Identifier	identifier	NN
cord-283340-ksyd5l56	49	4	:	:	:
cord-283340-ksyd5l56	49	5	CRD42020205979	CRD42020205979	NNP
cord-283340-ksyd5l56	49	6	)	)	-RRB-
cord-283340-ksyd5l56	49	7	.	.	.
cord-283340-ksyd5l56	50	1	The	the	DT
cord-283340-ksyd5l56	50	2	literature	literature	NN
cord-283340-ksyd5l56	50	3	search	search	NN
cord-283340-ksyd5l56	50	4	aimed	aim	VBN
cord-283340-ksyd5l56	50	5	to	to	TO
cord-283340-ksyd5l56	50	6	identify	identify	VB
cord-283340-ksyd5l56	50	7	systematic	systematic	JJ
cord-283340-ksyd5l56	50	8	reviews	review	NNS
cord-283340-ksyd5l56	50	9	that	that	WDT
cord-283340-ksyd5l56	50	10	evaluated	evaluate	VBD
cord-283340-ksyd5l56	50	11	the	the	DT
cord-283340-ksyd5l56	50	12	association	association	NN
cord-283340-ksyd5l56	50	13	between	between	IN
cord-283340-ksyd5l56	50	14	dyslipidemia	dyslipidemia	NNP
cord-283340-ksyd5l56	50	15	and	and	CC
cord-283340-ksyd5l56	50	16	COVID-19	covid-19	NN
cord-283340-ksyd5l56	50	17	.	.	.
cord-283340-ksyd5l56	51	1	To	to	TO
cord-283340-ksyd5l56	51	2	identify	identify	VB
cord-283340-ksyd5l56	51	3	relevant	relevant	JJ
cord-283340-ksyd5l56	51	4	systematic	systematic	JJ
cord-283340-ksyd5l56	51	5	reviews	review	NNS
cord-283340-ksyd5l56	51	6	and	and	CC
cord-283340-ksyd5l56	51	7	metaanalyses	metaanalyse	NNS
cord-283340-ksyd5l56	51	8	,	,	,
cord-283340-ksyd5l56	51	9	an	an	DT
cord-283340-ksyd5l56	51	10	electronic	electronic	JJ
cord-283340-ksyd5l56	51	11	search	search	NN
cord-283340-ksyd5l56	51	12	was	be	VBD
cord-283340-ksyd5l56	51	13	conducted	conduct	VBN
cord-283340-ksyd5l56	51	14	of	of	IN
cord-283340-ksyd5l56	51	15	4	4	CD
cord-283340-ksyd5l56	51	16	databases	database	NNS
cord-283340-ksyd5l56	51	17	(	(	-LRB-
cord-283340-ksyd5l56	51	18	MEDLINE	MEDLINE	NNP
cord-283340-ksyd5l56	51	19	,	,	,
cord-283340-ksyd5l56	51	20	Embase	Embase	NNP
cord-283340-ksyd5l56	51	21	,	,	,
cord-283340-ksyd5l56	51	22	Scopus	Scopus	NNP
cord-283340-ksyd5l56	51	23	,	,	,
cord-283340-ksyd5l56	51	24	and	and	CC
cord-283340-ksyd5l56	51	25	the	the	DT
cord-283340-ksyd5l56	51	26	Cochrane	Cochrane	NNP
cord-283340-ksyd5l56	51	27	Library	Library	NNP
cord-283340-ksyd5l56	51	28	)	)	-RRB-
cord-283340-ksyd5l56	51	29	from	from	IN
cord-283340-ksyd5l56	51	30	inception	inception	NN
cord-283340-ksyd5l56	51	31	until	until	IN
cord-283340-ksyd5l56	51	32	August	August	NNP
cord-283340-ksyd5l56	51	33	2020	2020	CD
cord-283340-ksyd5l56	51	34	.	.	.
cord-283340-ksyd5l56	52	1	These	these	DT
cord-283340-ksyd5l56	52	2	databases	database	NNS
cord-283340-ksyd5l56	52	3	are	be	VBP
cord-283340-ksyd5l56	52	4	frequently	frequently	RB
cord-283340-ksyd5l56	52	5	updated	update	VBN
cord-283340-ksyd5l56	52	6	when	when	WRB
cord-283340-ksyd5l56	52	7	new	new	JJ
cord-283340-ksyd5l56	52	8	research	research	NN
cord-283340-ksyd5l56	52	9	is	be	VBZ
cord-283340-ksyd5l56	52	10	disseminated	disseminate	VBN
cord-283340-ksyd5l56	52	11	in	in	IN
cord-283340-ksyd5l56	52	12	peer	peer	NN
cord-283340-ksyd5l56	52	13	-	-	HYPH
cord-283340-ksyd5l56	52	14	reviewed	review	VBN
cord-283340-ksyd5l56	52	15	publications	publication	NNS
cord-283340-ksyd5l56	52	16	and	and	CC
cord-283340-ksyd5l56	52	17	archive	archive	NN
cord-283340-ksyd5l56	52	18	services	service	NNS
cord-283340-ksyd5l56	52	19	become	become	VBP
cord-283340-ksyd5l56	52	20	available	available	JJ
cord-283340-ksyd5l56	52	21	.	.	.
cord-283340-ksyd5l56	53	1	The	the	DT
cord-283340-ksyd5l56	53	2	search	search	NN
cord-283340-ksyd5l56	53	3	strategies	strategy	NNS
cord-283340-ksyd5l56	53	4	were	be	VBD
cord-283340-ksyd5l56	53	5	developed	develop	VBN
cord-283340-ksyd5l56	53	6	by	by	IN
cord-283340-ksyd5l56	53	7	H.K.	H.K.	NNP
cord-283340-ksyd5l56	53	8	,	,	,
cord-283340-ksyd5l56	53	9	who	who	WP
cord-283340-ksyd5l56	53	10	has	have	VBZ
cord-283340-ksyd5l56	53	11	expertise	expertise	NN
cord-283340-ksyd5l56	53	12	in	in	IN
cord-283340-ksyd5l56	53	13	systematic	systematic	JJ
cord-283340-ksyd5l56	53	14	reviews	review	NNS
cord-283340-ksyd5l56	53	15	.	.	.
cord-283340-ksyd5l56	54	1	The	the	DT
cord-283340-ksyd5l56	54	2	search	search	NN
cord-283340-ksyd5l56	54	3	was	be	VBD
cord-283340-ksyd5l56	54	4	conducted	conduct	VBN
cord-283340-ksyd5l56	54	5	using	use	VBG
cord-283340-ksyd5l56	54	6	index	index	NN
cord-283340-ksyd5l56	54	7	terms	term	NNS
cord-283340-ksyd5l56	54	8	(	(	-LRB-
cord-283340-ksyd5l56	54	9	e.g.	e.g.	RB
cord-283340-ksyd5l56	54	10	,	,	,
cord-283340-ksyd5l56	54	11	MeSH	MeSH	NNP
cord-283340-ksyd5l56	54	12	and	and	CC
cord-283340-ksyd5l56	54	13	Emtree	Emtree	NNP
cord-283340-ksyd5l56	54	14	terms	term	NNS
cord-283340-ksyd5l56	54	15	)	)	-RRB-
cord-283340-ksyd5l56	54	16	and	and	CC
cord-283340-ksyd5l56	54	17	free	free	JJ
cord-283340-ksyd5l56	54	18	text	text	NN
cord-283340-ksyd5l56	54	19	words	word	NNS
cord-283340-ksyd5l56	54	20	and	and	CC
cord-283340-ksyd5l56	54	21	word	word	NN
cord-283340-ksyd5l56	54	22	variants	variant	NNS
cord-283340-ksyd5l56	54	23	.	.	.
cord-283340-ksyd5l56	55	1	The	the	DT
cord-283340-ksyd5l56	55	2	titles	title	NNS
cord-283340-ksyd5l56	55	3	and	and	CC
cord-283340-ksyd5l56	55	4	abstracts	abstract	NNS
cord-283340-ksyd5l56	55	5	from	from	IN
cord-283340-ksyd5l56	55	6	the	the	DT
cord-283340-ksyd5l56	55	7	literature	literature	NN
cord-283340-ksyd5l56	55	8	search	search	NN
cord-283340-ksyd5l56	55	9	were	be	VBD
cord-283340-ksyd5l56	55	10	screened	screen	VBN
cord-283340-ksyd5l56	55	11	by	by	IN
cord-283340-ksyd5l56	55	12	2	2	CD
cord-283340-ksyd5l56	55	13	independent	independent	JJ
cord-283340-ksyd5l56	55	14	reviewers	reviewer	NNS
cord-283340-ksyd5l56	55	15	(	(	-LRB-
cord-283340-ksyd5l56	55	16	G.J.C.	G.J.C.	NNP
cord-283340-ksyd5l56	55	17	and	and	CC
cord-283340-ksyd5l56	55	18	H.M.K.	H.M.K.	NNP
cord-283340-ksyd5l56	55	19	)	)	-RRB-
cord-283340-ksyd5l56	55	20	to	to	TO
cord-283340-ksyd5l56	55	21	identify	identify	VB
cord-283340-ksyd5l56	55	22	whether	whether	IN
cord-283340-ksyd5l56	55	23	they	-PRON-	PRP
cord-283340-ksyd5l56	55	24	contained	contain	VBD
cord-283340-ksyd5l56	55	25	relevant	relevant	JJ
cord-283340-ksyd5l56	55	26	content	content	NN
cord-283340-ksyd5l56	55	27	,	,	,
cord-283340-ksyd5l56	55	28	and	and	CC
cord-283340-ksyd5l56	55	29	duplicate	duplicate	JJ
cord-283340-ksyd5l56	55	30	studies	study	NNS
cord-283340-ksyd5l56	55	31	were	be	VBD
cord-283340-ksyd5l56	55	32	excluded	exclude	VBN
cord-283340-ksyd5l56	55	33	.	.	.
cord-283340-ksyd5l56	56	1	Additionally	additionally	RB
cord-283340-ksyd5l56	56	2	,	,	,
cord-283340-ksyd5l56	56	3	the	the	DT
cord-283340-ksyd5l56	56	4	same	same	JJ
cord-283340-ksyd5l56	56	5	reviewers	reviewer	NNS
cord-283340-ksyd5l56	56	6	conducted	conduct	VBD
cord-283340-ksyd5l56	56	7	citation	citation	NN
cord-283340-ksyd5l56	56	8	tracking	tracking	NN
cord-283340-ksyd5l56	56	9	or	or	CC
cord-283340-ksyd5l56	56	10	manual	manual	JJ
cord-283340-ksyd5l56	56	11	searches	search	NNS
cord-283340-ksyd5l56	56	12	of	of	IN
cord-283340-ksyd5l56	56	13	all	all	DT
cord-283340-ksyd5l56	56	14	references	reference	NNS
cord-283340-ksyd5l56	56	15	of	of	IN
cord-283340-ksyd5l56	56	16	all	all	DT
cord-283340-ksyd5l56	56	17	included	include	VBN
cord-283340-ksyd5l56	56	18	studies	study	NNS
cord-283340-ksyd5l56	56	19	and	and	CC
cord-283340-ksyd5l56	56	20	all	all	DT
cord-283340-ksyd5l56	56	21	included	include	VBD
cord-283340-ksyd5l56	56	22	systematic	systematic	JJ
cord-283340-ksyd5l56	56	23	reviews	review	NNS
cord-283340-ksyd5l56	56	24	.	.	.
cord-283340-ksyd5l56	57	1	Only	only	RB
cord-283340-ksyd5l56	57	2	English	english	JJ
cord-283340-ksyd5l56	57	3	-	-	HYPH
cord-283340-ksyd5l56	57	4	language	language	NN
cord-283340-ksyd5l56	57	5	publications	publication	NNS
cord-283340-ksyd5l56	57	6	that	that	WDT
cord-283340-ksyd5l56	57	7	presented	present	VBD
cord-283340-ksyd5l56	57	8	a	a	DT
cord-283340-ksyd5l56	57	9	quantitative	quantitative	JJ
cord-283340-ksyd5l56	57	10	or	or	CC
cord-283340-ksyd5l56	57	11	qualitative	qualitative	JJ
cord-283340-ksyd5l56	57	12	review	review	NN
cord-283340-ksyd5l56	57	13	regarding	regard	VBG
cord-283340-ksyd5l56	57	14	the	the	DT
cord-283340-ksyd5l56	57	15	relationship	relationship	NN
cord-283340-ksyd5l56	57	16	between	between	IN
cord-283340-ksyd5l56	57	17	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	57	18	and	and	CC
cord-283340-ksyd5l56	57	19	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	57	20	were	be	VBD
cord-283340-ksyd5l56	57	21	retrieved	retrieve	VBN
cord-283340-ksyd5l56	57	22	.	.	.
cord-283340-ksyd5l56	58	1	The	the	DT
cord-283340-ksyd5l56	58	2	following	follow	VBG
cord-283340-ksyd5l56	58	3	criteria	criterion	NNS
cord-283340-ksyd5l56	58	4	were	be	VBD
cord-283340-ksyd5l56	58	5	applied	apply	VBN
cord-283340-ksyd5l56	58	6	to	to	TO
cord-283340-ksyd5l56	58	7	identify	identify	VB
cord-283340-ksyd5l56	58	8	the	the	DT
cord-283340-ksyd5l56	58	9	articles	article	NNS
cord-283340-ksyd5l56	58	10	to	to	TO
cord-283340-ksyd5l56	58	11	be	be	VB
cord-283340-ksyd5l56	58	12	included	include	VBN
cord-283340-ksyd5l56	58	13	in	in	IN
cord-283340-ksyd5l56	58	14	the	the	DT
cord-283340-ksyd5l56	58	15	present	present	JJ
cord-283340-ksyd5l56	58	16	umbrella	umbrella	NN
cord-283340-ksyd5l56	58	17	review	review	NN
cord-283340-ksyd5l56	58	18	:	:	:
cord-283340-ksyd5l56	58	19	(	(	-LRB-
cord-283340-ksyd5l56	58	20	1	1	LS
cord-283340-ksyd5l56	58	21	)	)	-RRB-
cord-283340-ksyd5l56	58	22	systematic	systematic	JJ
cord-283340-ksyd5l56	58	23	reviews	review	NNS
cord-283340-ksyd5l56	59	1	and/or	and/or	CC
cord-283340-ksyd5l56	59	2	meta	meta	NNP
cord-283340-ksyd5l56	59	3	-	-	HYPH
cord-283340-ksyd5l56	59	4	analyses	analysis	NNS
cord-283340-ksyd5l56	59	5	;	;	,
cord-283340-ksyd5l56	59	6	(	(	-LRB-
cord-283340-ksyd5l56	59	7	2	2	LS
cord-283340-ksyd5l56	59	8	)	)	-RRB-
cord-283340-ksyd5l56	59	9	studies	study	NNS
cord-283340-ksyd5l56	59	10	involving	involve	VBG
cord-283340-ksyd5l56	59	11	adults	adult	NNS
cord-283340-ksyd5l56	59	12	who	who	WP
cord-283340-ksyd5l56	59	13	tested	test	VBD
cord-283340-ksyd5l56	59	14	positive	positive	JJ
cord-283340-ksyd5l56	59	15	for	for	IN
cord-283340-ksyd5l56	59	16	COVID-19	covid-19	NN
cord-283340-ksyd5l56	59	17	;	;	:
cord-283340-ksyd5l56	59	18	and	and	CC
cord-283340-ksyd5l56	59	19	(	(	-LRB-
cord-283340-ksyd5l56	59	20	3	3	LS
cord-283340-ksyd5l56	59	21	)	)	-RRB-
cord-283340-ksyd5l56	59	22	studies	study	NNS
cord-283340-ksyd5l56	59	23	reporting	report	VBG
cord-283340-ksyd5l56	59	24	the	the	DT
cord-283340-ksyd5l56	59	25	association	association	NN
cord-283340-ksyd5l56	59	26	between	between	IN
cord-283340-ksyd5l56	59	27	dyslipidemia	dyslipidemia	NNP
cord-283340-ksyd5l56	59	28	and	and	CC
cord-283340-ksyd5l56	59	29	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	59	30	infection	infection	NN
cord-283340-ksyd5l56	59	31	.	.	.
cord-283340-ksyd5l56	60	1	Two	two	CD
cord-283340-ksyd5l56	60	2	authors	author	NNS
cord-283340-ksyd5l56	60	3	(	(	-LRB-
cord-283340-ksyd5l56	60	4	G.J.C.	G.J.C.	NNP
cord-283340-ksyd5l56	60	5	and	and	CC
cord-283340-ksyd5l56	60	6	H.M.K.	H.M.K.	NNP
cord-283340-ksyd5l56	60	7	)	)	-RRB-
cord-283340-ksyd5l56	60	8	screened	screen	VBD
cord-283340-ksyd5l56	60	9	the	the	DT
cord-283340-ksyd5l56	60	10	titles	title	NNS
cord-283340-ksyd5l56	60	11	and	and	CC
cord-283340-ksyd5l56	60	12	abstracts	abstract	NNS
cord-283340-ksyd5l56	60	13	of	of	IN
cord-283340-ksyd5l56	60	14	the	the	DT
cord-283340-ksyd5l56	60	15	articles	article	NNS
cord-283340-ksyd5l56	60	16	independently	independently	RB
cord-283340-ksyd5l56	60	17	to	to	TO
cord-283340-ksyd5l56	60	18	evaluate	evaluate	VB
cord-283340-ksyd5l56	60	19	eligibility	eligibility	NN
cord-283340-ksyd5l56	60	20	for	for	IN
cord-283340-ksyd5l56	60	21	inclusion	inclusion	NN
cord-283340-ksyd5l56	60	22	.	.	.
cord-283340-ksyd5l56	61	1	If	if	IN
cord-283340-ksyd5l56	61	2	a	a	DT
cord-283340-ksyd5l56	61	3	consensus	consensus	NN
cord-283340-ksyd5l56	61	4	was	be	VBD
cord-283340-ksyd5l56	61	5	reached	reach	VBN
cord-283340-ksyd5l56	61	6	,	,	,
cord-283340-ksyd5l56	61	7	articles	article	NNS
cord-283340-ksyd5l56	61	8	were	be	VBD
cord-283340-ksyd5l56	61	9	either	either	RB
cord-283340-ksyd5l56	61	10	excluded	exclude	VBN
cord-283340-ksyd5l56	61	11	or	or	CC
cord-283340-ksyd5l56	61	12	moved	move	VBN
cord-283340-ksyd5l56	61	13	to	to	IN
cord-283340-ksyd5l56	61	14	the	the	DT
cord-283340-ksyd5l56	61	15	next	next	JJ
cord-283340-ksyd5l56	61	16	stage	stage	NN
cord-283340-ksyd5l56	61	17	for	for	IN
cord-283340-ksyd5l56	61	18	full	full	JJ
cord-283340-ksyd5l56	61	19	-	-	HYPH
cord-283340-ksyd5l56	61	20	text	text	NN
cord-283340-ksyd5l56	61	21	review	review	NN
cord-283340-ksyd5l56	61	22	.	.	.
cord-283340-ksyd5l56	62	1	If	if	IN
cord-283340-ksyd5l56	62	2	a	a	DT
cord-283340-ksyd5l56	62	3	consensus	consensus	NN
cord-283340-ksyd5l56	62	4	was	be	VBD
cord-283340-ksyd5l56	62	5	not	not	RB
cord-283340-ksyd5l56	62	6	reached	reach	VBN
cord-283340-ksyd5l56	62	7	,	,	,
cord-283340-ksyd5l56	62	8	the	the	DT
cord-283340-ksyd5l56	62	9	article	article	NN
cord-283340-ksyd5l56	62	10	was	be	VBD
cord-283340-ksyd5l56	62	11	moved	move	VBN
cord-283340-ksyd5l56	62	12	to	to	IN
cord-283340-ksyd5l56	62	13	the	the	DT
cord-283340-ksyd5l56	62	14	full	full	JJ
cord-283340-ksyd5l56	62	15	-	-	HYPH
cord-283340-ksyd5l56	62	16	text	text	NN
cord-283340-ksyd5l56	62	17	review	review	NN
cord-283340-ksyd5l56	62	18	stage	stage	NN
cord-283340-ksyd5l56	62	19	.	.	.
cord-283340-ksyd5l56	63	1	The	the	DT
cord-283340-ksyd5l56	63	2	full	full	JJ
cord-283340-ksyd5l56	63	3	texts	text	NNS
cord-283340-ksyd5l56	63	4	of	of	IN
cord-283340-ksyd5l56	63	5	the	the	DT
cord-283340-ksyd5l56	63	6	selected	select	VBN
cord-283340-ksyd5l56	63	7	articles	article	NNS
cord-283340-ksyd5l56	63	8	were	be	VBD
cord-283340-ksyd5l56	63	9	critically	critically	RB
cord-283340-ksyd5l56	63	10	appraised	appraise	VBN
cord-283340-ksyd5l56	63	11	to	to	TO
cord-283340-ksyd5l56	63	12	determine	determine	VB
cord-283340-ksyd5l56	63	13	their	-PRON-	PRP$
cord-283340-ksyd5l56	63	14	eligibility	eligibility	NN
cord-283340-ksyd5l56	63	15	for	for	IN
cord-283340-ksyd5l56	63	16	inclusion	inclusion	NN
cord-283340-ksyd5l56	63	17	in	in	IN
cord-283340-ksyd5l56	63	18	the	the	DT
cord-283340-ksyd5l56	63	19	umbrella	umbrella	NN
cord-283340-ksyd5l56	63	20	review	review	NN
cord-283340-ksyd5l56	63	21	.	.	.
cord-283340-ksyd5l56	64	1	Disagreements	disagreement	NNS
cord-283340-ksyd5l56	64	2	were	be	VBD
cord-283340-ksyd5l56	64	3	resolved	resolve	VBN
cord-283340-ksyd5l56	64	4	by	by	IN
cord-283340-ksyd5l56	64	5	discussion	discussion	NN
cord-283340-ksyd5l56	64	6	with	with	IN
cord-283340-ksyd5l56	64	7	a	a	DT
cord-283340-ksyd5l56	64	8	third	third	JJ
cord-283340-ksyd5l56	64	9	author	author	NN
cord-283340-ksyd5l56	64	10	(	(	-LRB-
cord-283340-ksyd5l56	64	11	H.K.	H.K.	NNP
cord-283340-ksyd5l56	64	12	)	)	-RRB-
cord-283340-ksyd5l56	64	13	until	until	IN
cord-283340-ksyd5l56	64	14	consensus	consensus	NN
cord-283340-ksyd5l56	64	15	was	be	VBD
cord-283340-ksyd5l56	64	16	reached	reach	VBN
cord-283340-ksyd5l56	64	17	.	.	.
cord-283340-ksyd5l56	65	1	Two	two	CD
cord-283340-ksyd5l56	65	2	authors	author	NNS
cord-283340-ksyd5l56	65	3	(	(	-LRB-
cord-283340-ksyd5l56	65	4	G.J.C.	G.J.C.	NNP
cord-283340-ksyd5l56	65	5	and	and	CC
cord-283340-ksyd5l56	65	6	H.M.K.	H.M.K.	NNP
cord-283340-ksyd5l56	65	7	)	)	-RRB-
cord-283340-ksyd5l56	65	8	independently	independently	RB
cord-283340-ksyd5l56	65	9	identified	identify	VBD
cord-283340-ksyd5l56	65	10	the	the	DT
cord-283340-ksyd5l56	65	11	studies	study	NNS
cord-283340-ksyd5l56	65	12	to	to	TO
cord-283340-ksyd5l56	65	13	be	be	VB
cord-283340-ksyd5l56	65	14	included	include	VBN
cord-283340-ksyd5l56	65	15	in	in	IN
cord-283340-ksyd5l56	65	16	this	this	DT
cord-283340-ksyd5l56	65	17	umbrella	umbrella	NN
cord-283340-ksyd5l56	65	18	review	review	NN
cord-283340-ksyd5l56	65	19	according	accord	VBG
cord-283340-ksyd5l56	65	20	to	to	IN
cord-283340-ksyd5l56	65	21	the	the	DT
cord-283340-ksyd5l56	65	22	pre	pre	JJ
cord-283340-ksyd5l56	65	23	-	-	JJ
cord-283340-ksyd5l56	65	24	specified	specified	JJ
cord-283340-ksyd5l56	65	25	inclusion	inclusion	NN
cord-283340-ksyd5l56	65	26	criteria	criterion	NNS
cord-283340-ksyd5l56	65	27	.	.	.
cord-283340-ksyd5l56	66	1	Discrepancies	discrepancy	NNS
cord-283340-ksyd5l56	66	2	in	in	IN
cord-283340-ksyd5l56	66	3	assessment	assessment	NN
cord-283340-ksyd5l56	66	4	were	be	VBD
cord-283340-ksyd5l56	66	5	resolved	resolve	VBN
cord-283340-ksyd5l56	66	6	after	after	IN
cord-283340-ksyd5l56	66	7	discussion	discussion	NN
cord-283340-ksyd5l56	66	8	with	with	IN
cord-283340-ksyd5l56	66	9	a	a	DT
cord-283340-ksyd5l56	66	10	third	third	JJ
cord-283340-ksyd5l56	66	11	author	author	NN
cord-283340-ksyd5l56	66	12	(	(	-LRB-
cord-283340-ksyd5l56	66	13	H.K.	H.K.	NNP
cord-283340-ksyd5l56	66	14	)	)	-RRB-
cord-283340-ksyd5l56	66	15	.	.	.
cord-283340-ksyd5l56	67	1	The	the	DT
cord-283340-ksyd5l56	67	2	following	follow	VBG
cord-283340-ksyd5l56	67	3	information	information	NN
cord-283340-ksyd5l56	67	4	were	be	VBD
cord-283340-ksyd5l56	67	5	extracted	extract	VBN
cord-283340-ksyd5l56	67	6	from	from	IN
cord-283340-ksyd5l56	67	7	eligible	eligible	JJ
cord-283340-ksyd5l56	67	8	articles	article	NNS
cord-283340-ksyd5l56	67	9	:	:	:
cord-283340-ksyd5l56	67	10	(	(	-LRB-
cord-283340-ksyd5l56	67	11	1	1	LS
cord-283340-ksyd5l56	67	12	)	)	-RRB-
cord-283340-ksyd5l56	67	13	authors	author	NNS
cord-283340-ksyd5l56	67	14	,	,	,
cord-283340-ksyd5l56	67	15	journal	journal	NN
cord-283340-ksyd5l56	67	16	details	detail	NNS
cord-283340-ksyd5l56	67	17	,	,	,
cord-283340-ksyd5l56	67	18	and	and	CC
cord-283340-ksyd5l56	67	19	year	year	NN
cord-283340-ksyd5l56	67	20	of	of	IN
cord-283340-ksyd5l56	67	21	publication	publication	NN
cord-283340-ksyd5l56	67	22	;	;	:
cord-283340-ksyd5l56	67	23	(	(	-LRB-
cord-283340-ksyd5l56	67	24	2	2	LS
cord-283340-ksyd5l56	67	25	)	)	-RRB-
cord-283340-ksyd5l56	67	26	descriptive	descriptive	JJ
cord-283340-ksyd5l56	67	27	information	information	NN
cord-283340-ksyd5l56	67	28	,	,	,
cord-283340-ksyd5l56	67	29	including	include	VBG
cord-283340-ksyd5l56	67	30	the	the	DT
cord-283340-ksyd5l56	67	31	databases	database	NNS
cord-283340-ksyd5l56	67	32	searched	search	VBN
cord-283340-ksyd5l56	67	33	,	,	,
cord-283340-ksyd5l56	67	34	the	the	DT
cord-283340-ksyd5l56	67	35	number	number	NN
cord-283340-ksyd5l56	67	36	of	of	IN
cord-283340-ksyd5l56	67	37	studies	study	NNS
cord-283340-ksyd5l56	67	38	included	include	VBN
cord-283340-ksyd5l56	67	39	,	,	,
cord-283340-ksyd5l56	67	40	the	the	DT
cord-283340-ksyd5l56	67	41	outcomes	outcome	NNS
cord-283340-ksyd5l56	67	42	of	of	IN
cord-283340-ksyd5l56	67	43	the	the	DT
cord-283340-ksyd5l56	67	44	studies	study	NNS
cord-283340-ksyd5l56	67	45	included	include	VBN
cord-283340-ksyd5l56	67	46	,	,	,
cord-283340-ksyd5l56	67	47	the	the	DT
cord-283340-ksyd5l56	67	48	total	total	JJ
cord-283340-ksyd5l56	67	49	number	number	NN
cord-283340-ksyd5l56	67	50	of	of	IN
cord-283340-ksyd5l56	67	51	patients	patient	NNS
cord-283340-ksyd5l56	67	52	,	,	,
cord-283340-ksyd5l56	67	53	and	and	CC
cord-283340-ksyd5l56	67	54	patients	patient	NNS
cord-283340-ksyd5l56	67	55	'	'	POS
cord-283340-ksyd5l56	67	56	age	age	NN
cord-283340-ksyd5l56	67	57	range	range	NN
cord-283340-ksyd5l56	67	58	;	;	:
cord-283340-ksyd5l56	67	59	and	and	CC
cord-283340-ksyd5l56	67	60	(	(	-LRB-
cord-283340-ksyd5l56	67	61	3	3	LS
cord-283340-ksyd5l56	67	62	)	)	-RRB-
cord-283340-ksyd5l56	67	63	the	the	DT
cord-283340-ksyd5l56	67	64	results	result	NNS
cord-283340-ksyd5l56	67	65	of	of	IN
cord-283340-ksyd5l56	67	66	the	the	DT
cord-283340-ksyd5l56	67	67	data	data	NN
cord-283340-ksyd5l56	67	68	synthesis	synthesis	NN
cord-283340-ksyd5l56	67	69	.	.	.
cord-283340-ksyd5l56	68	1	Two	two	CD
cord-283340-ksyd5l56	68	2	authors	author	NNS
cord-283340-ksyd5l56	68	3	(	(	-LRB-
cord-283340-ksyd5l56	68	4	G.J.C.	G.J.C.	NNP
cord-283340-ksyd5l56	68	5	and	and	CC
cord-283340-ksyd5l56	68	6	H.M.K.	H.M.K.	NNP
cord-283340-ksyd5l56	68	7	)	)	-RRB-
cord-283340-ksyd5l56	68	8	independently	independently	RB
cord-283340-ksyd5l56	68	9	evaluated	evaluate	VBD
cord-283340-ksyd5l56	68	10	the	the	DT
cord-283340-ksyd5l56	68	11	methodological	methodological	JJ
cord-283340-ksyd5l56	68	12	quality	quality	NN
cord-283340-ksyd5l56	68	13	of	of	IN
cord-283340-ksyd5l56	68	14	the	the	DT
cord-283340-ksyd5l56	68	15	included	include	VBN
cord-283340-ksyd5l56	68	16	studies	study	NNS
cord-283340-ksyd5l56	68	17	using	use	VBG
cord-283340-ksyd5l56	68	18	the	the	DT
cord-283340-ksyd5l56	68	19	A	a	DT
cord-283340-ksyd5l56	68	20	MeaSurement	MeaSurement	NNP
cord-283340-ksyd5l56	68	21	Tool	tool	NN
cord-283340-ksyd5l56	68	22	to	to	TO
cord-283340-ksyd5l56	68	23	Assess	assess	VB
cord-283340-ksyd5l56	68	24	systematic	systematic	JJ
cord-283340-ksyd5l56	68	25	Reviews	review	NNS
cord-283340-ksyd5l56	68	26	(	(	-LRB-
cord-283340-ksyd5l56	68	27	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	68	28	2	2	CD
cord-283340-ksyd5l56	68	29	)	)	-RRB-
cord-283340-ksyd5l56	68	30	tool	tool	NN
cord-283340-ksyd5l56	68	31	.	.	.
cord-283340-ksyd5l56	69	1	18	18	CD
cord-283340-ksyd5l56	69	2	Inconsistencies	inconsistency	NNS
cord-283340-ksyd5l56	69	3	were	be	VBD
cord-283340-ksyd5l56	69	4	resolved	resolve	VBN
cord-283340-ksyd5l56	69	5	through	through	IN
cord-283340-ksyd5l56	69	6	a	a	DT
cord-283340-ksyd5l56	69	7	discussion	discussion	NN
cord-283340-ksyd5l56	69	8	with	with	IN
cord-283340-ksyd5l56	69	9	a	a	DT
cord-283340-ksyd5l56	69	10	third	third	JJ
cord-283340-ksyd5l56	69	11	author	author	NN
cord-283340-ksyd5l56	69	12	(	(	-LRB-
cord-283340-ksyd5l56	69	13	H.K.	H.K.	NNP
cord-283340-ksyd5l56	69	14	)	)	-RRB-
cord-283340-ksyd5l56	69	15	.	.	.
cord-283340-ksyd5l56	70	1	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	70	2	2	2	CD
cord-283340-ksyd5l56	70	3	is	be	VBZ
cord-283340-ksyd5l56	70	4	a	a	DT
cord-283340-ksyd5l56	70	5	reliable	reliable	JJ
cord-283340-ksyd5l56	70	6	,	,	,
cord-283340-ksyd5l56	70	7	valid	valid	JJ
cord-283340-ksyd5l56	70	8	and	and	CC
cord-283340-ksyd5l56	70	9	critical	critical	JJ
cord-283340-ksyd5l56	70	10	assessment	assessment	NN
cord-283340-ksyd5l56	70	11	tool	tool	NN
cord-283340-ksyd5l56	70	12	developed	develop	VBN
cord-283340-ksyd5l56	70	13	from	from	IN
cord-283340-ksyd5l56	70	14	the	the	DT
cord-283340-ksyd5l56	70	15	initial	initial	JJ
cord-283340-ksyd5l56	70	16	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	70	17	in	in	IN
cord-283340-ksyd5l56	70	18	2017	2017	CD
cord-283340-ksyd5l56	70	19	.	.	.
cord-283340-ksyd5l56	71	1	[	[	-LRB-
cord-283340-ksyd5l56	71	2	18	18	CD
cord-283340-ksyd5l56	71	3	]	]	-RRB-
cord-283340-ksyd5l56	71	4	[	[	-LRB-
cord-283340-ksyd5l56	71	5	19	19	CD
cord-283340-ksyd5l56	71	6	]	]	-RRB-
cord-283340-ksyd5l56	71	7	[	[	-LRB-
cord-283340-ksyd5l56	71	8	20	20	CD
cord-283340-ksyd5l56	71	9	]	]	-RRB-
cord-283340-ksyd5l56	72	1	It	-PRON-	PRP
cord-283340-ksyd5l56	72	2	contains	contain	VBZ
cord-283340-ksyd5l56	72	3	16	16	CD
cord-283340-ksyd5l56	72	4	checklists	checklist	NNS
cord-283340-ksyd5l56	72	5	(	(	-LRB-
cord-283340-ksyd5l56	72	6	7	7	CD
cord-283340-ksyd5l56	72	7	critical	critical	JJ
cord-283340-ksyd5l56	72	8	checklists	checklist	NNS
cord-283340-ksyd5l56	72	9	and	and	CC
cord-283340-ksyd5l56	72	10	9	9	CD
cord-283340-ksyd5l56	72	11	non	non	JJ
cord-283340-ksyd5l56	72	12	-	-	JJ
cord-283340-ksyd5l56	72	13	critical	critical	JJ
cord-283340-ksyd5l56	72	14	checklists	checklist	NNS
cord-283340-ksyd5l56	72	15	)	)	-RRB-
cord-283340-ksyd5l56	72	16	for	for	IN
cord-283340-ksyd5l56	72	17	assessing	assess	VBG
cord-283340-ksyd5l56	72	18	systematic	systematic	JJ
cord-283340-ksyd5l56	72	19	reviews	review	NNS
cord-283340-ksyd5l56	72	20	and	and	CC
cord-283340-ksyd5l56	72	21	meta	meta	NNP
cord-283340-ksyd5l56	72	22	-	-	HYPH
cord-283340-ksyd5l56	72	23	analyses	analysis	NNS
cord-283340-ksyd5l56	72	24	,	,	,
cord-283340-ksyd5l56	72	25	including	include	VBG
cord-283340-ksyd5l56	72	26	randomized	randomized	JJ
cord-283340-ksyd5l56	72	27	controlled	control	VBN
cord-283340-ksyd5l56	72	28	trials	trial	NNS
cord-283340-ksyd5l56	72	29	,	,	,
cord-283340-ksyd5l56	72	30	observational	observational	JJ
cord-283340-ksyd5l56	72	31	studies	study	NNS
cord-283340-ksyd5l56	72	32	on	on	IN
cord-283340-ksyd5l56	72	33	exposure	exposure	NN
cord-283340-ksyd5l56	72	34	,	,	,
cord-283340-ksyd5l56	72	35	or	or	CC
cord-283340-ksyd5l56	72	36	both	both	DT
cord-283340-ksyd5l56	72	37	(	(	-LRB-
cord-283340-ksyd5l56	72	38	Table	table	NN
cord-283340-ksyd5l56	72	39	1	1	CD
cord-283340-ksyd5l56	72	40	)	)	-RRB-
cord-283340-ksyd5l56	72	41	.	.	.
cord-283340-ksyd5l56	73	1	The	the	DT
cord-283340-ksyd5l56	73	2	rating	rating	NN
cord-283340-ksyd5l56	73	3	criteria	criterion	NNS
cord-283340-ksyd5l56	73	4	of	of	IN
cord-283340-ksyd5l56	73	5	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	73	6	2	2	CD
cord-283340-ksyd5l56	73	7	are	be	VBP
cord-283340-ksyd5l56	73	8	as	as	IN
cord-283340-ksyd5l56	73	9	follows	follow	VBZ
cord-283340-ksyd5l56	73	10	:	:	:
cord-283340-ksyd5l56	73	11	the	the	DT
cord-283340-ksyd5l56	73	12	presence	presence	NN
cord-283340-ksyd5l56	73	13	of	of	IN
cord-283340-ksyd5l56	73	14	0	0	CD
cord-283340-ksyd5l56	73	15	-	-	SYM
cord-283340-ksyd5l56	73	16	1	1	CD
cord-283340-ksyd5l56	73	17	non	non	JJ
cord-283340-ksyd5l56	73	18	-	-	JJ
cord-283340-ksyd5l56	73	19	critical	critical	JJ
cord-283340-ksyd5l56	73	20	weakness	weakness	NN
cord-283340-ksyd5l56	73	21	is	be	VBZ
cord-283340-ksyd5l56	73	22	defined	define	VBN
cord-283340-ksyd5l56	73	23	as	as	IN
cord-283340-ksyd5l56	73	24	high	high	JJ
cord-283340-ksyd5l56	73	25	quality	quality	NN
cord-283340-ksyd5l56	73	26	;	;	:
cord-283340-ksyd5l56	73	27	more	more	JJR
cord-283340-ksyd5l56	73	28	than	than	IN
cord-283340-ksyd5l56	73	29	1	1	CD
cord-283340-ksyd5l56	73	30	non	non	JJ
cord-283340-ksyd5l56	73	31	-	-	JJ
cord-283340-ksyd5l56	73	32	critical	critical	JJ
cord-283340-ksyd5l56	73	33	weakness	weakness	NN
cord-283340-ksyd5l56	73	34	is	be	VBZ
cord-283340-ksyd5l56	73	35	defined	define	VBN
cord-283340-ksyd5l56	73	36	as	as	IN
cord-283340-ksyd5l56	73	37	moderate	moderate	JJ
cord-283340-ksyd5l56	73	38	quality	quality	NN
cord-283340-ksyd5l56	73	39	;	;	:
cord-283340-ksyd5l56	73	40	1	1	CD
cord-283340-ksyd5l56	73	41	critical	critical	JJ
cord-283340-ksyd5l56	73	42	flaw	flaw	NN
cord-283340-ksyd5l56	73	43	with	with	IN
cord-283340-ksyd5l56	73	44	or	or	CC
cord-283340-ksyd5l56	73	45	without	without	IN
cord-283340-ksyd5l56	73	46	noncritical	noncritical	JJ
cord-283340-ksyd5l56	73	47	weaknesses	weakness	NNS
cord-283340-ksyd5l56	73	48	is	be	VBZ
cord-283340-ksyd5l56	73	49	defined	define	VBN
cord-283340-ksyd5l56	73	50	as	as	IN
cord-283340-ksyd5l56	73	51	low	low	JJ
cord-283340-ksyd5l56	73	52	quality	quality	NN
cord-283340-ksyd5l56	73	53	;	;	:
cord-283340-ksyd5l56	73	54	and	and	CC
cord-283340-ksyd5l56	73	55	the	the	DT
cord-283340-ksyd5l56	73	56	presence	presence	NN
cord-283340-ksyd5l56	73	57	of	of	IN
cord-283340-ksyd5l56	73	58	more	more	JJR
cord-283340-ksyd5l56	73	59	than	than	IN
cord-283340-ksyd5l56	73	60	1	1	CD
cord-283340-ksyd5l56	73	61	critical	critical	JJ
cord-283340-ksyd5l56	73	62	flaw	flaw	NN
cord-283340-ksyd5l56	73	63	with	with	IN
cord-283340-ksyd5l56	73	64	or	or	CC
cord-283340-ksyd5l56	73	65	without	without	IN
cord-283340-ksyd5l56	73	66	non	non	JJ
cord-283340-ksyd5l56	73	67	-	-	JJ
cord-283340-ksyd5l56	73	68	critical	critical	JJ
cord-283340-ksyd5l56	73	69	weaknesses	weakness	NNS
cord-283340-ksyd5l56	73	70	is	be	VBZ
cord-283340-ksyd5l56	73	71	defined	define	VBN
cord-283340-ksyd5l56	73	72	as	as	IN
cord-283340-ksyd5l56	73	73	critically	critically	RB
cord-283340-ksyd5l56	73	74	low	low	JJ
cord-283340-ksyd5l56	73	75	quality	quality	NN
cord-283340-ksyd5l56	73	76	.	.	.
cord-283340-ksyd5l56	74	1	The	the	DT
cord-283340-ksyd5l56	74	2	author	author	NN
cord-283340-ksyd5l56	74	3	responsible	responsible	JJ
cord-283340-ksyd5l56	74	4	for	for	IN
cord-283340-ksyd5l56	74	5	the	the	DT
cord-283340-ksyd5l56	74	6	methodology	methodology	NN
cord-283340-ksyd5l56	74	7	of	of	IN
cord-283340-ksyd5l56	74	8	this	this	DT
cord-283340-ksyd5l56	74	9	study	study	NN
cord-283340-ksyd5l56	74	10	(	(	-LRB-
cord-283340-ksyd5l56	74	11	H.K.	H.K.	NNP
cord-283340-ksyd5l56	74	12	)	)	-RRB-
cord-283340-ksyd5l56	74	13	completed	complete	VBD
cord-283340-ksyd5l56	74	14	the	the	DT
cord-283340-ksyd5l56	74	15	online	online	JJ
cord-283340-ksyd5l56	74	16	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	74	17	2	2	CD
cord-283340-ksyd5l56	74	18	checklist	checklist	NN
cord-283340-ksyd5l56	74	19	available	available	JJ
cord-283340-ksyd5l56	74	20	on	on	IN
cord-283340-ksyd5l56	74	21	the	the	DT
cord-283340-ksyd5l56	74	22	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	74	23	website	website	NN
cord-283340-ksyd5l56	74	24	(	(	-LRB-
cord-283340-ksyd5l56	74	25	https://amstar.ca/Amstar_Checklist.php	https://amstar.ca/Amstar_Checklist.php	NNP
cord-283340-ksyd5l56	74	26	)	)	-RRB-
cord-283340-ksyd5l56	74	27	and	and	CC
cord-283340-ksyd5l56	74	28	a	a	DT
cord-283340-ksyd5l56	74	29	final	final	JJ
cord-283340-ksyd5l56	74	30	categorization	categorization	NN
cord-283340-ksyd5l56	74	31	of	of	IN
cord-283340-ksyd5l56	74	32	each	each	DT
cord-283340-ksyd5l56	74	33	systematic	systematic	JJ
cord-283340-ksyd5l56	74	34	review	review	NN
cord-283340-ksyd5l56	74	35	was	be	VBD
cord-283340-ksyd5l56	74	36	generated	generate	VBN
cord-283340-ksyd5l56	74	37	to	to	TO
cord-283340-ksyd5l56	74	38	classify	classify	VB
cord-283340-ksyd5l56	74	39	them	-PRON-	PRP
cord-283340-ksyd5l56	74	40	as	as	IN
cord-283340-ksyd5l56	74	41	high	high	JJ
cord-283340-ksyd5l56	74	42	,	,	,
cord-283340-ksyd5l56	74	43	moderate	moderate	JJ
cord-283340-ksyd5l56	74	44	,	,	,
cord-283340-ksyd5l56	74	45	low	low	JJ
cord-283340-ksyd5l56	74	46	,	,	,
cord-283340-ksyd5l56	74	47	or	or	CC
cord-283340-ksyd5l56	74	48	critically	critically	RB
cord-283340-ksyd5l56	74	49	low	low	JJ
cord-283340-ksyd5l56	74	50	quality	quality	NN
cord-283340-ksyd5l56	74	51	.	.	.
cord-283340-ksyd5l56	75	1	Two	two	CD
cord-283340-ksyd5l56	75	2	authors	author	NNS
cord-283340-ksyd5l56	75	3	(	(	-LRB-
cord-283340-ksyd5l56	75	4	G.J.C.	G.J.C.	NNP
cord-283340-ksyd5l56	75	5	and	and	CC
cord-283340-ksyd5l56	75	6	H.M.K.	H.M.K.	NNP
cord-283340-ksyd5l56	75	7	)	)	-RRB-
cord-283340-ksyd5l56	75	8	independently	independently	RB
cord-283340-ksyd5l56	75	9	extracted	extract	VBD
cord-283340-ksyd5l56	75	10	the	the	DT
cord-283340-ksyd5l56	75	11	outcomes	outcome	NNS
cord-283340-ksyd5l56	75	12	on	on	IN
cord-283340-ksyd5l56	75	13	the	the	DT
cord-283340-ksyd5l56	75	14	relationship	relationship	NN
cord-283340-ksyd5l56	75	15	of	of	IN
cord-283340-ksyd5l56	75	16	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	75	17	or	or	CC
cord-283340-ksyd5l56	75	18	non	non	JJ
cord-283340-ksyd5l56	75	19	-	-	JJ
cord-283340-ksyd5l56	75	20	dyslipidemia	dyslipidemia	JJ
cord-283340-ksyd5l56	75	21	and	and	CC
cord-283340-ksyd5l56	75	22	lipid	lipid	NN
cord-283340-ksyd5l56	75	23	profile	profile	NN
cord-283340-ksyd5l56	75	24	with	with	IN
cord-283340-ksyd5l56	75	25	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	75	26	infection	infection	NN
cord-283340-ksyd5l56	75	27	severity	severity	NN
cord-283340-ksyd5l56	75	28	from	from	IN
cord-283340-ksyd5l56	75	29	the	the	DT
cord-283340-ksyd5l56	75	30	identified	identify	VBN
cord-283340-ksyd5l56	75	31	systematic	systematic	JJ
cord-283340-ksyd5l56	75	32	reviews	review	NNS
cord-283340-ksyd5l56	75	33	and	and	CC
cord-283340-ksyd5l56	75	34	meta	meta	NNP
cord-283340-ksyd5l56	75	35	-	-	HYPH
cord-283340-ksyd5l56	75	36	analyses	analysis	NNS
cord-283340-ksyd5l56	75	37	.	.	.
cord-283340-ksyd5l56	76	1	We	-PRON-	PRP
cord-283340-ksyd5l56	76	2	recalculated	recalculate	VBD
cord-283340-ksyd5l56	76	3	the	the	DT
cord-283340-ksyd5l56	76	4	weighted	weighted	JJ
cord-283340-ksyd5l56	76	5	mean	mean	JJ
cord-283340-ksyd5l56	76	6	difference	difference	NN
cord-283340-ksyd5l56	76	7	(	(	-LRB-
cord-283340-ksyd5l56	76	8	WMD	WMD	NNP
cord-283340-ksyd5l56	76	9	)	)	-RRB-
cord-283340-ksyd5l56	76	10	or	or	CC
cord-283340-ksyd5l56	76	11	risk	risk	NN
cord-283340-ksyd5l56	76	12	ratio	ratio	NN
cord-283340-ksyd5l56	76	13	(	(	-LRB-
cord-283340-ksyd5l56	76	14	RR	RR	NNP
cord-283340-ksyd5l56	76	15	)	)	-RRB-
cord-283340-ksyd5l56	76	16	and	and	CC
cord-283340-ksyd5l56	76	17	the	the	DT
cord-283340-ksyd5l56	76	18	corresponding	corresponding	JJ
cord-283340-ksyd5l56	76	19	95	95	CD
cord-283340-ksyd5l56	76	20	%	%	NN
cord-283340-ksyd5l56	76	21	confidence	confidence	NN
cord-283340-ksyd5l56	76	22	intervals	interval	NNS
cord-283340-ksyd5l56	76	23	(	(	-LRB-
cord-283340-ksyd5l56	76	24	CIs	CIs	NNP
cord-283340-ksyd5l56	76	25	)	)	-RRB-
cord-283340-ksyd5l56	76	26	using	use	VBG
cord-283340-ksyd5l56	76	27	the	the	DT
cord-283340-ksyd5l56	76	28	data	datum	NNS
cord-283340-ksyd5l56	76	29	of	of	IN
cord-283340-ksyd5l56	76	30	the	the	DT
cord-283340-ksyd5l56	76	31	primary	primary	JJ
cord-283340-ksyd5l56	76	32	studies	study	NNS
cord-283340-ksyd5l56	76	33	included	include	VBN
cord-283340-ksyd5l56	76	34	in	in	IN
cord-283340-ksyd5l56	76	35	the	the	DT
cord-283340-ksyd5l56	76	36	published	publish	VBN
cord-283340-ksyd5l56	76	37	meta	meta	NNP
cord-283340-ksyd5l56	76	38	-	-	HYPH
cord-283340-ksyd5l56	76	39	analyses	analysis	NNS
cord-283340-ksyd5l56	76	40	.	.	.
cord-283340-ksyd5l56	77	1	We	-PRON-	PRP
cord-283340-ksyd5l56	77	2	used	use	VBD
cord-283340-ksyd5l56	77	3	the	the	DT
cord-283340-ksyd5l56	77	4	chi	chi	JJ
cord-283340-ksyd5l56	77	5	-	-	JJ
cord-283340-ksyd5l56	77	6	square	square	JJ
cord-283340-ksyd5l56	77	7	test	test	NN
cord-283340-ksyd5l56	77	8	for	for	IN
cord-283340-ksyd5l56	77	9	homogeneity	homogeneity	NN
cord-283340-ksyd5l56	77	10	and	and	CC
cord-283340-ksyd5l56	77	11	the	the	DT
cord-283340-ksyd5l56	77	12	I	i	NN
cord-283340-ksyd5l56	77	13	2	2	CD
cord-283340-ksyd5l56	77	14	test	test	NN
cord-283340-ksyd5l56	77	15	for	for	IN
cord-283340-ksyd5l56	77	16	heterogeneity	heterogeneity	NN
cord-283340-ksyd5l56	77	17	.	.	.
cord-283340-ksyd5l56	78	1	A	a	DT
cord-283340-ksyd5l56	78	2	level	level	NN
cord-283340-ksyd5l56	78	3	of	of	IN
cord-283340-ksyd5l56	78	4	10	10	CD
cord-283340-ksyd5l56	78	5	%	%	NN
cord-283340-ksyd5l56	78	6	significance	significance	NN
cord-283340-ksyd5l56	78	7	(	(	-LRB-
cord-283340-ksyd5l56	78	8	p<0.1	p<0.1	NNP
cord-283340-ksyd5l56	78	9	)	)	-RRB-
cord-283340-ksyd5l56	78	10	for	for	IN
cord-283340-ksyd5l56	78	11	the	the	DT
cord-283340-ksyd5l56	78	12	χ	χ	CD
cord-283340-ksyd5l56	78	13	2	2	CD
cord-283340-ksyd5l56	78	14	statistic	statistic	NN
cord-283340-ksyd5l56	78	15	or	or	CC
cord-283340-ksyd5l56	78	16	an	an	DT
cord-283340-ksyd5l56	78	17	I	i	NN
cord-283340-ksyd5l56	78	18	2	2	CD
cord-283340-ksyd5l56	78	19	greater	great	JJR
cord-283340-ksyd5l56	78	20	than	than	IN
cord-283340-ksyd5l56	78	21	50	50	CD
cord-283340-ksyd5l56	78	22	%	%	NN
cord-283340-ksyd5l56	78	23	was	be	VBD
cord-283340-ksyd5l56	78	24	considered	consider	VBN
cord-283340-ksyd5l56	78	25	to	to	TO
cord-283340-ksyd5l56	78	26	indicate	indicate	VB
cord-283340-ksyd5l56	78	27	considerable	considerable	JJ
cord-283340-ksyd5l56	78	28	heterogeneity	heterogeneity	NN
cord-283340-ksyd5l56	78	29	.	.	.
cord-283340-ksyd5l56	79	1	A	a	DT
cord-283340-ksyd5l56	79	2	fixed	fix	VBN
cord-283340-ksyd5l56	79	3	-	-	HYPH
cord-283340-ksyd5l56	79	4	effects	effect	NNS
cord-283340-ksyd5l56	79	5	model	model	NN
cord-283340-ksyd5l56	79	6	was	be	VBD
cord-283340-ksyd5l56	79	7	selected	select	VBN
cord-283340-ksyd5l56	79	8	if	if	IN
cord-283340-ksyd5l56	79	9	the	the	DT
cord-283340-ksyd5l56	79	10	p	p	NN
cord-283340-ksyd5l56	79	11	-	-	HYPH
cord-283340-ksyd5l56	79	12	value	value	NN
cord-283340-ksyd5l56	79	13	for	for	IN
cord-283340-ksyd5l56	79	14	the	the	DT
cord-283340-ksyd5l56	79	15	χ	χ	CD
cord-283340-ksyd5l56	79	16	2	2	CD
cord-283340-ksyd5l56	79	17	test	test	NN
cord-283340-ksyd5l56	79	18	was	be	VBD
cord-283340-ksyd5l56	79	19	>	>	XX
cord-283340-ksyd5l56	79	20	0.10	0.10	CD
cord-283340-ksyd5l56	79	21	and	and	CC
cord-283340-ksyd5l56	79	22	the	the	DT
cord-283340-ksyd5l56	79	23	I	i	NN
cord-283340-ksyd5l56	79	24	2	2	CD
cord-283340-ksyd5l56	79	25	value	value	NN
cord-283340-ksyd5l56	79	26	was	be	VBD
cord-283340-ksyd5l56	79	27	<	<	XX
cord-283340-ksyd5l56	79	28	50	50	CD
cord-283340-ksyd5l56	79	29	%	%	NN
cord-283340-ksyd5l56	79	30	.	.	.
cord-283340-ksyd5l56	80	1	If	if	IN
cord-283340-ksyd5l56	80	2	the	the	DT
cord-283340-ksyd5l56	80	3	I	i	NN
cord-283340-ksyd5l56	80	4	2	2	CD
cord-283340-ksyd5l56	80	5	value	value	NN
cord-283340-ksyd5l56	80	6	was	be	VBD
cord-283340-ksyd5l56	80	7	>	>	XX
cord-283340-ksyd5l56	80	8	50	50	CD
cord-283340-ksyd5l56	80	9	%	%	NN
cord-283340-ksyd5l56	80	10	,	,	,
cord-283340-ksyd5l56	80	11	a	a	DT
cord-283340-ksyd5l56	80	12	random	random	JJ
cord-283340-ksyd5l56	80	13	-	-	HYPH
cord-283340-ksyd5l56	80	14	effects	effect	NNS
cord-283340-ksyd5l56	80	15	model	model	NN
cord-283340-ksyd5l56	80	16	was	be	VBD
cord-283340-ksyd5l56	80	17	used	use	VBN
cord-283340-ksyd5l56	80	18	.	.	.
cord-283340-ksyd5l56	81	1	We	-PRON-	PRP
cord-283340-ksyd5l56	81	2	conducted	conduct	VBD
cord-283340-ksyd5l56	81	3	this	this	DT
cord-283340-ksyd5l56	81	4	meta	meta	NNP
cord-283340-ksyd5l56	81	5	-	-	HYPH
cord-283340-ksyd5l56	81	6	analysis	analysis	NN
cord-283340-ksyd5l56	81	7	using	use	VBG
cord-283340-ksyd5l56	81	8	the	the	DT
cord-283340-ksyd5l56	81	9	Revman	Revman	NNP
cord-283340-ksyd5l56	81	10	5.3	5.3	CD
cord-283340-ksyd5l56	81	11	software	software	NN
cord-283340-ksyd5l56	81	12	provided	provide	VBN
cord-283340-ksyd5l56	81	13	by	by	IN
cord-283340-ksyd5l56	81	14	the	the	DT
cord-283340-ksyd5l56	81	15	Cochrane	Cochrane	NNP
cord-283340-ksyd5l56	81	16	Collaboration	Collaboration	NNP
cord-283340-ksyd5l56	81	17	Network	Network	NNP
cord-283340-ksyd5l56	81	18	.	.	.
cord-283340-ksyd5l56	82	1	In	in	IN
cord-283340-ksyd5l56	82	2	this	this	DT
cord-283340-ksyd5l56	82	3	umbrella	umbrella	NN
cord-283340-ksyd5l56	82	4	review	review	NN
cord-283340-ksyd5l56	82	5	,	,	,
cord-283340-ksyd5l56	82	6	we	-PRON-	PRP
cord-283340-ksyd5l56	82	7	used	use	VBD
cord-283340-ksyd5l56	82	8	the	the	DT
cord-283340-ksyd5l56	82	9	Grading	Grading	NNP
cord-283340-ksyd5l56	82	10	of	of	IN
cord-283340-ksyd5l56	82	11	Recommendations	Recommendations	NNPS
cord-283340-ksyd5l56	82	12	,	,	,
cord-283340-ksyd5l56	82	13	Assessment	Assessment	NNP
cord-283340-ksyd5l56	82	14	,	,	,
cord-283340-ksyd5l56	82	15	Development	Development	NNP
cord-283340-ksyd5l56	82	16	,	,	,
cord-283340-ksyd5l56	82	17	and	and	CC
cord-283340-ksyd5l56	82	18	Evaluation	Evaluation	NNP
cord-283340-ksyd5l56	82	19	(	(	-LRB-
cord-283340-ksyd5l56	82	20	GRADE	grade	NN
cord-283340-ksyd5l56	82	21	)	)	-RRB-
cord-283340-ksyd5l56	82	22	system	system	NN
cord-283340-ksyd5l56	82	23	to	to	TO
cord-283340-ksyd5l56	82	24	evaluate	evaluate	VB
cord-283340-ksyd5l56	82	25	the	the	DT
cord-283340-ksyd5l56	82	26	quality	quality	NN
cord-283340-ksyd5l56	82	27	of	of	IN
cord-283340-ksyd5l56	82	28	evidence	evidence	NN
cord-283340-ksyd5l56	82	29	for	for	IN
cord-283340-ksyd5l56	82	30	each	each	DT
cord-283340-ksyd5l56	82	31	outcome	outcome	NN
cord-283340-ksyd5l56	82	32	.	.	.
cord-283340-ksyd5l56	83	1	21	21	CD
cord-283340-ksyd5l56	84	1	The	the	DT
cord-283340-ksyd5l56	84	2	GRADE	grade	NN
cord-283340-ksyd5l56	84	3	system	system	NN
cord-283340-ksyd5l56	84	4	includes	include	VBZ
cord-283340-ksyd5l56	84	5	5	5	CD
cord-283340-ksyd5l56	84	6	factors	factor	NNS
cord-283340-ksyd5l56	84	7	for	for	IN
cord-283340-ksyd5l56	84	8	downgrading	downgrade	VBG
cord-283340-ksyd5l56	84	9	and	and	CC
cord-283340-ksyd5l56	84	10	3	3	CD
cord-283340-ksyd5l56	84	11	factors	factor	NNS
cord-283340-ksyd5l56	84	12	for	for	IN
cord-283340-ksyd5l56	84	13	upgrading	upgrade	VBG
cord-283340-ksyd5l56	84	14	the	the	DT
cord-283340-ksyd5l56	84	15	quality	quality	NN
cord-283340-ksyd5l56	84	16	of	of	IN
cord-283340-ksyd5l56	84	17	evidence	evidence	NN
cord-283340-ksyd5l56	84	18	.	.	.
cord-283340-ksyd5l56	85	1	The	the	DT
cord-283340-ksyd5l56	85	2	baseline	baseline	JJ
cord-283340-ksyd5l56	85	3	quality	quality	NN
cord-283340-ksyd5l56	85	4	of	of	IN
cord-283340-ksyd5l56	85	5	evidence	evidence	NN
cord-283340-ksyd5l56	85	6	of	of	IN
cord-283340-ksyd5l56	85	7	health	health	NN
cord-283340-ksyd5l56	85	8	outcomes	outcome	NNS
cord-283340-ksyd5l56	85	9	depends	depend	VBZ
cord-283340-ksyd5l56	85	10	on	on	IN
cord-283340-ksyd5l56	85	11	the	the	DT
cord-283340-ksyd5l56	85	12	design	design	NN
cord-283340-ksyd5l56	85	13	of	of	IN
cord-283340-ksyd5l56	85	14	the	the	DT
cord-283340-ksyd5l56	85	15	primary	primary	JJ
cord-283340-ksyd5l56	85	16	study	study	NN
cord-283340-ksyd5l56	85	17	.	.	.
cord-283340-ksyd5l56	86	1	When	when	WRB
cord-283340-ksyd5l56	86	2	a	a	DT
cord-283340-ksyd5l56	86	3	serious	serious	JJ
cord-283340-ksyd5l56	86	4	or	or	CC
cord-283340-ksyd5l56	86	5	very	very	RB
cord-283340-ksyd5l56	86	6	serious	serious	JJ
cord-283340-ksyd5l56	86	7	defect	defect	NN
cord-283340-ksyd5l56	86	8	could	could	MD
cord-283340-ksyd5l56	86	9	occur	occur	VB
cord-283340-ksyd5l56	86	10	because	because	IN
cord-283340-ksyd5l56	86	11	of	of	IN
cord-283340-ksyd5l56	86	12	downgrading	downgrade	VBG
cord-283340-ksyd5l56	86	13	factors	factor	NNS
cord-283340-ksyd5l56	86	14	,	,	,
cord-283340-ksyd5l56	86	15	the	the	DT
cord-283340-ksyd5l56	86	16	evidence	evidence	NN
cord-283340-ksyd5l56	86	17	quality	quality	NN
cord-283340-ksyd5l56	86	18	is	be	VBZ
cord-283340-ksyd5l56	86	19	downgraded	downgrade	VBN
cord-283340-ksyd5l56	86	20	by	by	IN
cord-283340-ksyd5l56	86	21	1	1	CD
cord-283340-ksyd5l56	86	22	or	or	CC
cord-283340-ksyd5l56	86	23	2	2	CD
cord-283340-ksyd5l56	86	24	levels	level	NNS
cord-283340-ksyd5l56	86	25	,	,	,
cord-283340-ksyd5l56	86	26	respectively	respectively	RB
cord-283340-ksyd5l56	86	27	.	.	.
cord-283340-ksyd5l56	87	1	If	if	IN
cord-283340-ksyd5l56	87	2	the	the	DT
cord-283340-ksyd5l56	87	3	effect	effect	NN
cord-283340-ksyd5l56	87	4	is	be	VBZ
cord-283340-ksyd5l56	87	5	large	large	JJ
cord-283340-ksyd5l56	87	6	(	(	-LRB-
cord-283340-ksyd5l56	87	7	RR	rr	NN
cord-283340-ksyd5l56	87	8	/	/	SYM
cord-283340-ksyd5l56	87	9	odds	odd	NNS
cord-283340-ksyd5l56	87	10	ratio	ratio	NN
cord-283340-ksyd5l56	87	11	[	[	-LRB-
cord-283340-ksyd5l56	87	12	OR	or	CC
cord-283340-ksyd5l56	87	13	]	]	-RRB-
cord-283340-ksyd5l56	87	14	either	either	CC
cord-283340-ksyd5l56	87	15	>	>	SYM
cord-283340-ksyd5l56	87	16	2.0	2.0	CD
cord-283340-ksyd5l56	87	17	or	or	CC
cord-283340-ksyd5l56	87	18	<	<	XX
cord-283340-ksyd5l56	87	19	0.5	0.5	CD
cord-283340-ksyd5l56	87	20	)	)	-RRB-
cord-283340-ksyd5l56	87	21	or	or	CC
cord-283340-ksyd5l56	87	22	very	very	RB
cord-283340-ksyd5l56	87	23	large	large	JJ
cord-283340-ksyd5l56	87	24	(	(	-LRB-
cord-283340-ksyd5l56	87	25	RR/	rr/	NN
cord-283340-ksyd5l56	87	26	OR	or	CC
cord-283340-ksyd5l56	87	27	either	either	RB
cord-283340-ksyd5l56	87	28	>	>	XX
cord-283340-ksyd5l56	88	1	5.0	5.0	CD
cord-283340-ksyd5l56	88	2	or	or	CC
cord-283340-ksyd5l56	88	3	<	<	XX
cord-283340-ksyd5l56	88	4	0.2	0.2	CD
cord-283340-ksyd5l56	88	5	)	)	-RRB-
cord-283340-ksyd5l56	88	6	,	,	,
cord-283340-ksyd5l56	88	7	the	the	DT
cord-283340-ksyd5l56	88	8	evidence	evidence	NN
cord-283340-ksyd5l56	88	9	quality	quality	NN
cord-283340-ksyd5l56	88	10	is	be	VBZ
cord-283340-ksyd5l56	88	11	upgraded	upgrade	VBN
cord-283340-ksyd5l56	88	12	by	by	IN
cord-283340-ksyd5l56	88	13	1	1	CD
cord-283340-ksyd5l56	88	14	level	level	NN
cord-283340-ksyd5l56	88	15	or	or	CC
cord-283340-ksyd5l56	88	16	2	2	CD
cord-283340-ksyd5l56	88	17	levels	level	NNS
cord-283340-ksyd5l56	88	18	,	,	,
cord-283340-ksyd5l56	88	19	respectively	respectively	RB
cord-283340-ksyd5l56	88	20	.	.	.
cord-283340-ksyd5l56	89	1	If	if	IN
cord-283340-ksyd5l56	89	2	there	there	EX
cord-283340-ksyd5l56	89	3	is	be	VBZ
cord-283340-ksyd5l56	89	4	evidence	evidence	NN
cord-283340-ksyd5l56	89	5	that	that	IN
cord-283340-ksyd5l56	89	6	the	the	DT
cord-283340-ksyd5l56	89	7	influence	influence	NN
cord-283340-ksyd5l56	89	8	of	of	IN
cord-283340-ksyd5l56	89	9	all	all	DT
cord-283340-ksyd5l56	89	10	plausible	plausible	JJ
cord-283340-ksyd5l56	89	11	confounding	confound	VBG
cord-283340-ksyd5l56	89	12	would	would	MD
cord-283340-ksyd5l56	89	13	reduce	reduce	VB
cord-283340-ksyd5l56	89	14	a	a	DT
cord-283340-ksyd5l56	89	15	demonstrated	demonstrate	VBN
cord-283340-ksyd5l56	89	16	effect	effect	NN
cord-283340-ksyd5l56	89	17	or	or	CC
cord-283340-ksyd5l56	89	18	suggest	suggest	VBP
cord-283340-ksyd5l56	89	19	a	a	DT
cord-283340-ksyd5l56	89	20	spurious	spurious	JJ
cord-283340-ksyd5l56	89	21	effect	effect	NN
cord-283340-ksyd5l56	89	22	when	when	WRB
cord-283340-ksyd5l56	89	23	the	the	DT
cord-283340-ksyd5l56	89	24	results	result	NNS
cord-283340-ksyd5l56	89	25	showed	show	VBD
cord-283340-ksyd5l56	89	26	no	no	DT
cord-283340-ksyd5l56	89	27	effect	effect	NN
cord-283340-ksyd5l56	89	28	,	,	,
cord-283340-ksyd5l56	89	29	the	the	DT
cord-283340-ksyd5l56	89	30	evidence	evidence	NN
cord-283340-ksyd5l56	89	31	quality	quality	NN
cord-283340-ksyd5l56	89	32	is	be	VBZ
cord-283340-ksyd5l56	89	33	upgraded	upgrade	VBN
cord-283340-ksyd5l56	89	34	by	by	IN
cord-283340-ksyd5l56	89	35	1	1	CD
cord-283340-ksyd5l56	89	36	level	level	NN
cord-283340-ksyd5l56	89	37	.	.	.
cord-283340-ksyd5l56	90	1	The	the	DT
cord-283340-ksyd5l56	90	2	rating	rating	NN
cord-283340-ksyd5l56	90	3	criteria	criterion	NNS
cord-283340-ksyd5l56	90	4	of	of	IN
cord-283340-ksyd5l56	90	5	GRADE	grade	NN
cord-283340-ksyd5l56	90	6	are	be	VBP
cord-283340-ksyd5l56	90	7	as	as	IN
cord-283340-ksyd5l56	90	8	follows	follow	VBZ
cord-283340-ksyd5l56	90	9	:	:	:
cord-283340-ksyd5l56	90	10	the	the	DT
cord-283340-ksyd5l56	90	11	primary	primary	JJ
cord-283340-ksyd5l56	90	12	evidence	evidence	NN
cord-283340-ksyd5l56	90	13	quality	quality	NN
cord-283340-ksyd5l56	90	14	of	of	IN
cord-283340-ksyd5l56	90	15	an	an	DT
cord-283340-ksyd5l56	90	16	observational	observational	JJ
cord-283340-ksyd5l56	90	17	study	study	NN
cord-283340-ksyd5l56	90	18	is	be	VBZ
cord-283340-ksyd5l56	90	19	considered	consider	VBN
cord-283340-ksyd5l56	90	20	low	low	JJ
cord-283340-ksyd5l56	90	21	,	,	,
cord-283340-ksyd5l56	90	22	and	and	CC
cord-283340-ksyd5l56	90	23	the	the	DT
cord-283340-ksyd5l56	90	24	evidence	evidence	NN
cord-283340-ksyd5l56	90	25	quality	quality	NN
cord-283340-ksyd5l56	90	26	is	be	VBZ
cord-283340-ksyd5l56	90	27	downgraded	downgrade	VBN
cord-283340-ksyd5l56	90	28	to	to	IN
cord-283340-ksyd5l56	90	29	very	very	RB
cord-283340-ksyd5l56	90	30	low	low	JJ
cord-283340-ksyd5l56	90	31	if	if	IN
cord-283340-ksyd5l56	90	32	it	-PRON-	PRP
cord-283340-ksyd5l56	90	33	is	be	VBZ
cord-283340-ksyd5l56	90	34	downgraded	downgrade	VBN
cord-283340-ksyd5l56	90	35	by	by	IN
cord-283340-ksyd5l56	90	36	1	1	CD
cord-283340-ksyd5l56	90	37	level	level	NN
cord-283340-ksyd5l56	90	38	,	,	,
cord-283340-ksyd5l56	90	39	upgraded	upgrade	VBN
cord-283340-ksyd5l56	90	40	to	to	TO
cord-283340-ksyd5l56	90	41	moderate	moderate	VB
cord-283340-ksyd5l56	90	42	if	if	IN
cord-283340-ksyd5l56	90	43	it	-PRON-	PRP
cord-283340-ksyd5l56	90	44	is	be	VBZ
cord-283340-ksyd5l56	90	45	increased	increase	VBN
cord-283340-ksyd5l56	90	46	by	by	IN
cord-283340-ksyd5l56	90	47	1	1	CD
cord-283340-ksyd5l56	90	48	level	level	NN
cord-283340-ksyd5l56	90	49	,	,	,
cord-283340-ksyd5l56	90	50	and	and	CC
cord-283340-ksyd5l56	90	51	upgraded	upgrade	VBN
cord-283340-ksyd5l56	90	52	to	to	IN
cord-283340-ksyd5l56	90	53	high	high	JJ
cord-283340-ksyd5l56	90	54	if	if	IN
cord-283340-ksyd5l56	90	55	it	-PRON-	PRP
cord-283340-ksyd5l56	90	56	is	be	VBZ
cord-283340-ksyd5l56	90	57	increased	increase	VBN
cord-283340-ksyd5l56	90	58	by	by	IN
cord-283340-ksyd5l56	90	59	2	2	CD
cord-283340-ksyd5l56	90	60	levels	level	NNS
cord-283340-ksyd5l56	90	61	.	.	.
cord-283340-ksyd5l56	91	1	As	as	IN
cord-283340-ksyd5l56	91	2	a	a	DT
cord-283340-ksyd5l56	91	3	result	result	NN
cord-283340-ksyd5l56	91	4	,	,	,
cord-283340-ksyd5l56	91	5	the	the	DT
cord-283340-ksyd5l56	91	6	GRADE	grade	NN
cord-283340-ksyd5l56	91	7	system	system	NN
cord-283340-ksyd5l56	91	8	classifies	classify	VBZ
cord-283340-ksyd5l56	91	9	the	the	DT
cord-283340-ksyd5l56	91	10	evidence	evidence	NN
cord-283340-ksyd5l56	91	11	quality	quality	NN
cord-283340-ksyd5l56	91	12	of	of	IN
cord-283340-ksyd5l56	91	13	outcomes	outcome	NNS
cord-283340-ksyd5l56	91	14	from	from	IN
cord-283340-ksyd5l56	91	15	eligible	eligible	JJ
cord-283340-ksyd5l56	91	16	articles	article	NNS
cord-283340-ksyd5l56	91	17	as	as	IN
cord-283340-ksyd5l56	91	18	high	high	JJ
cord-283340-ksyd5l56	91	19	,	,	,
cord-283340-ksyd5l56	91	20	moderate	moderate	JJ
cord-283340-ksyd5l56	91	21	,	,	,
cord-283340-ksyd5l56	91	22	low	low	JJ
cord-283340-ksyd5l56	91	23	,	,	,
cord-283340-ksyd5l56	91	24	or	or	CC
cord-283340-ksyd5l56	91	25	very	very	RB
cord-283340-ksyd5l56	91	26	low	low	JJ
cord-283340-ksyd5l56	91	27	.	.	.
cord-283340-ksyd5l56	92	1	The	the	DT
cord-283340-ksyd5l56	92	2	GRADE	grade	NN
cord-283340-ksyd5l56	92	3	classification	classification	NN
cord-283340-ksyd5l56	92	4	was	be	VBD
cord-283340-ksyd5l56	92	5	independently	independently	RB
cord-283340-ksyd5l56	92	6	performed	perform	VBN
cord-283340-ksyd5l56	92	7	by	by	IN
cord-283340-ksyd5l56	92	8	2	2	CD
cord-283340-ksyd5l56	92	9	authors	author	NNS
cord-283340-ksyd5l56	92	10	(	(	-LRB-
cord-283340-ksyd5l56	92	11	G.J.C.	G.J.C.	NNP
cord-283340-ksyd5l56	92	12	and	and	CC
cord-283340-ksyd5l56	92	13	H.M.K.	H.M.K.	NNP
cord-283340-ksyd5l56	92	14	)	)	-RRB-
cord-283340-ksyd5l56	92	15	.	.	.
cord-283340-ksyd5l56	93	1	Any	any	DT
cord-283340-ksyd5l56	93	2	discrepancy	discrepancy	NN
cord-283340-ksyd5l56	93	3	was	be	VBD
cord-283340-ksyd5l56	93	4	resolved	resolve	VBN
cord-283340-ksyd5l56	93	5	via	via	IN
cord-283340-ksyd5l56	93	6	a	a	DT
cord-283340-ksyd5l56	93	7	discussion	discussion	NN
cord-283340-ksyd5l56	93	8	,	,	,
cord-283340-ksyd5l56	93	9	and	and	CC
cord-283340-ksyd5l56	93	10	all	all	DT
cord-283340-ksyd5l56	93	11	discrepancies	discrepancy	NNS
cord-283340-ksyd5l56	93	12	that	that	WDT
cord-283340-ksyd5l56	93	13	could	could	MD
cord-283340-ksyd5l56	93	14	not	not	RB
cord-283340-ksyd5l56	93	15	be	be	VB
cord-283340-ksyd5l56	93	16	resolved	resolve	VBN
cord-283340-ksyd5l56	93	17	through	through	IN
cord-283340-ksyd5l56	93	18	a	a	DT
cord-283340-ksyd5l56	93	19	discussion	discussion	NN
cord-283340-ksyd5l56	93	20	were	be	VBD
cord-283340-ksyd5l56	93	21	arbitrated	arbitrate	VBN
cord-283340-ksyd5l56	93	22	by	by	IN
cord-283340-ksyd5l56	93	23	a	a	DT
cord-283340-ksyd5l56	93	24	third	third	JJ
cord-283340-ksyd5l56	93	25	author	author	NN
cord-283340-ksyd5l56	93	26	(	(	-LRB-
cord-283340-ksyd5l56	93	27	H.K.	H.K.	NNP
cord-283340-ksyd5l56	93	28	)	)	-RRB-
cord-283340-ksyd5l56	93	29	.	.	.
cord-283340-ksyd5l56	94	1	Table	table	NN
cord-283340-ksyd5l56	94	2	1	1	CD
cord-283340-ksyd5l56	94	3	.	.	.
cord-283340-ksyd5l56	95	1	Checklists	checklist	NNS
cord-283340-ksyd5l56	95	2	for	for	IN
cord-283340-ksyd5l56	95	3	assessing	assess	VBG
cord-283340-ksyd5l56	95	4	systematic	systematic	JJ
cord-283340-ksyd5l56	95	5	reviews	review	NNS
cord-283340-ksyd5l56	95	6	and	and	CC
cord-283340-ksyd5l56	95	7	meta	meta	NNP
cord-283340-ksyd5l56	95	8	-	-	HYPH
cord-283340-ksyd5l56	95	9	analyses	analysis	NNS
cord-283340-ksyd5l56	95	10	according	accord	VBG
cord-283340-ksyd5l56	95	11	to	to	IN
cord-283340-ksyd5l56	95	12	the	the	DT
cord-283340-ksyd5l56	95	13	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	95	14	2	2	CD
cord-283340-ksyd5l56	95	15	tool	tool	NN
cord-283340-ksyd5l56	95	16	Item	item	NN
cord-283340-ksyd5l56	95	17	Checklists	checklist	NNS
cord-283340-ksyd5l56	95	18	(	(	-LRB-
cord-283340-ksyd5l56	95	19	7	7	CD
cord-283340-ksyd5l56	95	20	critical	critical	JJ
cord-283340-ksyd5l56	95	21	*	*	NFP
cord-283340-ksyd5l56	95	22	and	and	CC
cord-283340-ksyd5l56	95	23	9	9	CD
cord-283340-ksyd5l56	95	24	non	non	JJ
cord-283340-ksyd5l56	95	25	-	-	JJ
cord-283340-ksyd5l56	95	26	critical	critical	JJ
cord-283340-ksyd5l56	95	27	checklists	checklist	NNS
cord-283340-ksyd5l56	95	28	)	)	-RRB-
cord-283340-ksyd5l56	96	1	1	1	LS
cord-283340-ksyd5l56	97	1	Did	do	VBD
cord-283340-ksyd5l56	97	2	the	the	DT
cord-283340-ksyd5l56	97	3	research	research	NN
cord-283340-ksyd5l56	97	4	questions	question	NNS
cord-283340-ksyd5l56	97	5	and	and	CC
cord-283340-ksyd5l56	97	6	inclusion	inclusion	NN
cord-283340-ksyd5l56	97	7	criteria	criterion	NNS
cord-283340-ksyd5l56	97	8	for	for	IN
cord-283340-ksyd5l56	97	9	the	the	DT
cord-283340-ksyd5l56	97	10	review	review	NN
cord-283340-ksyd5l56	97	11	include	include	VBP
cord-283340-ksyd5l56	97	12	the	the	DT
cord-283340-ksyd5l56	97	13	components	component	NNS
cord-283340-ksyd5l56	97	14	of	of	IN
cord-283340-ksyd5l56	97	15	PICO	PICO	NNP
cord-283340-ksyd5l56	97	16	?	?	.
cord-283340-ksyd5l56	98	1	2	2	LS
cord-283340-ksyd5l56	99	1	*	*	NFP
cord-283340-ksyd5l56	99	2	Did	do	VBD
cord-283340-ksyd5l56	99	3	the	the	DT
cord-283340-ksyd5l56	99	4	report	report	NN
cord-283340-ksyd5l56	99	5	of	of	IN
cord-283340-ksyd5l56	99	6	the	the	DT
cord-283340-ksyd5l56	99	7	review	review	NN
cord-283340-ksyd5l56	99	8	contain	contain	VBP
cord-283340-ksyd5l56	99	9	an	an	DT
cord-283340-ksyd5l56	99	10	explicit	explicit	JJ
cord-283340-ksyd5l56	99	11	statement	statement	NN
cord-283340-ksyd5l56	99	12	that	that	IN
cord-283340-ksyd5l56	99	13	the	the	DT
cord-283340-ksyd5l56	99	14	review	review	NN
cord-283340-ksyd5l56	99	15	methods	method	NNS
cord-283340-ksyd5l56	99	16	were	be	VBD
cord-283340-ksyd5l56	99	17	established	establish	VBN
cord-283340-ksyd5l56	99	18	prior	prior	RB
cord-283340-ksyd5l56	99	19	to	to	IN
cord-283340-ksyd5l56	99	20	conduct	conduct	NN
cord-283340-ksyd5l56	99	21	of	of	IN
cord-283340-ksyd5l56	99	22	the	the	DT
cord-283340-ksyd5l56	99	23	review	review	NN
cord-283340-ksyd5l56	99	24	and	and	CC
cord-283340-ksyd5l56	99	25	did	do	VBD
cord-283340-ksyd5l56	99	26	the	the	DT
cord-283340-ksyd5l56	99	27	report	report	NN
cord-283340-ksyd5l56	99	28	justify	justify	VB
cord-283340-ksyd5l56	99	29	any	any	DT
cord-283340-ksyd5l56	99	30	significant	significant	JJ
cord-283340-ksyd5l56	99	31	deviations	deviation	NNS
cord-283340-ksyd5l56	99	32	from	from	IN
cord-283340-ksyd5l56	99	33	the	the	DT
cord-283340-ksyd5l56	99	34	protocol	protocol	NN
cord-283340-ksyd5l56	99	35	?	?	.
cord-283340-ksyd5l56	100	1	3	3	LS
cord-283340-ksyd5l56	101	1	Did	do	VBD
cord-283340-ksyd5l56	102	1	the	the	DT
cord-283340-ksyd5l56	102	2	review	review	NN
cord-283340-ksyd5l56	103	1	authors	author	NNS
cord-283340-ksyd5l56	103	2	explain	explain	VBP
cord-283340-ksyd5l56	103	3	their	-PRON-	PRP$
cord-283340-ksyd5l56	103	4	selection	selection	NN
cord-283340-ksyd5l56	103	5	of	of	IN
cord-283340-ksyd5l56	103	6	the	the	DT
cord-283340-ksyd5l56	103	7	study	study	NN
cord-283340-ksyd5l56	103	8	designs	design	NNS
cord-283340-ksyd5l56	103	9	for	for	IN
cord-283340-ksyd5l56	103	10	inclusion	inclusion	NN
cord-283340-ksyd5l56	103	11	in	in	IN
cord-283340-ksyd5l56	103	12	the	the	DT
cord-283340-ksyd5l56	103	13	review	review	NN
cord-283340-ksyd5l56	103	14	?	?	.
cord-283340-ksyd5l56	104	1	4	4	LS
cord-283340-ksyd5l56	105	1	*	*	NFP
cord-283340-ksyd5l56	105	2	Did	do	VBD
cord-283340-ksyd5l56	105	3	the	the	DT
cord-283340-ksyd5l56	105	4	review	review	NN
cord-283340-ksyd5l56	105	5	authors	author	NNS
cord-283340-ksyd5l56	105	6	use	use	VBP
cord-283340-ksyd5l56	105	7	a	a	DT
cord-283340-ksyd5l56	105	8	comprehensive	comprehensive	JJ
cord-283340-ksyd5l56	105	9	literature	literature	NN
cord-283340-ksyd5l56	105	10	search	search	NN
cord-283340-ksyd5l56	105	11	strategy	strategy	NN
cord-283340-ksyd5l56	105	12	?	?	.
cord-283340-ksyd5l56	106	1	5	5	LS
cord-283340-ksyd5l56	107	1	Did	do	VBD
cord-283340-ksyd5l56	108	1	the	the	DT
cord-283340-ksyd5l56	108	2	review	review	NN
cord-283340-ksyd5l56	108	3	authors	author	NNS
cord-283340-ksyd5l56	108	4	perform	perform	VBP
cord-283340-ksyd5l56	108	5	study	study	NN
cord-283340-ksyd5l56	108	6	selection	selection	NN
cord-283340-ksyd5l56	108	7	in	in	IN
cord-283340-ksyd5l56	108	8	duplicate	duplicate	NN
cord-283340-ksyd5l56	108	9	?	?	.
cord-283340-ksyd5l56	109	1	6	6	CD
cord-283340-ksyd5l56	110	1	Did	do	VBD
cord-283340-ksyd5l56	110	2	the	the	DT
cord-283340-ksyd5l56	110	3	review	review	NN
cord-283340-ksyd5l56	110	4	authors	author	NNS
cord-283340-ksyd5l56	110	5	perform	perform	VBP
cord-283340-ksyd5l56	110	6	data	data	NN
cord-283340-ksyd5l56	110	7	extraction	extraction	NN
cord-283340-ksyd5l56	110	8	in	in	IN
cord-283340-ksyd5l56	110	9	duplicate	duplicate	NN
cord-283340-ksyd5l56	110	10	?	?	.
cord-283340-ksyd5l56	111	1	7	7	CD
cord-283340-ksyd5l56	112	1	*	*	NFP
cord-283340-ksyd5l56	113	1	Did	do	VBD
cord-283340-ksyd5l56	114	1	the	the	DT
cord-283340-ksyd5l56	114	2	review	review	NN
cord-283340-ksyd5l56	114	3	authors	author	NNS
cord-283340-ksyd5l56	114	4	provide	provide	VBP
cord-283340-ksyd5l56	114	5	a	a	DT
cord-283340-ksyd5l56	114	6	list	list	NN
cord-283340-ksyd5l56	114	7	of	of	IN
cord-283340-ksyd5l56	114	8	excluded	exclude	VBN
cord-283340-ksyd5l56	114	9	studies	study	NNS
cord-283340-ksyd5l56	114	10	and	and	CC
cord-283340-ksyd5l56	114	11	justify	justify	VB
cord-283340-ksyd5l56	114	12	the	the	DT
cord-283340-ksyd5l56	114	13	exclusions	exclusion	NNS
cord-283340-ksyd5l56	114	14	?	?	.
cord-283340-ksyd5l56	115	1	8	8	CD
cord-283340-ksyd5l56	116	1	Did	do	VBD
cord-283340-ksyd5l56	116	2	the	the	DT
cord-283340-ksyd5l56	116	3	review	review	NN
cord-283340-ksyd5l56	116	4	authors	author	NNS
cord-283340-ksyd5l56	116	5	describe	describe	VBP
cord-283340-ksyd5l56	116	6	the	the	DT
cord-283340-ksyd5l56	116	7	included	include	VBN
cord-283340-ksyd5l56	116	8	studies	study	NNS
cord-283340-ksyd5l56	116	9	in	in	IN
cord-283340-ksyd5l56	116	10	adequate	adequate	JJ
cord-283340-ksyd5l56	116	11	detail	detail	NN
cord-283340-ksyd5l56	116	12	?	?	.
cord-283340-ksyd5l56	117	1	9	9	CD
cord-283340-ksyd5l56	118	1	*	*	NFP
cord-283340-ksyd5l56	118	2	Did	do	VBD
cord-283340-ksyd5l56	118	3	the	the	DT
cord-283340-ksyd5l56	118	4	review	review	NN
cord-283340-ksyd5l56	118	5	authors	author	NNS
cord-283340-ksyd5l56	118	6	use	use	VBP
cord-283340-ksyd5l56	118	7	a	a	DT
cord-283340-ksyd5l56	118	8	satisfactory	satisfactory	JJ
cord-283340-ksyd5l56	118	9	technique	technique	NN
cord-283340-ksyd5l56	118	10	for	for	IN
cord-283340-ksyd5l56	118	11	assessing	assess	VBG
cord-283340-ksyd5l56	118	12	the	the	DT
cord-283340-ksyd5l56	118	13	RoB	rob	NN
cord-283340-ksyd5l56	118	14	in	in	IN
cord-283340-ksyd5l56	118	15	individual	individual	JJ
cord-283340-ksyd5l56	118	16	studies	study	NNS
cord-283340-ksyd5l56	118	17	that	that	WDT
cord-283340-ksyd5l56	118	18	were	be	VBD
cord-283340-ksyd5l56	118	19	included	include	VBN
cord-283340-ksyd5l56	118	20	in	in	IN
cord-283340-ksyd5l56	118	21	the	the	DT
cord-283340-ksyd5l56	118	22	review	review	NN
cord-283340-ksyd5l56	118	23	?	?	.
cord-283340-ksyd5l56	119	1	10	10	CD
cord-283340-ksyd5l56	120	1	Did	do	VBD
cord-283340-ksyd5l56	120	2	the	the	DT
cord-283340-ksyd5l56	120	3	review	review	NN
cord-283340-ksyd5l56	120	4	authors	author	NNS
cord-283340-ksyd5l56	120	5	report	report	VBP
cord-283340-ksyd5l56	120	6	on	on	IN
cord-283340-ksyd5l56	120	7	the	the	DT
cord-283340-ksyd5l56	120	8	sources	source	NNS
cord-283340-ksyd5l56	120	9	of	of	IN
cord-283340-ksyd5l56	120	10	funding	funding	NN
cord-283340-ksyd5l56	120	11	for	for	IN
cord-283340-ksyd5l56	120	12	the	the	DT
cord-283340-ksyd5l56	120	13	studies	study	NNS
cord-283340-ksyd5l56	120	14	included	include	VBN
cord-283340-ksyd5l56	120	15	in	in	IN
cord-283340-ksyd5l56	120	16	the	the	DT
cord-283340-ksyd5l56	120	17	review	review	NN
cord-283340-ksyd5l56	120	18	?	?	.
cord-283340-ksyd5l56	121	1	11	11	CD
cord-283340-ksyd5l56	122	1	*	*	NFP
cord-283340-ksyd5l56	122	2	If	if	IN
cord-283340-ksyd5l56	122	3	meta	meta	NNP
cord-283340-ksyd5l56	122	4	-	-	HYPH
cord-283340-ksyd5l56	122	5	analysis	analysis	NN
cord-283340-ksyd5l56	122	6	was	be	VBD
cord-283340-ksyd5l56	122	7	justified	justify	VBN
cord-283340-ksyd5l56	122	8	did	do	VBD
cord-283340-ksyd5l56	122	9	the	the	DT
cord-283340-ksyd5l56	122	10	review	review	NN
cord-283340-ksyd5l56	122	11	authors	author	NNS
cord-283340-ksyd5l56	122	12	use	use	VBP
cord-283340-ksyd5l56	122	13	appropriate	appropriate	JJ
cord-283340-ksyd5l56	122	14	methods	method	NNS
cord-283340-ksyd5l56	122	15	for	for	IN
cord-283340-ksyd5l56	122	16	statistical	statistical	JJ
cord-283340-ksyd5l56	122	17	combination	combination	NN
cord-283340-ksyd5l56	122	18	of	of	IN
cord-283340-ksyd5l56	122	19	results	result	NNS
cord-283340-ksyd5l56	122	20	?	?	.
cord-283340-ksyd5l56	123	1	12	12	CD
cord-283340-ksyd5l56	124	1	If	if	IN
cord-283340-ksyd5l56	124	2	meta	meta	NNP
cord-283340-ksyd5l56	124	3	-	-	HYPH
cord-283340-ksyd5l56	124	4	analysis	analysis	NN
cord-283340-ksyd5l56	124	5	was	be	VBD
cord-283340-ksyd5l56	124	6	performed	perform	VBN
cord-283340-ksyd5l56	124	7	did	do	VBD
cord-283340-ksyd5l56	124	8	the	the	DT
cord-283340-ksyd5l56	124	9	review	review	NN
cord-283340-ksyd5l56	124	10	authors	author	NNS
cord-283340-ksyd5l56	124	11	assess	assess	VBP
cord-283340-ksyd5l56	124	12	the	the	DT
cord-283340-ksyd5l56	124	13	potential	potential	JJ
cord-283340-ksyd5l56	124	14	impact	impact	NN
cord-283340-ksyd5l56	124	15	of	of	IN
cord-283340-ksyd5l56	124	16	RoB	RoB	NNP
cord-283340-ksyd5l56	124	17	in	in	IN
cord-283340-ksyd5l56	124	18	individual	individual	JJ
cord-283340-ksyd5l56	124	19	studies	study	NNS
cord-283340-ksyd5l56	124	20	on	on	IN
cord-283340-ksyd5l56	124	21	the	the	DT
cord-283340-ksyd5l56	124	22	results	result	NNS
cord-283340-ksyd5l56	124	23	of	of	IN
cord-283340-ksyd5l56	124	24	the	the	DT
cord-283340-ksyd5l56	124	25	meta	meta	NNP
cord-283340-ksyd5l56	124	26	-	-	HYPH
cord-283340-ksyd5l56	124	27	analysis	analysis	NN
cord-283340-ksyd5l56	124	28	or	or	CC
cord-283340-ksyd5l56	124	29	other	other	JJ
cord-283340-ksyd5l56	124	30	evidence	evidence	NN
cord-283340-ksyd5l56	124	31	synthesis	synthesis	NN
cord-283340-ksyd5l56	124	32	?	?	.
cord-283340-ksyd5l56	125	1	13	13	CD
cord-283340-ksyd5l56	126	1	*	*	NFP
cord-283340-ksyd5l56	127	1	Did	do	VBD
cord-283340-ksyd5l56	128	1	the	the	DT
cord-283340-ksyd5l56	128	2	review	review	NN
cord-283340-ksyd5l56	128	3	authors	author	NNS
cord-283340-ksyd5l56	128	4	account	account	VBP
cord-283340-ksyd5l56	128	5	for	for	IN
cord-283340-ksyd5l56	128	6	RoB	RoB	NNP
cord-283340-ksyd5l56	128	7	in	in	IN
cord-283340-ksyd5l56	128	8	individual	individual	JJ
cord-283340-ksyd5l56	128	9	studies	study	NNS
cord-283340-ksyd5l56	128	10	when	when	WRB
cord-283340-ksyd5l56	128	11	interpreting	interpret	VBG
cord-283340-ksyd5l56	128	12	/	/	SYM
cord-283340-ksyd5l56	128	13	discussing	discuss	VBG
cord-283340-ksyd5l56	128	14	the	the	DT
cord-283340-ksyd5l56	128	15	results	result	NNS
cord-283340-ksyd5l56	128	16	of	of	IN
cord-283340-ksyd5l56	128	17	the	the	DT
cord-283340-ksyd5l56	128	18	review	review	NN
cord-283340-ksyd5l56	128	19	?	?	.
cord-283340-ksyd5l56	129	1	14	14	CD
cord-283340-ksyd5l56	130	1	Did	do	VBD
cord-283340-ksyd5l56	130	2	the	the	DT
cord-283340-ksyd5l56	130	3	review	review	NN
cord-283340-ksyd5l56	130	4	authors	author	NNS
cord-283340-ksyd5l56	130	5	provide	provide	VBP
cord-283340-ksyd5l56	130	6	a	a	DT
cord-283340-ksyd5l56	130	7	satisfactory	satisfactory	JJ
cord-283340-ksyd5l56	130	8	explanation	explanation	NN
cord-283340-ksyd5l56	130	9	for	for	IN
cord-283340-ksyd5l56	130	10	,	,	,
cord-283340-ksyd5l56	130	11	and	and	CC
cord-283340-ksyd5l56	130	12	discussion	discussion	NN
cord-283340-ksyd5l56	130	13	of	of	IN
cord-283340-ksyd5l56	130	14	,	,	,
cord-283340-ksyd5l56	130	15	any	any	DT
cord-283340-ksyd5l56	130	16	heterogeneity	heterogeneity	NN
cord-283340-ksyd5l56	130	17	observed	observe	VBN
cord-283340-ksyd5l56	130	18	in	in	IN
cord-283340-ksyd5l56	130	19	the	the	DT
cord-283340-ksyd5l56	130	20	results	result	NNS
cord-283340-ksyd5l56	130	21	of	of	IN
cord-283340-ksyd5l56	130	22	the	the	DT
cord-283340-ksyd5l56	130	23	review	review	NN
cord-283340-ksyd5l56	130	24	?	?	.
cord-283340-ksyd5l56	131	1	15	15	CD
cord-283340-ksyd5l56	132	1	*	*	NFP
cord-283340-ksyd5l56	132	2	If	if	IN
cord-283340-ksyd5l56	132	3	they	-PRON-	PRP
cord-283340-ksyd5l56	132	4	performed	perform	VBD
cord-283340-ksyd5l56	132	5	quantitative	quantitative	JJ
cord-283340-ksyd5l56	132	6	synthesis	synthesis	NN
cord-283340-ksyd5l56	132	7	did	do	VBD
cord-283340-ksyd5l56	132	8	the	the	DT
cord-283340-ksyd5l56	132	9	review	review	NN
cord-283340-ksyd5l56	132	10	authors	author	NNS
cord-283340-ksyd5l56	132	11	carry	carry	VBP
cord-283340-ksyd5l56	132	12	out	out	RP
cord-283340-ksyd5l56	132	13	an	an	DT
cord-283340-ksyd5l56	132	14	adequate	adequate	JJ
cord-283340-ksyd5l56	132	15	investigation	investigation	NN
cord-283340-ksyd5l56	132	16	of	of	IN
cord-283340-ksyd5l56	132	17	publication	publication	NN
cord-283340-ksyd5l56	132	18	bias	bias	NN
cord-283340-ksyd5l56	132	19	(	(	-LRB-
cord-283340-ksyd5l56	132	20	small	small	JJ
cord-283340-ksyd5l56	132	21	study	study	NN
cord-283340-ksyd5l56	132	22	bias	bias	NN
cord-283340-ksyd5l56	132	23	)	)	-RRB-
cord-283340-ksyd5l56	132	24	and	and	CC
cord-283340-ksyd5l56	132	25	discuss	discuss	VB
cord-283340-ksyd5l56	132	26	its	-PRON-	PRP$
cord-283340-ksyd5l56	132	27	likely	likely	JJ
cord-283340-ksyd5l56	132	28	impact	impact	NN
cord-283340-ksyd5l56	132	29	on	on	IN
cord-283340-ksyd5l56	132	30	the	the	DT
cord-283340-ksyd5l56	132	31	results	result	NNS
cord-283340-ksyd5l56	132	32	of	of	IN
cord-283340-ksyd5l56	132	33	the	the	DT
cord-283340-ksyd5l56	132	34	review	review	NN
cord-283340-ksyd5l56	132	35	?	?	.
cord-283340-ksyd5l56	133	1	16	16	CD
cord-283340-ksyd5l56	134	1	Did	do	VBD
cord-283340-ksyd5l56	135	1	the	the	DT
cord-283340-ksyd5l56	135	2	review	review	NN
cord-283340-ksyd5l56	135	3	authors	author	NNS
cord-283340-ksyd5l56	135	4	report	report	VBP
cord-283340-ksyd5l56	135	5	any	any	DT
cord-283340-ksyd5l56	135	6	potential	potential	JJ
cord-283340-ksyd5l56	135	7	sources	source	NNS
cord-283340-ksyd5l56	135	8	of	of	IN
cord-283340-ksyd5l56	135	9	conflict	conflict	NN
cord-283340-ksyd5l56	135	10	of	of	IN
cord-283340-ksyd5l56	135	11	interest	interest	NN
cord-283340-ksyd5l56	135	12	,	,	,
cord-283340-ksyd5l56	135	13	including	include	VBG
cord-283340-ksyd5l56	135	14	any	any	DT
cord-283340-ksyd5l56	135	15	funding	funding	NN
cord-283340-ksyd5l56	135	16	they	-PRON-	PRP
cord-283340-ksyd5l56	135	17	received	receive	VBD
cord-283340-ksyd5l56	135	18	for	for	IN
cord-283340-ksyd5l56	135	19	conducting	conduct	VBG
cord-283340-ksyd5l56	135	20	the	the	DT
cord-283340-ksyd5l56	135	21	review	review	NN
cord-283340-ksyd5l56	135	22	?	?	.
cord-283340-ksyd5l56	136	1	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	136	2	,	,	,
cord-283340-ksyd5l56	136	3	A	a	DT
cord-283340-ksyd5l56	136	4	MeaSurement	MeaSurement	NNP
cord-283340-ksyd5l56	136	5	Tool	tool	NN
cord-283340-ksyd5l56	136	6	to	to	TO
cord-283340-ksyd5l56	136	7	Assess	assess	VB
cord-283340-ksyd5l56	136	8	systematic	systematic	JJ
cord-283340-ksyd5l56	136	9	Reviews	review	NNS
cord-283340-ksyd5l56	136	10	;	;	:
cord-283340-ksyd5l56	136	11	PICO	PICO	NNP
cord-283340-ksyd5l56	136	12	,	,	,
cord-283340-ksyd5l56	136	13	population	population	NN
cord-283340-ksyd5l56	136	14	,	,	,
cord-283340-ksyd5l56	136	15	intervention	intervention	NN
cord-283340-ksyd5l56	136	16	,	,	,
cord-283340-ksyd5l56	136	17	comparison	comparison	NN
cord-283340-ksyd5l56	136	18	,	,	,
cord-283340-ksyd5l56	136	19	and	and	CC
cord-283340-ksyd5l56	136	20	outcome	outcome	NN
cord-283340-ksyd5l56	136	21	;	;	:
cord-283340-ksyd5l56	136	22	RoB	RoB	NNP
cord-283340-ksyd5l56	136	23	,	,	,
cord-283340-ksyd5l56	136	24	risk	risk	NN
cord-283340-ksyd5l56	136	25	of	of	IN
cord-283340-ksyd5l56	136	26	bias	bias	NN
cord-283340-ksyd5l56	136	27	.	.	.
cord-283340-ksyd5l56	137	1	The	the	DT
cord-283340-ksyd5l56	137	2	literature	literature	NN
cord-283340-ksyd5l56	137	3	search	search	NN
cord-283340-ksyd5l56	137	4	performed	perform	VBN
cord-283340-ksyd5l56	137	5	using	use	VBG
cord-283340-ksyd5l56	137	6	the	the	DT
cord-283340-ksyd5l56	137	7	keywords	keyword	NNS
cord-283340-ksyd5l56	137	8	shown	show	VBN
cord-283340-ksyd5l56	137	9	in	in	IN
cord-283340-ksyd5l56	137	10	Table	Table	NNP
cord-283340-ksyd5l56	137	11	2	2	CD
cord-283340-ksyd5l56	137	12	yielded	yield	VBD
cord-283340-ksyd5l56	137	13	several	several	JJ
cord-283340-ksyd5l56	137	14	studies	study	NNS
cord-283340-ksyd5l56	137	15	.	.	.
cord-283340-ksyd5l56	138	1	Of	of	IN
cord-283340-ksyd5l56	138	2	the	the	DT
cord-283340-ksyd5l56	138	3	35	35	CD
cord-283340-ksyd5l56	138	4	articles	article	NNS
cord-283340-ksyd5l56	138	5	identified	identify	VBN
cord-283340-ksyd5l56	138	6	,	,	,
cord-283340-ksyd5l56	138	7	3	3	CD
cord-283340-ksyd5l56	138	8	duplicates	duplicate	NNS
cord-283340-ksyd5l56	138	9	were	be	VBD
cord-283340-ksyd5l56	138	10	removed	remove	VBN
cord-283340-ksyd5l56	138	11	.	.	.
cord-283340-ksyd5l56	139	1	After	after	IN
cord-283340-ksyd5l56	139	2	exclusion	exclusion	NN
cord-283340-ksyd5l56	139	3	of	of	IN
cord-283340-ksyd5l56	139	4	14	14	CD
cord-283340-ksyd5l56	139	5	articles	article	NNS
cord-283340-ksyd5l56	139	6	through	through	IN
cord-283340-ksyd5l56	139	7	title	title	NN
cord-283340-ksyd5l56	139	8	and	and	CC
cord-283340-ksyd5l56	139	9	abstract	abstract	JJ
cord-283340-ksyd5l56	139	10	screening	screening	NN
cord-283340-ksyd5l56	139	11	,	,	,
cord-283340-ksyd5l56	139	12	the	the	DT
cord-283340-ksyd5l56	139	13	full	full	JJ
cord-283340-ksyd5l56	139	14	texts	text	NNS
cord-283340-ksyd5l56	139	15	of	of	IN
cord-283340-ksyd5l56	139	16	18	18	CD
cord-283340-ksyd5l56	139	17	articles	article	NNS
cord-283340-ksyd5l56	139	18	were	be	VBD
cord-283340-ksyd5l56	139	19	assessed	assess	VBN
cord-283340-ksyd5l56	139	20	.	.	.
cord-283340-ksyd5l56	140	1	Fourteen	fourteen	CD
cord-283340-ksyd5l56	140	2	studies	study	NNS
cord-283340-ksyd5l56	140	3	that	that	WDT
cord-283340-ksyd5l56	140	4	did	do	VBD
cord-283340-ksyd5l56	140	5	not	not	RB
cord-283340-ksyd5l56	140	6	address	address	VB
cord-283340-ksyd5l56	140	7	our	-PRON-	PRP$
cord-283340-ksyd5l56	140	8	topic	topic	NN
cord-283340-ksyd5l56	140	9	of	of	IN
cord-283340-ksyd5l56	140	10	interest	interest	NN
cord-283340-ksyd5l56	140	11	22	22	CD
cord-283340-ksyd5l56	140	12	-	-	SYM
cord-283340-ksyd5l56	140	13	35	35	CD
cord-283340-ksyd5l56	140	14	were	be	VBD
cord-283340-ksyd5l56	140	15	excluded	exclude	VBN
cord-283340-ksyd5l56	140	16	.	.	.
cord-283340-ksyd5l56	141	1	Two	two	CD
cord-283340-ksyd5l56	141	2	studies	study	NNS
cord-283340-ksyd5l56	141	3	were	be	VBD
cord-283340-ksyd5l56	141	4	excluded	exclude	VBN
cord-283340-ksyd5l56	141	5	because	because	IN
cord-283340-ksyd5l56	141	6	their	-PRON-	PRP$
cord-283340-ksyd5l56	141	7	focuses	focus	NNS
cord-283340-ksyd5l56	141	8	were	be	VBD
cord-283340-ksyd5l56	141	9	on	on	IN
cord-283340-ksyd5l56	141	10	lipoprotein	lipoprotein	NN
cord-283340-ksyd5l56	141	11	(	(	-LRB-
cord-283340-ksyd5l56	141	12	a	a	LS
cord-283340-ksyd5l56	141	13	)	)	-RRB-
cord-283340-ksyd5l56	141	14	36	36	CD
cord-283340-ksyd5l56	141	15	and	and	CC
cord-283340-ksyd5l56	141	16	obesity	obesity	NN
cord-283340-ksyd5l56	141	17	,	,	,
cord-283340-ksyd5l56	141	18	37	37	CD
cord-283340-ksyd5l56	141	19	respectively	respectively	RB
cord-283340-ksyd5l56	141	20	.	.	.
cord-283340-ksyd5l56	142	1	Two	two	CD
cord-283340-ksyd5l56	142	2	studies	study	NNS
cord-283340-ksyd5l56	142	3	remained	remain	VBD
cord-283340-ksyd5l56	142	4	after	after	IN
cord-283340-ksyd5l56	142	5	full	full	JJ
cord-283340-ksyd5l56	142	6	-	-	HYPH
cord-283340-ksyd5l56	142	7	text	text	NN
cord-283340-ksyd5l56	142	8	screening	screening	NN
cord-283340-ksyd5l56	142	9	using	use	VBG
cord-283340-ksyd5l56	142	10	the	the	DT
cord-283340-ksyd5l56	142	11	eligibility	eligibility	NN
cord-283340-ksyd5l56	142	12	criteria	criterion	NNS
cord-283340-ksyd5l56	142	13	;	;	:
cord-283340-ksyd5l56	142	14	these	these	DT
cord-283340-ksyd5l56	142	15	were	be	VBD
cord-283340-ksyd5l56	142	16	the	the	DT
cord-283340-ksyd5l56	142	17	studies	study	NNS
cord-283340-ksyd5l56	142	18	by	by	IN
cord-283340-ksyd5l56	142	19	Hariyanto	Hariyanto	NNP
cord-283340-ksyd5l56	142	20	and	and	CC
cord-283340-ksyd5l56	142	21	Kurniawan	Kurniawan	NNP
cord-283340-ksyd5l56	142	22	38	38	CD
cord-283340-ksyd5l56	142	23	and	and	CC
cord-283340-ksyd5l56	142	24	Zaki	Zaki	NNP
cord-283340-ksyd5l56	142	25	et	et	NNP
cord-283340-ksyd5l56	142	26	al	al	NNP
cord-283340-ksyd5l56	142	27	.	.	.
cord-283340-ksyd5l56	143	1	39	39	CD
cord-283340-ksyd5l56	143	2	Finally	finally	RB
cord-283340-ksyd5l56	143	3	,	,	,
cord-283340-ksyd5l56	143	4	2	2	CD
cord-283340-ksyd5l56	143	5	studies	study	NNS
cord-283340-ksyd5l56	143	6	including	include	VBG
cord-283340-ksyd5l56	143	7	a	a	DT
cord-283340-ksyd5l56	143	8	total	total	NN
cord-283340-ksyd5l56	143	9	of	of	IN
cord-283340-ksyd5l56	143	10	7,951	7,951	CD
cord-283340-ksyd5l56	143	11	COVID-19-positive	covid-19-positive	JJ
cord-283340-ksyd5l56	143	12	participants	participant	NNS
cord-283340-ksyd5l56	143	13	were	be	VBD
cord-283340-ksyd5l56	143	14	included	include	VBN
cord-283340-ksyd5l56	143	15	in	in	IN
cord-283340-ksyd5l56	143	16	the	the	DT
cord-283340-ksyd5l56	143	17	current	current	JJ
cord-283340-ksyd5l56	143	18	overview	overview	NN
cord-283340-ksyd5l56	143	19	.	.	.
cord-283340-ksyd5l56	144	1	The	the	DT
cord-283340-ksyd5l56	144	2	process	process	NN
cord-283340-ksyd5l56	144	3	followed	follow	VBD
cord-283340-ksyd5l56	144	4	in	in	IN
cord-283340-ksyd5l56	144	5	the	the	DT
cord-283340-ksyd5l56	144	6	selection	selection	NN
cord-283340-ksyd5l56	144	7	of	of	IN
cord-283340-ksyd5l56	144	8	eligible	eligible	JJ
cord-283340-ksyd5l56	144	9	studies	study	NNS
cord-283340-ksyd5l56	144	10	is	be	VBZ
cord-283340-ksyd5l56	144	11	summarized	summarize	VBN
cord-283340-ksyd5l56	144	12	in	in	IN
cord-283340-ksyd5l56	144	13	Fig	Fig	NNP
cord-283340-ksyd5l56	144	14	.	.	.
cord-283340-ksyd5l56	145	1	1	1	LS
cord-283340-ksyd5l56	145	2	.	.	.
cord-283340-ksyd5l56	146	1	Table	table	NN
cord-283340-ksyd5l56	146	2	3	3	CD
cord-283340-ksyd5l56	146	3	.	.	.
cord-283340-ksyd5l56	147	1	Both	both	DT
cord-283340-ksyd5l56	147	2	of	of	IN
cord-283340-ksyd5l56	147	3	the	the	DT
cord-283340-ksyd5l56	147	4	included	include	VBN
cord-283340-ksyd5l56	147	5	reviews	review	NNS
cord-283340-ksyd5l56	147	6	had	have	VBD
cord-283340-ksyd5l56	147	7	critical	critical	JJ
cord-283340-ksyd5l56	147	8	weaknesses	weakness	NNS
cord-283340-ksyd5l56	147	9	according	accord	VBG
cord-283340-ksyd5l56	147	10	to	to	IN
cord-283340-ksyd5l56	147	11	the	the	DT
cord-283340-ksyd5l56	147	12	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	147	13	2	2	CD
cord-283340-ksyd5l56	147	14	criteria	criterion	NNS
cord-283340-ksyd5l56	147	15	.	.	.
cord-283340-ksyd5l56	148	1	They	-PRON-	PRP
cord-283340-ksyd5l56	148	2	had	have	VBD
cord-283340-ksyd5l56	148	3	in	in	IN
cord-283340-ksyd5l56	148	4	common	common	JJ
cord-283340-ksyd5l56	148	5	2	2	CD
cord-283340-ksyd5l56	148	6	critical	critical	JJ
cord-283340-ksyd5l56	148	7	flaws	flaw	NNS
cord-283340-ksyd5l56	148	8	in	in	IN
cord-283340-ksyd5l56	148	9	terms	term	NNS
cord-283340-ksyd5l56	148	10	of	of	IN
cord-283340-ksyd5l56	148	11	assessing	assess	VBG
cord-283340-ksyd5l56	148	12	the	the	DT
cord-283340-ksyd5l56	148	13	risk	risk	NN
cord-283340-ksyd5l56	148	14	of	of	IN
cord-283340-ksyd5l56	148	15	bias	bias	NN
cord-283340-ksyd5l56	148	16	(	(	-LRB-
cord-283340-ksyd5l56	148	17	RoB	RoB	NNP
cord-283340-ksyd5l56	148	18	)	)	-RRB-
cord-283340-ksyd5l56	148	19	in	in	IN
cord-283340-ksyd5l56	148	20	individual	individual	JJ
cord-283340-ksyd5l56	148	21	studies	study	NNS
cord-283340-ksyd5l56	148	22	that	that	WDT
cord-283340-ksyd5l56	148	23	were	be	VBD
cord-283340-ksyd5l56	148	24	included	include	VBN
cord-283340-ksyd5l56	148	25	in	in	IN
cord-283340-ksyd5l56	148	26	the	the	DT
cord-283340-ksyd5l56	148	27	review	review	NN
cord-283340-ksyd5l56	148	28	and	and	CC
cord-283340-ksyd5l56	148	29	accounting	account	VBG
cord-283340-ksyd5l56	148	30	for	for	IN
cord-283340-ksyd5l56	148	31	RoB	RoB	NNP
cord-283340-ksyd5l56	148	32	in	in	IN
cord-283340-ksyd5l56	148	33	individual	individual	JJ
cord-283340-ksyd5l56	148	34	studies	study	NNS
cord-283340-ksyd5l56	148	35	when	when	WRB
cord-283340-ksyd5l56	148	36	interpreting	interpret	VBG
cord-283340-ksyd5l56	148	37	/	/	SYM
cord-283340-ksyd5l56	148	38	discussing	discuss	VBG
cord-283340-ksyd5l56	148	39	the	the	DT
cord-283340-ksyd5l56	148	40	results	result	NNS
cord-283340-ksyd5l56	148	41	of	of	IN
cord-283340-ksyd5l56	148	42	the	the	DT
cord-283340-ksyd5l56	148	43	review	review	NN
cord-283340-ksyd5l56	148	44	.	.	.
cord-283340-ksyd5l56	149	1	Additionally	additionally	RB
cord-283340-ksyd5l56	149	2	,	,	,
cord-283340-ksyd5l56	149	3	the	the	DT
cord-283340-ksyd5l56	149	4	study	study	NN
cord-283340-ksyd5l56	149	5	of	of	IN
cord-283340-ksyd5l56	149	6	Hariyanto	Hariyanto	NNP
cord-283340-ksyd5l56	149	7	and	and	CC
cord-283340-ksyd5l56	149	8	Kurniawan	Kurniawan	NNP
cord-283340-ksyd5l56	149	9	38	38	CD
cord-283340-ksyd5l56	149	10	showed	show	VBD
cord-283340-ksyd5l56	149	11	critical	critical	JJ
cord-283340-ksyd5l56	149	12	flaws	flaw	NNS
cord-283340-ksyd5l56	149	13	in	in	IN
cord-283340-ksyd5l56	149	14	terms	term	NNS
cord-283340-ksyd5l56	149	15	of	of	IN
cord-283340-ksyd5l56	149	16	:	:	:
cord-283340-ksyd5l56	149	17	using	use	VBG
cord-283340-ksyd5l56	149	18	a	a	DT
cord-283340-ksyd5l56	149	19	comprehensive	comprehensive	JJ
cord-283340-ksyd5l56	149	20	literature	literature	NN
cord-283340-ksyd5l56	149	21	search	search	NN
cord-283340-ksyd5l56	149	22	strategy	strategy	NN
cord-283340-ksyd5l56	149	23	;	;	:
cord-283340-ksyd5l56	149	24	providing	provide	VBG
cord-283340-ksyd5l56	149	25	a	a	DT
cord-283340-ksyd5l56	149	26	list	list	NN
cord-283340-ksyd5l56	149	27	of	of	IN
cord-283340-ksyd5l56	149	28	excluded	exclude	VBN
cord-283340-ksyd5l56	149	29	studies	study	NNS
cord-283340-ksyd5l56	149	30	and	and	CC
cord-283340-ksyd5l56	149	31	justifying	justify	VBG
cord-283340-ksyd5l56	149	32	the	the	DT
cord-283340-ksyd5l56	149	33	exclusions	exclusion	NNS
cord-283340-ksyd5l56	149	34	;	;	,
cord-283340-ksyd5l56	149	35	using	use	VBG
cord-283340-ksyd5l56	149	36	appropriate	appropriate	JJ
cord-283340-ksyd5l56	149	37	methods	method	NNS
cord-283340-ksyd5l56	149	38	for	for	IN
cord-283340-ksyd5l56	149	39	the	the	DT
cord-283340-ksyd5l56	149	40	statistical	statistical	JJ
cord-283340-ksyd5l56	149	41	combination	combination	NN
cord-283340-ksyd5l56	149	42	of	of	IN
cord-283340-ksyd5l56	149	43	results	result	NNS
cord-283340-ksyd5l56	149	44	if	if	IN
cord-283340-ksyd5l56	149	45	a	a	DT
cord-283340-ksyd5l56	149	46	meta	meta	JJ
cord-283340-ksyd5l56	149	47	-	-	HYPH
cord-283340-ksyd5l56	149	48	analysis	analysis	NN
cord-283340-ksyd5l56	149	49	was	be	VBD
cord-283340-ksyd5l56	149	50	performed	perform	VBN
cord-283340-ksyd5l56	149	51	;	;	:
cord-283340-ksyd5l56	149	52	performing	perform	VBG
cord-283340-ksyd5l56	149	53	an	an	DT
cord-283340-ksyd5l56	149	54	adequate	adequate	JJ
cord-283340-ksyd5l56	149	55	investigation	investigation	NN
cord-283340-ksyd5l56	149	56	of	of	IN
cord-283340-ksyd5l56	149	57	publication	publication	NN
cord-283340-ksyd5l56	149	58	bias	bias	NN
cord-283340-ksyd5l56	149	59	(	(	-LRB-
cord-283340-ksyd5l56	149	60	small	small	JJ
cord-283340-ksyd5l56	149	61	study	study	NN
cord-283340-ksyd5l56	149	62	bias	bias	NN
cord-283340-ksyd5l56	149	63	)	)	-RRB-
cord-283340-ksyd5l56	149	64	;	;	:
cord-283340-ksyd5l56	149	65	and	and	CC
cord-283340-ksyd5l56	149	66	discussing	discuss	VBG
cord-283340-ksyd5l56	149	67	its	-PRON-	PRP$
cord-283340-ksyd5l56	149	68	likely	likely	JJ
cord-283340-ksyd5l56	149	69	impact	impact	NN
cord-283340-ksyd5l56	149	70	on	on	IN
cord-283340-ksyd5l56	149	71	the	the	DT
cord-283340-ksyd5l56	149	72	results	result	NNS
cord-283340-ksyd5l56	149	73	of	of	IN
cord-283340-ksyd5l56	149	74	the	the	DT
cord-283340-ksyd5l56	149	75	review	review	NN
cord-283340-ksyd5l56	149	76	if	if	IN
cord-283340-ksyd5l56	149	77	a	a	DT
cord-283340-ksyd5l56	149	78	quantitative	quantitative	JJ
cord-283340-ksyd5l56	149	79	synthesis	synthesis	NN
cord-283340-ksyd5l56	149	80	was	be	VBD
cord-283340-ksyd5l56	149	81	carried	carry	VBN
cord-283340-ksyd5l56	149	82	out	out	RP
cord-283340-ksyd5l56	149	83	.	.	.
cord-283340-ksyd5l56	150	1	The	the	DT
cord-283340-ksyd5l56	150	2	latter	latter	JJ
cord-283340-ksyd5l56	150	3	2	2	CD
cord-283340-ksyd5l56	150	4	factors	factor	NNS
cord-283340-ksyd5l56	150	5	were	be	VBD
cord-283340-ksyd5l56	150	6	not	not	RB
cord-283340-ksyd5l56	150	7	considered	consider	VBN
cord-283340-ksyd5l56	150	8	in	in	IN
cord-283340-ksyd5l56	150	9	the	the	DT
cord-283340-ksyd5l56	150	10	study	study	NN
cord-283340-ksyd5l56	150	11	of	of	IN
cord-283340-ksyd5l56	150	12	Zaki	Zaki	NNP
cord-283340-ksyd5l56	150	13	et	et	NNP
cord-283340-ksyd5l56	150	14	al	al	NNP
cord-283340-ksyd5l56	150	15	.	.	.
cord-283340-ksyd5l56	151	1	39	39	CD
cord-283340-ksyd5l56	152	1	because	because	IN
cord-283340-ksyd5l56	152	2	it	-PRON-	PRP
cord-283340-ksyd5l56	152	3	did	do	VBD
cord-283340-ksyd5l56	152	4	not	not	RB
cord-283340-ksyd5l56	152	5	contain	contain	VB
cord-283340-ksyd5l56	152	6	a	a	DT
cord-283340-ksyd5l56	152	7	meta	meta	NN
cord-283340-ksyd5l56	152	8	-	-	HYPH
cord-283340-ksyd5l56	152	9	analysis	analysis	NN
cord-283340-ksyd5l56	152	10	.	.	.
cord-283340-ksyd5l56	153	1	According	accord	VBG
cord-283340-ksyd5l56	153	2	to	to	IN
cord-283340-ksyd5l56	153	3	the	the	DT
cord-283340-ksyd5l56	153	4	rating	rating	NN
cord-283340-ksyd5l56	153	5	criteria	criterion	NNS
cord-283340-ksyd5l56	153	6	of	of	IN
cord-283340-ksyd5l56	153	7	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	153	8	2	2	CD
cord-283340-ksyd5l56	153	9	,	,	,
cord-283340-ksyd5l56	153	10	both	both	DT
cord-283340-ksyd5l56	153	11	of	of	IN
cord-283340-ksyd5l56	153	12	these	these	DT
cord-283340-ksyd5l56	153	13	studies	study	NNS
cord-283340-ksyd5l56	153	14	showed	show	VBD
cord-283340-ksyd5l56	153	15	critically	critically	RB
cord-283340-ksyd5l56	153	16	low	low	JJ
cord-283340-ksyd5l56	153	17	quality	quality	NN
cord-283340-ksyd5l56	153	18	.	.	.
cord-283340-ksyd5l56	154	1	In	in	IN
cord-283340-ksyd5l56	154	2	terms	term	NNS
cord-283340-ksyd5l56	154	3	of	of	IN
cord-283340-ksyd5l56	154	4	the	the	DT
cord-283340-ksyd5l56	154	5	GRADE	grade	NN
cord-283340-ksyd5l56	154	6	system	system	NN
cord-283340-ksyd5l56	154	7	,	,	,
cord-283340-ksyd5l56	154	8	we	-PRON-	PRP
cord-283340-ksyd5l56	154	9	evaluated	evaluate	VBD
cord-283340-ksyd5l56	154	10	only	only	RB
cord-283340-ksyd5l56	154	11	the	the	DT
cord-283340-ksyd5l56	154	12	study	study	NN
cord-283340-ksyd5l56	154	13	of	of	IN
cord-283340-ksyd5l56	154	14	Hariyanto	Hariyanto	NNP
cord-283340-ksyd5l56	154	15	and	and	CC
cord-283340-ksyd5l56	154	16	Kurniawan	Kurniawan	NNP
cord-283340-ksyd5l56	154	17	,	,	,
cord-283340-ksyd5l56	154	18	38	38	CD
cord-283340-ksyd5l56	154	19	which	which	WDT
cord-283340-ksyd5l56	154	20	conducted	conduct	VBD
cord-283340-ksyd5l56	154	21	a	a	DT
cord-283340-ksyd5l56	154	22	meta	meta	JJ
cord-283340-ksyd5l56	154	23	-	-	HYPH
cord-283340-ksyd5l56	154	24	analysis	analysis	NN
cord-283340-ksyd5l56	154	25	regarding	regard	VBG
cord-283340-ksyd5l56	154	26	severe	severe	JJ
cord-283340-ksyd5l56	154	27	outcomes	outcome	NNS
cord-283340-ksyd5l56	154	28	of	of	IN
cord-283340-ksyd5l56	154	29	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	154	30	infection	infection	NN
cord-283340-ksyd5l56	154	31	between	between	IN
cord-283340-ksyd5l56	154	32	non	non	JJ
cord-283340-ksyd5l56	154	33	-	-	JJ
cord-283340-ksyd5l56	154	34	dyslipidemia	dyslipidemia	JJ
cord-283340-ksyd5l56	154	35	and	and	CC
cord-283340-ksyd5l56	154	36	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	154	37	groups	group	NNS
cord-283340-ksyd5l56	154	38	.	.	.
cord-283340-ksyd5l56	155	1	Zaki	Zaki	NNP
cord-283340-ksyd5l56	155	2	et	et	NNP
cord-283340-ksyd5l56	155	3	al	al	NNP
cord-283340-ksyd5l56	155	4	.	.	.
cord-283340-ksyd5l56	156	1	39	39	CD
cord-283340-ksyd5l56	156	2	performed	perform	VBD
cord-283340-ksyd5l56	156	3	a	a	DT
cord-283340-ksyd5l56	156	4	systematic	systematic	JJ
cord-283340-ksyd5l56	156	5	review	review	NN
cord-283340-ksyd5l56	156	6	without	without	IN
cord-283340-ksyd5l56	156	7	a	a	DT
cord-283340-ksyd5l56	156	8	meta	meta	JJ
cord-283340-ksyd5l56	156	9	-	-	HYPH
cord-283340-ksyd5l56	156	10	analysis	analysis	NN
cord-283340-ksyd5l56	156	11	and	and	CC
cord-283340-ksyd5l56	156	12	included	include	VBD
cord-283340-ksyd5l56	156	13	various	various	JJ
cord-283340-ksyd5l56	156	14	types	type	NNS
cord-283340-ksyd5l56	156	15	of	of	IN
cord-283340-ksyd5l56	156	16	studies	study	NNS
cord-283340-ksyd5l56	156	17	such	such	JJ
cord-283340-ksyd5l56	156	18	as	as	IN
cord-283340-ksyd5l56	156	19	clinical	clinical	JJ
cord-283340-ksyd5l56	156	20	studies	study	NNS
cord-283340-ksyd5l56	156	21	,	,	,
cord-283340-ksyd5l56	156	22	in	in	IN
cord-283340-ksyd5l56	156	23	vitro	vitro	FW
cord-283340-ksyd5l56	156	24	cell	cell	NN
cord-283340-ksyd5l56	156	25	studies	study	NNS
cord-283340-ksyd5l56	156	26	,	,	,
cord-283340-ksyd5l56	156	27	and	and	CC
cord-283340-ksyd5l56	156	28	a	a	DT
cord-283340-ksyd5l56	156	29	review	review	NN
cord-283340-ksyd5l56	156	30	;	;	:
cord-283340-ksyd5l56	156	31	therefore	therefore	RB
cord-283340-ksyd5l56	156	32	,	,	,
cord-283340-ksyd5l56	156	33	it	-PRON-	PRP
cord-283340-ksyd5l56	156	34	was	be	VBD
cord-283340-ksyd5l56	156	35	difficult	difficult	JJ
cord-283340-ksyd5l56	156	36	to	to	TO
cord-283340-ksyd5l56	156	37	apply	apply	VB
cord-283340-ksyd5l56	156	38	the	the	DT
cord-283340-ksyd5l56	156	39	GRADE	grade	NN
cord-283340-ksyd5l56	156	40	system	system	NN
cord-283340-ksyd5l56	156	41	to	to	IN
cord-283340-ksyd5l56	156	42	each	each	DT
cord-283340-ksyd5l56	156	43	outcome	outcome	NN
cord-283340-ksyd5l56	156	44	in	in	IN
cord-283340-ksyd5l56	156	45	their	-PRON-	PRP$
cord-283340-ksyd5l56	156	46	study	study	NN
cord-283340-ksyd5l56	156	47	.	.	.
cord-283340-ksyd5l56	157	1	Consequently	consequently	RB
cord-283340-ksyd5l56	157	2	,	,	,
cord-283340-ksyd5l56	157	3	as	as	IN
cord-283340-ksyd5l56	157	4	the	the	DT
cord-283340-ksyd5l56	157	5	primary	primary	JJ
cord-283340-ksyd5l56	157	6	evidence	evidence	NN
cord-283340-ksyd5l56	157	7	quality	quality	NN
cord-283340-ksyd5l56	157	8	of	of	IN
cord-283340-ksyd5l56	157	9	observational	observational	JJ
cord-283340-ksyd5l56	157	10	studies	study	NNS
cord-283340-ksyd5l56	157	11	is	be	VBZ
cord-283340-ksyd5l56	157	12	considered	consider	VBN
cord-283340-ksyd5l56	157	13	to	to	TO
cord-283340-ksyd5l56	157	14	be	be	VB
cord-283340-ksyd5l56	157	15	low	low	JJ
cord-283340-ksyd5l56	157	16	in	in	IN
cord-283340-ksyd5l56	157	17	the	the	DT
cord-283340-ksyd5l56	157	18	GRADE	grade	NN
cord-283340-ksyd5l56	157	19	system	system	NN
cord-283340-ksyd5l56	157	20	,	,	,
cord-283340-ksyd5l56	157	21	the	the	DT
cord-283340-ksyd5l56	157	22	systematic	systematic	JJ
cord-283340-ksyd5l56	157	23	review	review	NN
cord-283340-ksyd5l56	157	24	was	be	VBD
cord-283340-ksyd5l56	157	25	initially	initially	RB
cord-283340-ksyd5l56	157	26	graded	grade	VBN
cord-283340-ksyd5l56	157	27	as	as	IN
cord-283340-ksyd5l56	157	28	low	low	JJ
cord-283340-ksyd5l56	157	29	.	.	.
cord-283340-ksyd5l56	158	1	Since	since	IN
cord-283340-ksyd5l56	158	2	there	there	EX
cord-283340-ksyd5l56	158	3	were	be	VBD
cord-283340-ksyd5l56	158	4	no	no	DT
cord-283340-ksyd5l56	158	5	issues	issue	NNS
cord-283340-ksyd5l56	158	6	requiring	require	VBG
cord-283340-ksyd5l56	158	7	down	down	RP
cord-283340-ksyd5l56	158	8	-	-	HYPH
cord-283340-ksyd5l56	158	9	grading	grading	NN
cord-283340-ksyd5l56	158	10	,	,	,
cord-283340-ksyd5l56	158	11	the	the	DT
cord-283340-ksyd5l56	158	12	study	study	NN
cord-283340-ksyd5l56	158	13	of	of	IN
cord-283340-ksyd5l56	158	14	Hariyanto	Hariyanto	NNP
cord-283340-ksyd5l56	158	15	and	and	CC
cord-283340-ksyd5l56	158	16	Kurniawan	Kurniawan	NNP
cord-283340-ksyd5l56	158	17	38	38	CD
cord-283340-ksyd5l56	158	18	regarding	regard	VBG
cord-283340-ksyd5l56	158	19	the	the	DT
cord-283340-ksyd5l56	158	20	relationship	relationship	NN
cord-283340-ksyd5l56	158	21	between	between	IN
cord-283340-ksyd5l56	158	22	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	158	23	and	and	CC
cord-283340-ksyd5l56	158	24	the	the	DT
cord-283340-ksyd5l56	158	25	severity	severity	NN
cord-283340-ksyd5l56	158	26	of	of	IN
cord-283340-ksyd5l56	158	27	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	158	28	infection	infection	NN
cord-283340-ksyd5l56	158	29	was	be	VBD
cord-283340-ksyd5l56	158	30	finally	finally	RB
cord-283340-ksyd5l56	158	31	graded	grade	VBN
cord-283340-ksyd5l56	158	32	as	as	IN
cord-283340-ksyd5l56	158	33	providing	provide	VBG
cord-283340-ksyd5l56	158	34	a	a	DT
cord-283340-ksyd5l56	158	35	low	low	JJ
cord-283340-ksyd5l56	158	36	quality	quality	NN
cord-283340-ksyd5l56	158	37	of	of	IN
cord-283340-ksyd5l56	158	38	evidence	evidence	NN
cord-283340-ksyd5l56	158	39	.	.	.
cord-283340-ksyd5l56	159	1	There	there	EX
cord-283340-ksyd5l56	159	2	were	be	VBD
cord-283340-ksyd5l56	159	3	no	no	DT
cord-283340-ksyd5l56	159	4	overlapping	overlap	VBG
cord-283340-ksyd5l56	159	5	studies	study	NNS
cord-283340-ksyd5l56	159	6	in	in	IN
cord-283340-ksyd5l56	159	7	the	the	DT
cord-283340-ksyd5l56	159	8	systematic	systematic	JJ
cord-283340-ksyd5l56	159	9	reviews	review	NNS
cord-283340-ksyd5l56	159	10	included	include	VBN
cord-283340-ksyd5l56	159	11	in	in	IN
cord-283340-ksyd5l56	159	12	this	this	DT
cord-283340-ksyd5l56	159	13	umbrella	umbrella	NN
cord-283340-ksyd5l56	159	14	review	review	NN
cord-283340-ksyd5l56	159	15	.	.	.
cord-283340-ksyd5l56	160	1	Since	since	IN
cord-283340-ksyd5l56	160	2	data	datum	NNS
cord-283340-ksyd5l56	160	3	were	be	VBD
cord-283340-ksyd5l56	160	4	available	available	JJ
cord-283340-ksyd5l56	160	5	from	from	IN
cord-283340-ksyd5l56	160	6	1	1	CD
cord-283340-ksyd5l56	160	7	study	study	NN
cord-283340-ksyd5l56	160	8	41	41	CD
cord-283340-ksyd5l56	160	9	included	include	VBD
cord-283340-ksyd5l56	160	10	in	in	IN
cord-283340-ksyd5l56	160	11	the	the	DT
cord-283340-ksyd5l56	160	12	review	review	NN
cord-283340-ksyd5l56	160	13	of	of	IN
cord-283340-ksyd5l56	160	14	Zaki	Zaki	NNP
cord-283340-ksyd5l56	160	15	et	et	NNP
cord-283340-ksyd5l56	160	16	al	al	NNP
cord-283340-ksyd5l56	160	17	.	.	.
cord-283340-ksyd5l56	161	1	39	39	CD
cord-283340-ksyd5l56	161	2	on	on	IN
cord-283340-ksyd5l56	161	3	the	the	DT
cord-283340-ksyd5l56	161	4	relationship	relationship	NN
cord-283340-ksyd5l56	161	5	of	of	IN
cord-283340-ksyd5l56	161	6	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	161	7	with	with	IN
cord-283340-ksyd5l56	161	8	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	161	9	severity	severity	NN
cord-283340-ksyd5l56	161	10	,	,	,
cord-283340-ksyd5l56	161	11	we	-PRON-	PRP
cord-283340-ksyd5l56	161	12	performed	perform	VBD
cord-283340-ksyd5l56	161	13	a	a	DT
cord-283340-ksyd5l56	161	14	meta	meta	JJ
cord-283340-ksyd5l56	161	15	-	-	HYPH
cord-283340-ksyd5l56	161	16	analysis	analysis	NN
cord-283340-ksyd5l56	161	17	combining	combining	NN
cord-283340-ksyd5l56	161	18	data	datum	NNS
cord-283340-ksyd5l56	161	19	from	from	IN
cord-283340-ksyd5l56	161	20	the	the	DT
cord-283340-ksyd5l56	161	21	2	2	CD
cord-283340-ksyd5l56	161	22	reviews	review	NNS
cord-283340-ksyd5l56	161	23	.	.	.
cord-283340-ksyd5l56	162	1	Our	-PRON-	PRP$
cord-283340-ksyd5l56	162	2	meta	meta	JJ
cord-283340-ksyd5l56	162	3	-	-	HYPH
cord-283340-ksyd5l56	162	4	analysis	analysis	NN
cord-283340-ksyd5l56	162	5	showed	show	VBD
cord-283340-ksyd5l56	162	6	that	that	IN
cord-283340-ksyd5l56	162	7	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	162	8	was	be	VBD
cord-283340-ksyd5l56	162	9	;	;	:
cord-283340-ksyd5l56	162	10	Fig	Fig	NNP
cord-283340-ksyd5l56	162	11	.	.	.
cord-283340-ksyd5l56	162	12	3	3	CD
cord-283340-ksyd5l56	162	13	)	)	-RRB-
cord-283340-ksyd5l56	162	14	.	.	.
cord-283340-ksyd5l56	163	1	Regarding	regard	VBG
cord-283340-ksyd5l56	163	2	the	the	DT
cord-283340-ksyd5l56	163	3	other	other	JJ
cord-283340-ksyd5l56	163	4	issues	issue	NNS
cord-283340-ksyd5l56	163	5	,	,	,
cord-283340-ksyd5l56	163	6	since	since	IN
cord-283340-ksyd5l56	163	7	the	the	DT
cord-283340-ksyd5l56	163	8	limited	limited	JJ
cord-283340-ksyd5l56	163	9	number	number	NN
cord-283340-ksyd5l56	163	10	of	of	IN
cord-283340-ksyd5l56	163	11	eligible	eligible	JJ
cord-283340-ksyd5l56	163	12	reviews	review	NNS
cord-283340-ksyd5l56	163	13	restricted	restrict	VBD
cord-283340-ksyd5l56	163	14	our	-PRON-	PRP$
cord-283340-ksyd5l56	163	15	ability	ability	NN
cord-283340-ksyd5l56	163	16	to	to	TO
cord-283340-ksyd5l56	163	17	synthesize	synthesize	VB
cord-283340-ksyd5l56	163	18	and	and	CC
cord-283340-ksyd5l56	163	19	interpret	interpret	VB
cord-283340-ksyd5l56	163	20	their	-PRON-	PRP$
cord-283340-ksyd5l56	163	21	findings	finding	NNS
cord-283340-ksyd5l56	163	22	,	,	,
cord-283340-ksyd5l56	163	23	a	a	DT
cord-283340-ksyd5l56	163	24	narrative	narrative	NN
cord-283340-ksyd5l56	163	25	synthesis	synthesis	NN
cord-283340-ksyd5l56	163	26	of	of	IN
cord-283340-ksyd5l56	163	27	the	the	DT
cord-283340-ksyd5l56	163	28	evidence	evidence	NN
cord-283340-ksyd5l56	163	29	is	be	VBZ
cord-283340-ksyd5l56	163	30	presented	present	VBN
cord-283340-ksyd5l56	163	31	in	in	IN
cord-283340-ksyd5l56	163	32	the	the	DT
cord-283340-ksyd5l56	163	33	Discussion	Discussion	NNP
cord-283340-ksyd5l56	163	34	section	section	NN
cord-283340-ksyd5l56	163	35	.	.	.
cord-283340-ksyd5l56	164	1	The	the	DT
cord-283340-ksyd5l56	164	2	2	2	CD
cord-283340-ksyd5l56	164	3	reviews	review	NNS
cord-283340-ksyd5l56	164	4	included	include	VBN
cord-283340-ksyd5l56	164	5	in	in	IN
cord-283340-ksyd5l56	164	6	current	current	JJ
cord-283340-ksyd5l56	164	7	umbrella	umbrella	NN
cord-283340-ksyd5l56	164	8	review	review	NN
cord-283340-ksyd5l56	164	9	were	be	VBD
cord-283340-ksyd5l56	164	10	more	more	RBR
cord-283340-ksyd5l56	164	11	suitable	suitable	JJ
cord-283340-ksyd5l56	164	12	for	for	IN
cord-283340-ksyd5l56	164	13	providing	provide	VBG
cord-283340-ksyd5l56	164	14	qualitative	qualitative	JJ
cord-283340-ksyd5l56	164	15	summaries	summary	NNS
cord-283340-ksyd5l56	164	16	of	of	IN
cord-283340-ksyd5l56	164	17	the	the	DT
cord-283340-ksyd5l56	164	18	evidence	evidence	NN
cord-283340-ksyd5l56	164	19	than	than	IN
cord-283340-ksyd5l56	164	20	for	for	IN
cord-283340-ksyd5l56	164	21	conducting	conduct	VBG
cord-283340-ksyd5l56	164	22	a	a	DT
cord-283340-ksyd5l56	164	23	meta	meta	JJ
cord-283340-ksyd5l56	164	24	-	-	HYPH
cord-283340-ksyd5l56	164	25	analysis	analysis	NN
cord-283340-ksyd5l56	164	26	.	.	.
cord-283340-ksyd5l56	165	1	Considerable	considerable	JJ
cord-283340-ksyd5l56	165	2	evidence	evidence	NN
cord-283340-ksyd5l56	165	3	has	have	VBZ
cord-283340-ksyd5l56	165	4	been	be	VBN
cord-283340-ksyd5l56	165	5	amassed	amass	VBN
cord-283340-ksyd5l56	165	6	that	that	IN
cord-283340-ksyd5l56	165	7	a	a	DT
cord-283340-ksyd5l56	165	8	history	history	NN
cord-283340-ksyd5l56	165	9	of	of	IN
cord-283340-ksyd5l56	165	10	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	165	11	disease	disease	NN
cord-283340-ksyd5l56	165	12	or	or	CC
cord-283340-ksyd5l56	165	13	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	165	14	risk	risk	NN
cord-283340-ksyd5l56	165	15	factors	factor	NNS
cord-283340-ksyd5l56	165	16	such	such	JJ
cord-283340-ksyd5l56	165	17	as	as	IN
cord-283340-ksyd5l56	165	18	hypertension	hypertension	NN
cord-283340-ksyd5l56	165	19	and	and	CC
cord-283340-ksyd5l56	165	20	diabetes	diabetes	NN
cord-283340-ksyd5l56	165	21	is	be	VBZ
cord-283340-ksyd5l56	165	22	closely	closely	RB
cord-283340-ksyd5l56	165	23	related	relate	VBN
cord-283340-ksyd5l56	165	24	to	to	IN
cord-283340-ksyd5l56	165	25	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	165	26	infection	infection	NN
cord-283340-ksyd5l56	165	27	and	and	CC
cord-283340-ksyd5l56	165	28	severity	severity	NN
cord-283340-ksyd5l56	165	29	.	.	.
cord-283340-ksyd5l56	166	1	5	5	CD
cord-283340-ksyd5l56	166	2	,	,	,
cord-283340-ksyd5l56	166	3	6	6	CD
cord-283340-ksyd5l56	166	4	,	,	,
cord-283340-ksyd5l56	166	5	11	11	CD
cord-283340-ksyd5l56	166	6	Since	since	IN
cord-283340-ksyd5l56	166	7	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	166	8	is	be	VBZ
cord-283340-ksyd5l56	166	9	one	one	CD
cord-283340-ksyd5l56	166	10	of	of	IN
cord-283340-ksyd5l56	166	11	the	the	DT
cord-283340-ksyd5l56	166	12	most	most	RBS
cord-283340-ksyd5l56	166	13	important	important	JJ
cord-283340-ksyd5l56	166	14	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	166	15	risk	risk	NN
cord-283340-ksyd5l56	166	16	factors	factor	NNS
cord-283340-ksyd5l56	166	17	,	,	,
cord-283340-ksyd5l56	166	18	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	166	19	is	be	VBZ
cord-283340-ksyd5l56	166	20	also	also	RB
cord-283340-ksyd5l56	166	21	likely	likely	JJ
cord-283340-ksyd5l56	166	22	to	to	TO
cord-283340-ksyd5l56	166	23	be	be	VB
cord-283340-ksyd5l56	166	24	closely	closely	RB
cord-283340-ksyd5l56	166	25	related	relate	VBN
cord-283340-ksyd5l56	166	26	to	to	IN
cord-283340-ksyd5l56	166	27	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	166	28	.	.	.
cord-283340-ksyd5l56	167	1	However	however	RB
cord-283340-ksyd5l56	167	2	,	,	,
cord-283340-ksyd5l56	167	3	research	research	NN
cord-283340-ksyd5l56	167	4	on	on	IN
cord-283340-ksyd5l56	167	5	the	the	DT
cord-283340-ksyd5l56	167	6	role	role	NN
cord-283340-ksyd5l56	167	7	of	of	IN
cord-283340-ksyd5l56	167	8	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	167	9	in	in	IN
cord-283340-ksyd5l56	167	10	the	the	DT
cord-283340-ksyd5l56	167	11	risk	risk	NN
cord-283340-ksyd5l56	167	12	and	and	CC
cord-283340-ksyd5l56	167	13	severity	severity	NN
cord-283340-ksyd5l56	167	14	of	of	IN
cord-283340-ksyd5l56	167	15	COVID-19	covid-19	NN
cord-283340-ksyd5l56	167	16	is	be	VBZ
cord-283340-ksyd5l56	167	17	relatively	relatively	RB
cord-283340-ksyd5l56	167	18	lacking	lacking	JJ
cord-283340-ksyd5l56	167	19	.	.	.
cord-283340-ksyd5l56	168	1	One	one	CD
cord-283340-ksyd5l56	168	2	cause	cause	NN
cord-283340-ksyd5l56	168	3	may	may	MD
cord-283340-ksyd5l56	168	4	be	be	VB
cord-283340-ksyd5l56	168	5	that	that	IN
cord-283340-ksyd5l56	168	6	the	the	DT
cord-283340-ksyd5l56	168	7	definition	definition	NN
cord-283340-ksyd5l56	168	8	of	of	IN
cord-283340-ksyd5l56	168	9	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	168	10	itself	-PRON-	PRP
cord-283340-ksyd5l56	168	11	is	be	VBZ
cord-283340-ksyd5l56	168	12	rather	rather	RB
cord-283340-ksyd5l56	168	13	complicated	complicated	JJ
cord-283340-ksyd5l56	168	14	,	,	,
cord-283340-ksyd5l56	168	15	unlike	unlike	IN
cord-283340-ksyd5l56	168	16	diabetes	diabetes	NN
cord-283340-ksyd5l56	168	17	mellitus	mellitus	NN
cord-283340-ksyd5l56	168	18	,	,	,
cord-283340-ksyd5l56	168	19	hypertension	hypertension	NN
cord-283340-ksyd5l56	168	20	,	,	,
cord-283340-ksyd5l56	168	21	and	and	CC
cord-283340-ksyd5l56	168	22	obesity	obesity	NN
cord-283340-ksyd5l56	168	23	.	.	.
cord-283340-ksyd5l56	169	1	Furthermore	furthermore	RB
cord-283340-ksyd5l56	169	2	,	,	,
cord-283340-ksyd5l56	169	3	numerous	numerous	JJ
cord-283340-ksyd5l56	169	4	reports	report	NNS
cord-283340-ksyd5l56	169	5	have	have	VBP
cord-283340-ksyd5l56	169	6	stated	state	VBN
cord-283340-ksyd5l56	169	7	that	that	IN
cord-283340-ksyd5l56	169	8	rapid	rapid	JJ
cord-283340-ksyd5l56	169	9	changes	change	NNS
cord-283340-ksyd5l56	169	10	in	in	IN
cord-283340-ksyd5l56	169	11	the	the	DT
cord-283340-ksyd5l56	169	12	lipid	lipid	NN
cord-283340-ksyd5l56	169	13	profile	profile	NN
cord-283340-ksyd5l56	169	14	appear	appear	VBP
cord-283340-ksyd5l56	169	15	to	to	TO
cord-283340-ksyd5l56	169	16	occur	occur	VB
cord-283340-ksyd5l56	169	17	in	in	IN
cord-283340-ksyd5l56	169	18	response	response	NN
cord-283340-ksyd5l56	169	19	to	to	IN
cord-283340-ksyd5l56	169	20	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	169	21	infection	infection	NN
cord-283340-ksyd5l56	169	22	and	and	CC
cord-283340-ksyd5l56	169	23	the	the	DT
cord-283340-ksyd5l56	169	24	progression	progression	NN
cord-283340-ksyd5l56	169	25	of	of	IN
cord-283340-ksyd5l56	169	26	the	the	DT
cord-283340-ksyd5l56	169	27	disease	disease	NN
cord-283340-ksyd5l56	169	28	.	.	.
cord-283340-ksyd5l56	170	1	46	46	CD
cord-283340-ksyd5l56	171	1	Therefore	therefore	RB
cord-283340-ksyd5l56	171	2	,	,	,
cord-283340-ksyd5l56	171	3	there	there	EX
cord-283340-ksyd5l56	171	4	may	may	MD
cord-283340-ksyd5l56	171	5	be	be	VB
cord-283340-ksyd5l56	171	6	a	a	DT
cord-283340-ksyd5l56	171	7	major	major	JJ
cord-283340-ksyd5l56	171	8	difference	difference	NN
cord-283340-ksyd5l56	171	9	between	between	IN
cord-283340-ksyd5l56	171	10	defining	define	VBG
cord-283340-ksyd5l56	171	11	the	the	DT
cord-283340-ksyd5l56	171	12	presence	presence	NN
cord-283340-ksyd5l56	171	13	of	of	IN
cord-283340-ksyd5l56	171	14	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	171	15	before	before	IN
cord-283340-ksyd5l56	171	16	being	be	VBG
cord-283340-ksyd5l56	171	17	diagnosed	diagnose	VBN
cord-283340-ksyd5l56	171	18	with	with	IN
cord-283340-ksyd5l56	171	19	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	171	20	,	,	,
cord-283340-ksyd5l56	171	21	and	and	CC
cord-283340-ksyd5l56	171	22	defining	define	VBG
cord-283340-ksyd5l56	171	23	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	171	24	at	at	IN
cord-283340-ksyd5l56	171	25	the	the	DT
cord-283340-ksyd5l56	171	26	time	time	NN
cord-283340-ksyd5l56	171	27	of	of	IN
cord-283340-ksyd5l56	171	28	hospitalization	hospitalization	NN
cord-283340-ksyd5l56	171	29	after	after	IN
cord-283340-ksyd5l56	171	30	a	a	DT
cord-283340-ksyd5l56	171	31	patient	patient	NN
cord-283340-ksyd5l56	171	32	is	be	VBZ
cord-283340-ksyd5l56	171	33	diagnosed	diagnose	VBN
cord-283340-ksyd5l56	171	34	with	with	IN
cord-283340-ksyd5l56	171	35	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	171	36	.	.	.
cord-283340-ksyd5l56	172	1	In	in	IN
cord-283340-ksyd5l56	172	2	the	the	DT
cord-283340-ksyd5l56	172	3	meta	meta	JJ
cord-283340-ksyd5l56	172	4	-	-	HYPH
cord-283340-ksyd5l56	172	5	analysis	analysis	NN
cord-283340-ksyd5l56	172	6	conducted	conduct	VBN
cord-283340-ksyd5l56	172	7	by	by	IN
cord-283340-ksyd5l56	172	8	Hariyanto	Hariyanto	NNP
cord-283340-ksyd5l56	172	9	and	and	CC
cord-283340-ksyd5l56	172	10	Kurniawan	Kurniawan	NNP
cord-283340-ksyd5l56	172	11	,	,	,
cord-283340-ksyd5l56	172	12	38	38	CD
cord-283340-ksyd5l56	172	13	testing	testing	NN
cord-283340-ksyd5l56	172	14	or	or	CC
cord-283340-ksyd5l56	172	15	the	the	DT
cord-283340-ksyd5l56	172	16	use	use	NN
cord-283340-ksyd5l56	172	17	of	of	IN
cord-283340-ksyd5l56	172	18	lipid	lipid	NN
cord-283340-ksyd5l56	172	19	-	-	HYPH
cord-283340-ksyd5l56	172	20	lowering	lower	VBG
cord-283340-ksyd5l56	172	21	drugs	drug	NNS
cord-283340-ksyd5l56	172	22	.	.	.
cord-283340-ksyd5l56	173	1	Four	four	CD
cord-283340-ksyd5l56	173	2	of	of	IN
cord-283340-ksyd5l56	173	3	the	the	DT
cord-283340-ksyd5l56	173	4	7	7	CD
cord-283340-ksyd5l56	173	5	studies	study	NNS
cord-283340-ksyd5l56	173	6	were	be	VBD
cord-283340-ksyd5l56	173	7	conducted	conduct	VBN
cord-283340-ksyd5l56	173	8	in	in	IN
cord-283340-ksyd5l56	173	9	China	China	NNP
cord-283340-ksyd5l56	173	10	,	,	,
cord-283340-ksyd5l56	173	11	and	and	CC
cord-283340-ksyd5l56	173	12	1	1	CD
cord-283340-ksyd5l56	173	13	study	study	VB
cord-283340-ksyd5l56	173	14	each	each	DT
cord-283340-ksyd5l56	173	15	from	from	IN
cord-283340-ksyd5l56	173	16	the	the	DT
cord-283340-ksyd5l56	173	17	US	US	NNP
cord-283340-ksyd5l56	173	18	,	,	,
cord-283340-ksyd5l56	173	19	France	France	NNP
cord-283340-ksyd5l56	173	20	,	,	,
cord-283340-ksyd5l56	173	21	and	and	CC
cord-283340-ksyd5l56	173	22	Korea	Korea	NNP
cord-283340-ksyd5l56	173	23	was	be	VBD
cord-283340-ksyd5l56	173	24	included	include	VBN
cord-283340-ksyd5l56	173	25	.	.	.
cord-283340-ksyd5l56	174	1	The	the	DT
cord-283340-ksyd5l56	174	2	prevalence	prevalence	NN
cord-283340-ksyd5l56	174	3	of	of	IN
cord-283340-ksyd5l56	174	4	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	174	5	in	in	IN
cord-283340-ksyd5l56	174	6	these	these	DT
cord-283340-ksyd5l56	174	7	studies	study	NNS
cord-283340-ksyd5l56	174	8	differed	differ	VBD
cord-283340-ksyd5l56	174	9	dramatically	dramatically	RB
cord-283340-ksyd5l56	174	10	.	.	.
cord-283340-ksyd5l56	175	1	In	in	IN
cord-283340-ksyd5l56	175	2	particular	particular	JJ
cord-283340-ksyd5l56	175	3	,	,	,
cord-283340-ksyd5l56	175	4	in	in	IN
cord-283340-ksyd5l56	175	5	the	the	DT
cord-283340-ksyd5l56	175	6	studies	study	NNS
cord-283340-ksyd5l56	175	7	conducted	conduct	VBN
cord-283340-ksyd5l56	175	8	in	in	IN
cord-283340-ksyd5l56	175	9	China	China	NNP
cord-283340-ksyd5l56	175	10	,	,	,
cord-283340-ksyd5l56	175	11	Hong	Hong	NNP
cord-283340-ksyd5l56	175	12	Kong	Kong	NNP
cord-283340-ksyd5l56	175	13	,	,	,
cord-283340-ksyd5l56	175	14	and	and	CC
cord-283340-ksyd5l56	175	15	Korea	Korea	NNP
cord-283340-ksyd5l56	175	16	,	,	,
cord-283340-ksyd5l56	175	17	47,48,50	47,48,50	CD
cord-283340-ksyd5l56	175	18	-	-	SYM
cord-283340-ksyd5l56	175	19	52	52	CD
cord-283340-ksyd5l56	175	20	the	the	DT
cord-283340-ksyd5l56	175	21	prevalence	prevalence	NN
cord-283340-ksyd5l56	175	22	of	of	IN
cord-283340-ksyd5l56	175	23	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	175	24	was	be	VBD
cord-283340-ksyd5l56	175	25	much	much	RB
cord-283340-ksyd5l56	175	26	lower	low	JJR
cord-283340-ksyd5l56	175	27	than	than	IN
cord-283340-ksyd5l56	175	28	that	that	DT
cord-283340-ksyd5l56	175	29	in	in	IN
cord-283340-ksyd5l56	175	30	the	the	DT
cord-283340-ksyd5l56	175	31	other	other	JJ
cord-283340-ksyd5l56	175	32	studies	study	NNS
cord-283340-ksyd5l56	175	33	(	(	-LRB-
cord-283340-ksyd5l56	175	34	1%-10	1%-10	CD
cord-283340-ksyd5l56	175	35	%	%	NN
cord-283340-ksyd5l56	175	36	)	)	-RRB-
cord-283340-ksyd5l56	175	37	.	.	.
cord-283340-ksyd5l56	176	1	In	in	IN
cord-283340-ksyd5l56	176	2	the	the	DT
cord-283340-ksyd5l56	176	3	US	US	NNP
cord-283340-ksyd5l56	176	4	study	study	NN
cord-283340-ksyd5l56	176	5	,	,	,
cord-283340-ksyd5l56	176	6	45	45	CD
cord-283340-ksyd5l56	176	7	the	the	DT
cord-283340-ksyd5l56	176	8	number	number	NN
cord-283340-ksyd5l56	176	9	of	of	IN
cord-283340-ksyd5l56	176	10	patients	patient	NNS
cord-283340-ksyd5l56	176	11	with	with	IN
cord-283340-ksyd5l56	176	12	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	176	13	was	be	VBD
cord-283340-ksyd5l56	176	14	1,714	1,714	CD
cord-283340-ksyd5l56	176	15	,	,	,
cord-283340-ksyd5l56	176	16	with	with	IN
cord-283340-ksyd5l56	176	17	a	a	DT
cord-283340-ksyd5l56	176	18	prevalence	prevalence	NN
cord-283340-ksyd5l56	176	19	of	of	IN
cord-283340-ksyd5l56	176	20	32.5	32.5	CD
cord-283340-ksyd5l56	176	21	%	%	NN
cord-283340-ksyd5l56	176	22	,	,	,
cord-283340-ksyd5l56	176	23	and	and	CC
cord-283340-ksyd5l56	176	24	in	in	IN
cord-283340-ksyd5l56	176	25	the	the	DT
cord-283340-ksyd5l56	176	26	French	french	JJ
cord-283340-ksyd5l56	176	27	study	study	NN
cord-283340-ksyd5l56	176	28	,	,	,
cord-283340-ksyd5l56	176	29	49	49	CD
cord-283340-ksyd5l56	176	30	34	34	CD
cord-283340-ksyd5l56	176	31	patients	patient	NNS
cord-283340-ksyd5l56	176	32	had	have	VBD
cord-283340-ksyd5l56	176	33	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	176	34	,	,	,
cord-283340-ksyd5l56	176	35	with	with	IN
cord-283340-ksyd5l56	176	36	a	a	DT
cord-283340-ksyd5l56	176	37	prevalence	prevalence	NN
cord-283340-ksyd5l56	176	38	of	of	IN
cord-283340-ksyd5l56	176	39	28	28	CD
cord-283340-ksyd5l56	176	40	%	%	NN
cord-283340-ksyd5l56	176	41	.	.	.
cord-283340-ksyd5l56	177	1	Since	since	IN
cord-283340-ksyd5l56	177	2	there	there	EX
cord-283340-ksyd5l56	177	3	were	be	VBD
cord-283340-ksyd5l56	177	4	no	no	DT
cord-283340-ksyd5l56	177	5	overlapping	overlap	VBG
cord-283340-ksyd5l56	177	6	studies	study	NNS
cord-283340-ksyd5l56	177	7	in	in	IN
cord-283340-ksyd5l56	177	8	each	each	DT
cord-283340-ksyd5l56	177	9	systematic	systematic	JJ
cord-283340-ksyd5l56	177	10	review	review	NN
cord-283340-ksyd5l56	177	11	included	include	VBN
cord-283340-ksyd5l56	177	12	in	in	IN
cord-283340-ksyd5l56	177	13	this	this	DT
cord-283340-ksyd5l56	177	14	umbrella	umbrella	NN
cord-283340-ksyd5l56	177	15	review	review	NN
cord-283340-ksyd5l56	177	16	,	,	,
cord-283340-ksyd5l56	177	17	we	-PRON-	PRP
cord-283340-ksyd5l56	177	18	performed	perform	VBD
cord-283340-ksyd5l56	177	19	a	a	DT
cord-283340-ksyd5l56	177	20	new	new	JJ
cord-283340-ksyd5l56	177	21	meta	meta	NN
cord-283340-ksyd5l56	177	22	-	-	HYPH
cord-283340-ksyd5l56	177	23	analysis	analysis	NN
cord-283340-ksyd5l56	177	24	to	to	TO
cord-283340-ksyd5l56	177	25	analyze	analyze	VB
cord-283340-ksyd5l56	177	26	the	the	DT
cord-283340-ksyd5l56	177	27	relationship	relationship	NN
cord-283340-ksyd5l56	177	28	between	between	IN
cord-283340-ksyd5l56	177	29	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	177	30	and	and	CC
cord-283340-ksyd5l56	177	31	the	the	DT
cord-283340-ksyd5l56	177	32	severity	severity	NN
cord-283340-ksyd5l56	177	33	of	of	IN
cord-283340-ksyd5l56	177	34	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	177	35	quantitatively	quantitatively	RB
cord-283340-ksyd5l56	177	36	.	.	.
cord-283340-ksyd5l56	178	1	However	however	RB
cord-283340-ksyd5l56	178	2	,	,	,
cord-283340-ksyd5l56	178	3	of	of	IN
cord-283340-ksyd5l56	178	4	the	the	DT
cord-283340-ksyd5l56	178	5	3	3	CD
cord-283340-ksyd5l56	178	6	studies	study	NNS
cord-283340-ksyd5l56	178	7	included	include	VBN
cord-283340-ksyd5l56	178	8	in	in	IN
cord-283340-ksyd5l56	178	9	the	the	DT
cord-283340-ksyd5l56	178	10	review	review	NN
cord-283340-ksyd5l56	178	11	of	of	IN
cord-283340-ksyd5l56	178	12	Zaki	Zaki	NNP
cord-283340-ksyd5l56	178	13	et	et	NNP
cord-283340-ksyd5l56	178	14	al	al	NNP
cord-283340-ksyd5l56	178	15	.	.	NNP
cord-283340-ksyd5l56	178	16	,	,	,
cord-283340-ksyd5l56	178	17	39	39	CD
cord-283340-ksyd5l56	178	18	only	only	RB
cord-283340-ksyd5l56	178	19	1	1	CD
cord-283340-ksyd5l56	178	20	study	study	NN
cord-283340-ksyd5l56	178	21	41	41	CD
cord-283340-ksyd5l56	178	22	described	describe	VBD
cord-283340-ksyd5l56	178	23	the	the	DT
cord-283340-ksyd5l56	178	24	presence	presence	NN
cord-283340-ksyd5l56	178	25	of	of	IN
cord-283340-ksyd5l56	178	26	underlying	underlie	VBG
cord-283340-ksyd5l56	178	27	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	178	28	.	.	.
cord-283340-ksyd5l56	179	1	In	in	IN
cord-283340-ksyd5l56	179	2	our	-PRON-	PRP$
cord-283340-ksyd5l56	179	3	new	new	JJ
cord-283340-ksyd5l56	179	4	meta	meta	JJ
cord-283340-ksyd5l56	179	5	-	-	HYPH
cord-283340-ksyd5l56	179	6	analysis	analysis	NN
cord-283340-ksyd5l56	179	7	of	of	IN
cord-283340-ksyd5l56	179	8	a	a	DT
cord-283340-ksyd5l56	179	9	total	total	NN
cord-283340-ksyd5l56	179	10	of	of	IN
cord-283340-ksyd5l56	179	11	8	8	CD
cord-283340-ksyd5l56	179	12	studies	study	NNS
cord-283340-ksyd5l56	179	13	,	,	,
cord-283340-ksyd5l56	179	14	combining	combine	VBG
cord-283340-ksyd5l56	179	15	the	the	DT
cord-283340-ksyd5l56	179	16	7	7	CD
cord-283340-ksyd5l56	179	17	studies	study	NNS
cord-283340-ksyd5l56	179	18	45,47	45,47	CD
cord-283340-ksyd5l56	179	19	-	-	SYM
cord-283340-ksyd5l56	179	20	52	52	CD
cord-283340-ksyd5l56	179	21	included	include	VBD
cord-283340-ksyd5l56	179	22	in	in	IN
cord-283340-ksyd5l56	179	23	the	the	DT
cord-283340-ksyd5l56	179	24	study	study	NN
cord-283340-ksyd5l56	179	25	of	of	IN
cord-283340-ksyd5l56	179	26	Hariyanto	Hariyanto	NNP
cord-283340-ksyd5l56	179	27	and	and	CC
cord-283340-ksyd5l56	179	28	Kurniawan	Kurniawan	NNP
cord-283340-ksyd5l56	179	29	38	38	CD
cord-283340-ksyd5l56	179	30	and	and	CC
cord-283340-ksyd5l56	179	31	the	the	DT
cord-283340-ksyd5l56	179	32	single	single	JJ
cord-283340-ksyd5l56	179	33	study	study	NN
cord-283340-ksyd5l56	179	34	41	41	CD
cord-283340-ksyd5l56	179	35	included	include	VBD
cord-283340-ksyd5l56	179	36	in	in	IN
cord-283340-ksyd5l56	179	37	the	the	DT
cord-283340-ksyd5l56	179	38	review	review	NN
cord-283340-ksyd5l56	179	39	of	of	IN
cord-283340-ksyd5l56	179	40	Zaki	Zaki	NNP
cord-283340-ksyd5l56	179	41	et	et	NNP
cord-283340-ksyd5l56	179	42	al	al	NNP
cord-283340-ksyd5l56	179	43	.	.	NNP
cord-283340-ksyd5l56	179	44	,	,	,
cord-283340-ksyd5l56	179	45	39	39	CD
cord-283340-ksyd5l56	179	46	the	the	DT
cord-283340-ksyd5l56	179	47	relationship	relationship	NN
cord-283340-ksyd5l56	179	48	between	between	IN
cord-283340-ksyd5l56	179	49	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	179	50	and	and	CC
cord-283340-ksyd5l56	179	51	severe	severe	JJ
cord-283340-ksyd5l56	179	52	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	179	53	was	be	VBD
cord-283340-ksyd5l56	179	54	confirmed	confirm	VBN
cord-283340-ksyd5l56	179	55	.	.	.
cord-283340-ksyd5l56	180	1	However	however	RB
cord-283340-ksyd5l56	180	2	,	,	,
cord-283340-ksyd5l56	180	3	a	a	DT
cord-283340-ksyd5l56	180	4	relevant	relevant	JJ
cord-283340-ksyd5l56	180	5	limitation	limitation	NN
cord-283340-ksyd5l56	180	6	may	may	MD
cord-283340-ksyd5l56	180	7	be	be	VB
cord-283340-ksyd5l56	180	8	that	that	IN
cord-283340-ksyd5l56	180	9	all	all	DT
cord-283340-ksyd5l56	180	10	studies	study	NNS
cord-283340-ksyd5l56	180	11	included	include	VBN
cord-283340-ksyd5l56	180	12	in	in	IN
cord-283340-ksyd5l56	180	13	the	the	DT
cord-283340-ksyd5l56	180	14	2	2	CD
cord-283340-ksyd5l56	180	15	systematic	systematic	JJ
cord-283340-ksyd5l56	180	16	analyses	analysis	NNS
cord-283340-ksyd5l56	180	17	could	could	MD
cord-283340-ksyd5l56	180	18	not	not	RB
cord-283340-ksyd5l56	180	19	be	be	VB
cord-283340-ksyd5l56	180	20	analyzed	analyze	VBN
cord-283340-ksyd5l56	180	21	.	.	.
cord-283340-ksyd5l56	181	1	Nevertheless	nevertheless	RB
cord-283340-ksyd5l56	181	2	,	,	,
cord-283340-ksyd5l56	181	3	given	give	VBN
cord-283340-ksyd5l56	181	4	the	the	DT
cord-283340-ksyd5l56	181	5	results	result	NNS
cord-283340-ksyd5l56	181	6	so	so	RB
cord-283340-ksyd5l56	181	7	far	far	RB
cord-283340-ksyd5l56	181	8	,	,	,
cord-283340-ksyd5l56	181	9	the	the	DT
cord-283340-ksyd5l56	181	10	prognosis	prognosis	NN
cord-283340-ksyd5l56	181	11	of	of	IN
cord-283340-ksyd5l56	181	12	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	181	13	seems	seem	VBZ
cord-283340-ksyd5l56	181	14	poor	poor	JJ
cord-283340-ksyd5l56	181	15	in	in	IN
cord-283340-ksyd5l56	181	16	patients	patient	NNS
cord-283340-ksyd5l56	181	17	with	with	IN
cord-283340-ksyd5l56	181	18	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	181	19	,	,	,
cord-283340-ksyd5l56	181	20	so	so	IN
cord-283340-ksyd5l56	181	21	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	181	22	should	should	MD
cord-283340-ksyd5l56	181	23	be	be	VB
cord-283340-ksyd5l56	181	24	regarded	regard	VBN
cord-283340-ksyd5l56	181	25	as	as	IN
cord-283340-ksyd5l56	181	26	another	another	DT
cord-283340-ksyd5l56	181	27	important	important	JJ
cord-283340-ksyd5l56	181	28	factor	factor	NN
cord-283340-ksyd5l56	181	29	in	in	IN
cord-283340-ksyd5l56	181	30	risk	risk	NN
cord-283340-ksyd5l56	181	31	stratification	stratification	NN
cord-283340-ksyd5l56	181	32	models	model	NNS
cord-283340-ksyd5l56	181	33	for	for	IN
cord-283340-ksyd5l56	181	34	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	181	35	.	.	.
cord-283340-ksyd5l56	182	1	Prior	prior	RB
cord-283340-ksyd5l56	182	2	to	to	IN
cord-283340-ksyd5l56	182	3	the	the	DT
cord-283340-ksyd5l56	182	4	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	182	5	pandemic	pandemic	NN
cord-283340-ksyd5l56	182	6	,	,	,
cord-283340-ksyd5l56	182	7	extensive	extensive	JJ
cord-283340-ksyd5l56	182	8	research	research	NN
cord-283340-ksyd5l56	182	9	explored	explore	VBD
cord-283340-ksyd5l56	182	10	the	the	DT
cord-283340-ksyd5l56	182	11	link	link	NN
cord-283340-ksyd5l56	182	12	between	between	IN
cord-283340-ksyd5l56	182	13	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	182	14	and	and	CC
cord-283340-ksyd5l56	182	15	viral	viral	JJ
cord-283340-ksyd5l56	182	16	infections	infection	NNS
cord-283340-ksyd5l56	182	17	.	.	.
cord-283340-ksyd5l56	183	1	In	in	IN
cord-283340-ksyd5l56	183	2	general	general	JJ
cord-283340-ksyd5l56	183	3	,	,	,
cord-283340-ksyd5l56	183	4	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	183	5	in	in	IN
cord-283340-ksyd5l56	183	6	the	the	DT
cord-283340-ksyd5l56	183	7	cell	cell	NN
cord-283340-ksyd5l56	183	8	membrane	membrane	NN
cord-283340-ksyd5l56	183	9	plays	play	VBZ
cord-283340-ksyd5l56	183	10	an	an	DT
cord-283340-ksyd5l56	183	11	important	important	JJ
cord-283340-ksyd5l56	183	12	role	role	NN
cord-283340-ksyd5l56	183	13	when	when	WRB
cord-283340-ksyd5l56	183	14	a	a	DT
cord-283340-ksyd5l56	183	15	virus	virus	NN
cord-283340-ksyd5l56	183	16	enters	enter	VBZ
cord-283340-ksyd5l56	183	17	the	the	DT
cord-283340-ksyd5l56	183	18	host	host	NN
cord-283340-ksyd5l56	183	19	cell	cell	NN
cord-283340-ksyd5l56	183	20	,	,	,
cord-283340-ksyd5l56	183	21	43	43	CD
cord-283340-ksyd5l56	183	22	and	and	CC
cord-283340-ksyd5l56	183	23	the	the	DT
cord-283340-ksyd5l56	183	24	efficiency	efficiency	NN
cord-283340-ksyd5l56	183	25	of	of	IN
cord-283340-ksyd5l56	183	26	viral	viral	JJ
cord-283340-ksyd5l56	183	27	infection	infection	NN
cord-283340-ksyd5l56	183	28	is	be	VBZ
cord-283340-ksyd5l56	183	29	significantly	significantly	RB
cord-283340-ksyd5l56	183	30	reduced	reduce	VBN
cord-283340-ksyd5l56	183	31	when	when	WRB
cord-283340-ksyd5l56	183	32	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	183	33	deficiency	deficiency	NN
cord-283340-ksyd5l56	183	34	is	be	VBZ
cord-283340-ksyd5l56	183	35	induced	induce	VBN
cord-283340-ksyd5l56	183	36	in	in	IN
cord-283340-ksyd5l56	183	37	the	the	DT
cord-283340-ksyd5l56	183	38	cell	cell	NN
cord-283340-ksyd5l56	183	39	membrane	membrane	NN
cord-283340-ksyd5l56	183	40	.	.	.
cord-283340-ksyd5l56	184	1	44	44	CD
cord-283340-ksyd5l56	185	1	After	after	IN
cord-283340-ksyd5l56	185	2	a	a	DT
cord-283340-ksyd5l56	185	3	viral	viral	JJ
cord-283340-ksyd5l56	185	4	infection	infection	NN
cord-283340-ksyd5l56	185	5	has	have	VBZ
cord-283340-ksyd5l56	185	6	already	already	RB
cord-283340-ksyd5l56	185	7	occurred	occur	VBN
cord-283340-ksyd5l56	185	8	,	,	,
cord-283340-ksyd5l56	185	9	increased	increase	VBN
cord-283340-ksyd5l56	185	10	levels	level	NNS
cord-283340-ksyd5l56	185	11	of	of	IN
cord-283340-ksyd5l56	185	12	LDL	ldl	NN
cord-283340-ksyd5l56	185	13	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	185	14	itself	-PRON-	PRP
cord-283340-ksyd5l56	185	15	can	can	MD
cord-283340-ksyd5l56	185	16	interact	interact	VB
cord-283340-ksyd5l56	185	17	with	with	IN
cord-283340-ksyd5l56	185	18	macrophages	macrophage	NNS
cord-283340-ksyd5l56	185	19	in	in	IN
cord-283340-ksyd5l56	185	20	atherosclerotic	atherosclerotic	JJ
cord-283340-ksyd5l56	185	21	plaques	plaque	NNS
cord-283340-ksyd5l56	185	22	or	or	CC
cord-283340-ksyd5l56	185	23	engage	engage	VB
cord-283340-ksyd5l56	185	24	in	in	IN
cord-283340-ksyd5l56	185	25	inflammasome	inflammasome	NN
cord-283340-ksyd5l56	185	26	activation	activation	NN
cord-283340-ksyd5l56	185	27	and	and	CC
cord-283340-ksyd5l56	185	28	increase	increase	VB
cord-283340-ksyd5l56	185	29	the	the	DT
cord-283340-ksyd5l56	185	30	secretion	secretion	NN
cord-283340-ksyd5l56	185	31	of	of	IN
cord-283340-ksyd5l56	185	32	proinflammatory	proinflammatory	JJ
cord-283340-ksyd5l56	185	33	cytokines	cytokine	NNS
cord-283340-ksyd5l56	185	34	.	.	.
cord-283340-ksyd5l56	186	1	53	53	CD
cord-283340-ksyd5l56	186	2	,	,	,
cord-283340-ksyd5l56	186	3	54	54	CD
cord-283340-ksyd5l56	187	1	Furthermore	furthermore	RB
cord-283340-ksyd5l56	187	2	,	,	,
cord-283340-ksyd5l56	187	3	low	low	JJ
cord-283340-ksyd5l56	187	4	HDL	HDL	NNP
cord-283340-ksyd5l56	187	5	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	187	6	may	may	MD
cord-283340-ksyd5l56	187	7	cause	cause	VB
cord-283340-ksyd5l56	187	8	dysregulation	dysregulation	NN
cord-283340-ksyd5l56	187	9	in	in	IN
cord-283340-ksyd5l56	187	10	the	the	DT
cord-283340-ksyd5l56	187	11	innate	innate	JJ
cord-283340-ksyd5l56	187	12	immune	immune	JJ
cord-283340-ksyd5l56	187	13	response	response	NN
cord-283340-ksyd5l56	187	14	,	,	,
cord-283340-ksyd5l56	187	15	a	a	DT
cord-283340-ksyd5l56	187	16	first	first	JJ
cord-283340-ksyd5l56	187	17	-	-	HYPH
cord-283340-ksyd5l56	187	18	line	line	NN
cord-283340-ksyd5l56	187	19	defense	defense	NN
cord-283340-ksyd5l56	187	20	mechanism	mechanism	NN
cord-283340-ksyd5l56	187	21	against	against	IN
cord-283340-ksyd5l56	187	22	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	187	23	infection	infection	NN
cord-283340-ksyd5l56	187	24	.	.	.
cord-283340-ksyd5l56	188	1	55	55	CD
cord-283340-ksyd5l56	189	1	Lastly	lastly	RB
cord-283340-ksyd5l56	189	2	,	,	,
cord-283340-ksyd5l56	189	3	LDL	ldl	NN
cord-283340-ksyd5l56	189	4	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	189	5	or	or	CC
cord-283340-ksyd5l56	189	6	triglyceride	triglyceride	NN
cord-283340-ksyd5l56	189	7	accumulation	accumulation	NN
cord-283340-ksyd5l56	189	8	may	may	MD
cord-283340-ksyd5l56	189	9	cause	cause	VB
cord-283340-ksyd5l56	189	10	endothelial	endothelial	JJ
cord-283340-ksyd5l56	189	11	dysfunction	dysfunction	NN
cord-283340-ksyd5l56	189	12	,	,	,
cord-283340-ksyd5l56	189	13	increasing	increase	VBG
cord-283340-ksyd5l56	189	14	the	the	DT
cord-283340-ksyd5l56	189	15	risk	risk	NN
cord-283340-ksyd5l56	189	16	of	of	IN
cord-283340-ksyd5l56	189	17	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	189	18	complications	complication	NNS
cord-283340-ksyd5l56	189	19	,	,	,
cord-283340-ksyd5l56	189	20	leading	lead	VBG
cord-283340-ksyd5l56	189	21	to	to	IN
cord-283340-ksyd5l56	189	22	severe	severe	JJ
cord-283340-ksyd5l56	189	23	outcomes	outcome	NNS
cord-283340-ksyd5l56	189	24	.	.	.
cord-283340-ksyd5l56	190	1	56	56	CD
cord-283340-ksyd5l56	191	1	However	however	RB
cord-283340-ksyd5l56	191	2	,	,	,
cord-283340-ksyd5l56	191	3	the	the	DT
cord-283340-ksyd5l56	191	4	systematic	systematic	JJ
cord-283340-ksyd5l56	191	5	review	review	NN
cord-283340-ksyd5l56	191	6	of	of	IN
cord-283340-ksyd5l56	191	7	Zaki	Zaki	NNP
cord-283340-ksyd5l56	191	8	et	et	NNP
cord-283340-ksyd5l56	191	9	al	al	NNP
cord-283340-ksyd5l56	191	10	.	.	.
cord-283340-ksyd5l56	192	1	39	39	CD
cord-283340-ksyd5l56	192	2	presented	present	VBD
cord-283340-ksyd5l56	192	3	completely	completely	RB
cord-283340-ksyd5l56	192	4	different	different	JJ
cord-283340-ksyd5l56	192	5	results	result	NNS
cord-283340-ksyd5l56	192	6	.	.	.
cord-283340-ksyd5l56	193	1	In	in	IN
cord-283340-ksyd5l56	193	2	their	-PRON-	PRP$
cord-283340-ksyd5l56	193	3	study	study	NN
cord-283340-ksyd5l56	193	4	,	,	,
cord-283340-ksyd5l56	193	5	total	total	JJ
cord-283340-ksyd5l56	193	6	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	193	7	,	,	,
cord-283340-ksyd5l56	193	8	HDL	HDL	NNP
cord-283340-ksyd5l56	193	9	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	193	10	,	,	,
cord-283340-ksyd5l56	193	11	and	and	CC
cord-283340-ksyd5l56	193	12	LDL	ldl	NN
cord-283340-ksyd5l56	193	13	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	193	14	levels	level	NNS
cord-283340-ksyd5l56	193	15	were	be	VBD
cord-283340-ksyd5l56	193	16	consistently	consistently	RB
cord-283340-ksyd5l56	193	17	lower	low	JJR
cord-283340-ksyd5l56	193	18	in	in	IN
cord-283340-ksyd5l56	193	19	the	the	DT
cord-283340-ksyd5l56	193	20	COVID-19-infected	COVID-19-infected	NNP
cord-283340-ksyd5l56	193	21	group	group	NN
cord-283340-ksyd5l56	193	22	than	than	IN
cord-283340-ksyd5l56	193	23	in	in	IN
cord-283340-ksyd5l56	193	24	the	the	DT
cord-283340-ksyd5l56	193	25	control	control	NN
cord-283340-ksyd5l56	193	26	group	group	NN
cord-283340-ksyd5l56	193	27	,	,	,
cord-283340-ksyd5l56	193	28	and	and	CC
cord-283340-ksyd5l56	193	29	HDL	HDL	NNP
cord-283340-ksyd5l56	193	30	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	193	31	was	be	VBD
cord-283340-ksyd5l56	193	32	significantly	significantly	RB
cord-283340-ksyd5l56	193	33	lower	low	JJR
cord-283340-ksyd5l56	193	34	in	in	IN
cord-283340-ksyd5l56	193	35	patients	patient	NNS
cord-283340-ksyd5l56	193	36	with	with	IN
cord-283340-ksyd5l56	193	37	a	a	DT
cord-283340-ksyd5l56	193	38	high	high	JJ
cord-283340-ksyd5l56	193	39	severity	severity	NN
cord-283340-ksyd5l56	193	40	of	of	IN
cord-283340-ksyd5l56	193	41	disease	disease	NN
cord-283340-ksyd5l56	193	42	.	.	.
cord-283340-ksyd5l56	194	1	Zaki	Zaki	NNP
cord-283340-ksyd5l56	194	2	et	et	NNP
cord-283340-ksyd5l56	194	3	al	al	NNP
cord-283340-ksyd5l56	194	4	.	.	.
cord-283340-ksyd5l56	195	1	39	39	CD
cord-283340-ksyd5l56	195	2	performed	perform	VBD
cord-283340-ksyd5l56	195	3	a	a	DT
cord-283340-ksyd5l56	195	4	systematic	systematic	JJ
cord-283340-ksyd5l56	195	5	review	review	NN
cord-283340-ksyd5l56	195	6	of	of	IN
cord-283340-ksyd5l56	195	7	the	the	DT
cord-283340-ksyd5l56	195	8	associations	association	NNS
cord-283340-ksyd5l56	195	9	of	of	IN
cord-283340-ksyd5l56	195	10	various	various	JJ
cord-283340-ksyd5l56	195	11	comorbidities	comorbiditie	NNS
cord-283340-ksyd5l56	195	12	,	,	,
cord-283340-ksyd5l56	195	13	such	such	JJ
cord-283340-ksyd5l56	195	14	as	as	IN
cord-283340-ksyd5l56	195	15	hypertension	hypertension	NN
cord-283340-ksyd5l56	195	16	,	,	,
cord-283340-ksyd5l56	195	17	diabetes	diabetes	NN
cord-283340-ksyd5l56	195	18	,	,	,
cord-283340-ksyd5l56	195	19	high	high	JJ
cord-283340-ksyd5l56	195	20	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	195	21	,	,	,
cord-283340-ksyd5l56	195	22	and	and	CC
cord-283340-ksyd5l56	195	23	cancer	cancer	NN
cord-283340-ksyd5l56	195	24	,	,	,
cord-283340-ksyd5l56	195	25	with	with	IN
cord-283340-ksyd5l56	195	26	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	195	27	severity	severity	NN
cord-283340-ksyd5l56	195	28	.	.	.
cord-283340-ksyd5l56	196	1	A	a	DT
cord-283340-ksyd5l56	196	2	total	total	NN
cord-283340-ksyd5l56	196	3	of	of	IN
cord-283340-ksyd5l56	196	4	54	54	CD
cord-283340-ksyd5l56	196	5	articles	article	NNS
cord-283340-ksyd5l56	196	6	were	be	VBD
cord-283340-ksyd5l56	196	7	included	include	VBN
cord-283340-ksyd5l56	196	8	,	,	,
cord-283340-ksyd5l56	196	9	and	and	CC
cord-283340-ksyd5l56	196	10	the	the	DT
cord-283340-ksyd5l56	196	11	authors	author	NNS
cord-283340-ksyd5l56	196	12	stated	state	VBD
cord-283340-ksyd5l56	196	13	that	that	IN
cord-283340-ksyd5l56	196	14	8	8	CD
cord-283340-ksyd5l56	196	15	analyzed	analyze	VBD
cord-283340-ksyd5l56	196	16	high	high	JJ
cord-283340-ksyd5l56	196	17	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	196	18	levels	level	NNS
cord-283340-ksyd5l56	196	19	,	,	,
cord-283340-ksyd5l56	196	20	but	but	CC
cord-283340-ksyd5l56	196	21	only	only	RB
cord-283340-ksyd5l56	196	22	3	3	CD
cord-283340-ksyd5l56	196	23	observational	observational	JJ
cord-283340-ksyd5l56	196	24	studies	study	NNS
cord-283340-ksyd5l56	196	25	were	be	VBD
cord-283340-ksyd5l56	196	26	finally	finally	RB
cord-283340-ksyd5l56	196	27	included	include	VBN
cord-283340-ksyd5l56	196	28	.	.	.
cord-283340-ksyd5l56	197	1	All	all	DT
cord-283340-ksyd5l56	197	2	3	3	CD
cord-283340-ksyd5l56	197	3	of	of	IN
cord-283340-ksyd5l56	197	4	those	those	DT
cord-283340-ksyd5l56	197	5	studies	study	NNS
cord-283340-ksyd5l56	197	6	were	be	VBD
cord-283340-ksyd5l56	197	7	conducted	conduct	VBN
cord-283340-ksyd5l56	197	8	in	in	IN
cord-283340-ksyd5l56	197	9	China	China	NNP
cord-283340-ksyd5l56	197	10	.	.	.
cord-283340-ksyd5l56	198	1	[	[	-LRB-
cord-283340-ksyd5l56	198	2	40	40	CD
cord-283340-ksyd5l56	198	3	]	]	-RRB-
cord-283340-ksyd5l56	198	4	[	[	-LRB-
cord-283340-ksyd5l56	198	5	41	41	CD
cord-283340-ksyd5l56	198	6	]	]	-RRB-
cord-283340-ksyd5l56	199	1	[	[	-LRB-
cord-283340-ksyd5l56	199	2	42	42	CD
cord-283340-ksyd5l56	199	3	]	]	-RRB-
cord-283340-ksyd5l56	200	1	Two	two	CD
cord-283340-ksyd5l56	200	2	studies	study	NNS
cord-283340-ksyd5l56	200	3	did	do	VBD
cord-283340-ksyd5l56	200	4	not	not	RB
cord-283340-ksyd5l56	200	5	confirm	confirm	VB
cord-283340-ksyd5l56	200	6	the	the	DT
cord-283340-ksyd5l56	200	7	presence	presence	NN
cord-283340-ksyd5l56	200	8	or	or	CC
cord-283340-ksyd5l56	200	9	absence	absence	NN
cord-283340-ksyd5l56	200	10	of	of	IN
cord-283340-ksyd5l56	200	11	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	200	12	from	from	IN
cord-283340-ksyd5l56	200	13	patients	patient	NNS
cord-283340-ksyd5l56	200	14	'	'	POS
cord-283340-ksyd5l56	200	15	medical	medical	JJ
cord-283340-ksyd5l56	200	16	records	record	NNS
cord-283340-ksyd5l56	200	17	,	,	,
cord-283340-ksyd5l56	200	18	40	40	CD
cord-283340-ksyd5l56	200	19	,	,	,
cord-283340-ksyd5l56	200	20	42	42	CD
cord-283340-ksyd5l56	200	21	and	and	CC
cord-283340-ksyd5l56	200	22	in	in	IN
cord-283340-ksyd5l56	200	23	1	1	CD
cord-283340-ksyd5l56	200	24	study	study	NN
cord-283340-ksyd5l56	200	25	,	,	,
cord-283340-ksyd5l56	200	26	the	the	DT
cord-283340-ksyd5l56	200	27	presence	presence	NN
cord-283340-ksyd5l56	200	28	of	of	IN
cord-283340-ksyd5l56	200	29	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	200	30	was	be	VBD
cord-283340-ksyd5l56	200	31	described	describe	VBN
cord-283340-ksyd5l56	200	32	,	,	,
cord-283340-ksyd5l56	200	33	but	but	CC
cord-283340-ksyd5l56	200	34	its	-PRON-	PRP$
cord-283340-ksyd5l56	200	35	relationship	relationship	NN
cord-283340-ksyd5l56	200	36	with	with	IN
cord-283340-ksyd5l56	200	37	severity	severity	NN
cord-283340-ksyd5l56	200	38	was	be	VBD
cord-283340-ksyd5l56	200	39	not	not	RB
cord-283340-ksyd5l56	200	40	investigated	investigate	VBN
cord-283340-ksyd5l56	200	41	.	.	.
cord-283340-ksyd5l56	201	1	41	41	CD
cord-283340-ksyd5l56	202	1	Instead	instead	RB
cord-283340-ksyd5l56	202	2	,	,	,
cord-283340-ksyd5l56	202	3	in	in	IN
cord-283340-ksyd5l56	202	4	all	all	DT
cord-283340-ksyd5l56	202	5	studies	study	NNS
cord-283340-ksyd5l56	202	6	,	,	,
cord-283340-ksyd5l56	202	7	various	various	JJ
cord-283340-ksyd5l56	202	8	lipid	lipid	NN
cord-283340-ksyd5l56	202	9	profiles	profile	NNS
cord-283340-ksyd5l56	202	10	were	be	VBD
cord-283340-ksyd5l56	202	11	tested	test	VBN
cord-283340-ksyd5l56	202	12	at	at	IN
cord-283340-ksyd5l56	202	13	the	the	DT
cord-283340-ksyd5l56	202	14	time	time	NN
cord-283340-ksyd5l56	202	15	of	of	IN
cord-283340-ksyd5l56	202	16	admission	admission	NN
cord-283340-ksyd5l56	202	17	,	,	,
cord-283340-ksyd5l56	202	18	and	and	CC
cord-283340-ksyd5l56	202	19	in	in	IN
cord-283340-ksyd5l56	202	20	1	1	CD
cord-283340-ksyd5l56	202	21	study	study	NN
cord-283340-ksyd5l56	202	22	,	,	,
cord-283340-ksyd5l56	202	23	40	40	CD
cord-283340-ksyd5l56	202	24	tests	test	NNS
cord-283340-ksyd5l56	202	25	were	be	VBD
cord-283340-ksyd5l56	202	26	performed	perform	VBN
cord-283340-ksyd5l56	202	27	serially	serially	RB
cord-283340-ksyd5l56	202	28	at	at	IN
cord-283340-ksyd5l56	202	29	intervals	interval	NNS
cord-283340-ksyd5l56	202	30	of	of	IN
cord-283340-ksyd5l56	202	31	2	2	CD
cord-283340-ksyd5l56	202	32	days	day	NNS
cord-283340-ksyd5l56	202	33	for	for	IN
cord-283340-ksyd5l56	202	34	more	more	JJR
cord-283340-ksyd5l56	202	35	than	than	IN
cord-283340-ksyd5l56	202	36	2	2	CD
cord-283340-ksyd5l56	202	37	weeks	week	NNS
cord-283340-ksyd5l56	202	38	to	to	TO
cord-283340-ksyd5l56	202	39	analyze	analyze	VB
cord-283340-ksyd5l56	202	40	the	the	DT
cord-283340-ksyd5l56	202	41	relationship	relationship	NN
cord-283340-ksyd5l56	202	42	between	between	IN
cord-283340-ksyd5l56	202	43	lipid	lipid	NN
cord-283340-ksyd5l56	202	44	parameters	parameter	NNS
cord-283340-ksyd5l56	202	45	and	and	CC
cord-283340-ksyd5l56	202	46	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	202	47	severity	severity	NN
cord-283340-ksyd5l56	202	48	.	.	.
cord-283340-ksyd5l56	203	1	Among	among	IN
cord-283340-ksyd5l56	203	2	the	the	DT
cord-283340-ksyd5l56	203	3	7	7	CD
cord-283340-ksyd5l56	203	4	studies	study	NNS
cord-283340-ksyd5l56	203	5	included	include	VBN
cord-283340-ksyd5l56	203	6	in	in	IN
cord-283340-ksyd5l56	203	7	the	the	DT
cord-283340-ksyd5l56	203	8	analysis	analysis	NN
cord-283340-ksyd5l56	203	9	of	of	IN
cord-283340-ksyd5l56	203	10	Hariyanto	Hariyanto	NNP
cord-283340-ksyd5l56	203	11	and	and	CC
cord-283340-ksyd5l56	203	12	Kurniawan	Kurniawan	NNP
cord-283340-ksyd5l56	203	13	38	38	CD
cord-283340-ksyd5l56	203	14	described	describe	VBD
cord-283340-ksyd5l56	203	15	earlier	early	RBR
cord-283340-ksyd5l56	203	16	,	,	,
cord-283340-ksyd5l56	203	17	1	1	CD
cord-283340-ksyd5l56	203	18	study	study	NN
cord-283340-ksyd5l56	203	19	45	45	CD
cord-283340-ksyd5l56	203	20	specified	specify	VBN
cord-283340-ksyd5l56	203	21	that	that	IN
cord-283340-ksyd5l56	203	22	patients	patient	NNS
cord-283340-ksyd5l56	203	23	'	'	POS
cord-283340-ksyd5l56	203	24	baseline	baseline	JJ
cord-283340-ksyd5l56	203	25	lipid	lipid	NN
cord-283340-ksyd5l56	203	26	profile	profile	NN
cord-283340-ksyd5l56	203	27	was	be	VBD
cord-283340-ksyd5l56	203	28	analyzed	analyze	VBN
cord-283340-ksyd5l56	203	29	.	.	.
cord-283340-ksyd5l56	204	1	We	-PRON-	PRP
cord-283340-ksyd5l56	204	2	found	find	VBD
cord-283340-ksyd5l56	204	3	that	that	IN
cord-283340-ksyd5l56	204	4	higher	high	JJR
cord-283340-ksyd5l56	204	5	total	total	NN
cord-283340-ksyd5l56	204	6	,	,	,
cord-283340-ksyd5l56	204	7	LDL	LDL	NNP
cord-283340-ksyd5l56	204	8	,	,	,
cord-283340-ksyd5l56	204	9	and	and	CC
cord-283340-ksyd5l56	204	10	HDL	HDL	NNP
cord-283340-ksyd5l56	204	11	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	204	12	levels	level	NNS
cord-283340-ksyd5l56	204	13	showed	show	VBD
cord-283340-ksyd5l56	204	14	an	an	DT
cord-283340-ksyd5l56	204	15	inverse	inverse	JJ
cord-283340-ksyd5l56	204	16	association	association	NN
cord-283340-ksyd5l56	204	17	with	with	IN
cord-283340-ksyd5l56	204	18	severe	severe	JJ
cord-283340-ksyd5l56	204	19	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	204	20	in	in	IN
cord-283340-ksyd5l56	204	21	our	-PRON-	PRP$
cord-283340-ksyd5l56	204	22	new	new	JJ
cord-283340-ksyd5l56	204	23	meta	meta	JJ
cord-283340-ksyd5l56	204	24	-	-	HYPH
cord-283340-ksyd5l56	204	25	analysis	analysis	NN
cord-283340-ksyd5l56	204	26	.	.	.
cord-283340-ksyd5l56	205	1	Consistently	consistently	RB
cord-283340-ksyd5l56	205	2	with	with	IN
cord-283340-ksyd5l56	205	3	our	-PRON-	PRP$
cord-283340-ksyd5l56	205	4	results	result	NNS
cord-283340-ksyd5l56	205	5	,	,	,
cord-283340-ksyd5l56	205	6	Fan	Fan	NNP
cord-283340-ksyd5l56	205	7	et	et	NNP
cord-283340-ksyd5l56	205	8	al	al	NNP
cord-283340-ksyd5l56	205	9	.	.	.
cord-283340-ksyd5l56	206	1	57	57	CD
cord-283340-ksyd5l56	206	2	and	and	CC
cord-283340-ksyd5l56	206	3	Wei	Wei	NNP
cord-283340-ksyd5l56	206	4	et	et	NNP
cord-283340-ksyd5l56	206	5	al	al	NNP
cord-283340-ksyd5l56	206	6	.	.	.
cord-283340-ksyd5l56	207	1	58	58	CD
cord-283340-ksyd5l56	207	2	reported	report	VBD
cord-283340-ksyd5l56	207	3	similar	similar	JJ
cord-283340-ksyd5l56	207	4	findings	finding	NNS
cord-283340-ksyd5l56	207	5	from	from	IN
cord-283340-ksyd5l56	207	6	2	2	CD
cord-283340-ksyd5l56	207	7	small	small	JJ
cord-283340-ksyd5l56	207	8	observational	observational	JJ
cord-283340-ksyd5l56	207	9	studies	study	NNS
cord-283340-ksyd5l56	207	10	.	.	.
cord-283340-ksyd5l56	208	1	In	in	IN
cord-283340-ksyd5l56	208	2	studies	study	NNS
cord-283340-ksyd5l56	208	3	of	of	IN
cord-283340-ksyd5l56	208	4	21	21	CD
cord-283340-ksyd5l56	208	5	and	and	CC
cord-283340-ksyd5l56	208	6	597	597	CD
cord-283340-ksyd5l56	208	7	patients	patient	NNS
cord-283340-ksyd5l56	208	8	,	,	,
cord-283340-ksyd5l56	208	9	patients	patient	NNS
cord-283340-ksyd5l56	208	10	infected	infect	VBN
cord-283340-ksyd5l56	208	11	with	with	IN
cord-283340-ksyd5l56	208	12	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	208	13	had	have	VBD
cord-283340-ksyd5l56	208	14	lower	low	JJR
cord-283340-ksyd5l56	208	15	total	total	JJ
cord-283340-ksyd5l56	208	16	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	208	17	and	and	CC
cord-283340-ksyd5l56	208	18	LDL	ldl	NN
cord-283340-ksyd5l56	208	19	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	208	20	levels	level	NNS
cord-283340-ksyd5l56	208	21	than	than	IN
cord-283340-ksyd5l56	208	22	healthy	healthy	JJ
cord-283340-ksyd5l56	208	23	controls	control	NNS
cord-283340-ksyd5l56	208	24	.	.	.
cord-283340-ksyd5l56	209	1	Severe	severe	JJ
cord-283340-ksyd5l56	209	2	cases	case	NNS
cord-283340-ksyd5l56	209	3	had	have	VBD
cord-283340-ksyd5l56	209	4	lower	low	JJR
cord-283340-ksyd5l56	209	5	total	total	JJ
cord-283340-ksyd5l56	209	6	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	209	7	,	,	,
cord-283340-ksyd5l56	209	8	LDL	ldl	NN
cord-283340-ksyd5l56	209	9	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	209	10	,	,	,
cord-283340-ksyd5l56	209	11	and	and	CC
cord-283340-ksyd5l56	209	12	HDL	HDL	NNP
cord-283340-ksyd5l56	209	13	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	209	14	levels	level	NNS
cord-283340-ksyd5l56	209	15	.	.	.
cord-283340-ksyd5l56	210	1	The	the	DT
cord-283340-ksyd5l56	210	2	authors	author	NNS
cord-283340-ksyd5l56	210	3	suggested	suggest	VBD
cord-283340-ksyd5l56	210	4	that	that	IN
cord-283340-ksyd5l56	210	5	their	-PRON-	PRP$
cord-283340-ksyd5l56	210	6	findings	finding	NNS
cord-283340-ksyd5l56	210	7	may	may	MD
cord-283340-ksyd5l56	210	8	be	be	VB
cord-283340-ksyd5l56	210	9	explained	explain	VBN
cord-283340-ksyd5l56	210	10	by	by	IN
cord-283340-ksyd5l56	210	11	changes	change	NNS
cord-283340-ksyd5l56	210	12	in	in	IN
cord-283340-ksyd5l56	210	13	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	210	14	metabolism	metabolism	NN
cord-283340-ksyd5l56	210	15	due	due	JJ
cord-283340-ksyd5l56	210	16	to	to	IN
cord-283340-ksyd5l56	210	17	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	210	18	infection	infection	NN
cord-283340-ksyd5l56	210	19	,	,	,
cord-283340-ksyd5l56	210	20	changes	change	NNS
cord-283340-ksyd5l56	210	21	in	in	IN
cord-283340-ksyd5l56	210	22	lipid	lipid	NN
cord-283340-ksyd5l56	210	23	metabolism	metabolism	NN
cord-283340-ksyd5l56	210	24	due	due	IN
cord-283340-ksyd5l56	210	25	to	to	IN
cord-283340-ksyd5l56	210	26	hyperinflammation	hyperinflammation	NN
cord-283340-ksyd5l56	210	27	,	,	,
cord-283340-ksyd5l56	210	28	leakage	leakage	NN
cord-283340-ksyd5l56	210	29	of	of	IN
cord-283340-ksyd5l56	210	30	LDL	ldl	NN
cord-283340-ksyd5l56	210	31	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	210	32	due	due	JJ
cord-283340-ksyd5l56	210	33	to	to	IN
cord-283340-ksyd5l56	210	34	increased	increase	VBN
cord-283340-ksyd5l56	210	35	vascular	vascular	JJ
cord-283340-ksyd5l56	210	36	permeability	permeability	NN
cord-283340-ksyd5l56	210	37	,	,	,
cord-283340-ksyd5l56	210	38	and	and	CC
cord-283340-ksyd5l56	210	39	accelerated	accelerated	JJ
cord-283340-ksyd5l56	210	40	lipid	lipid	NN
cord-283340-ksyd5l56	210	41	degradation	degradation	NN
cord-283340-ksyd5l56	210	42	.	.	.
cord-283340-ksyd5l56	211	1	Changes	change	NNS
cord-283340-ksyd5l56	211	2	in	in	IN
cord-283340-ksyd5l56	211	3	lipid	lipid	NN
cord-283340-ksyd5l56	211	4	metabolism	metabolism	NN
cord-283340-ksyd5l56	211	5	are	be	VBP
cord-283340-ksyd5l56	211	6	an	an	DT
cord-283340-ksyd5l56	211	7	early	early	JJ
cord-283340-ksyd5l56	211	8	step	step	NN
cord-283340-ksyd5l56	211	9	in	in	IN
cord-283340-ksyd5l56	211	10	atherogenesis	atherogenesis	NN
cord-283340-ksyd5l56	211	11	and	and	CC
cord-283340-ksyd5l56	211	12	can	can	MD
cord-283340-ksyd5l56	211	13	cause	cause	VB
cord-283340-ksyd5l56	211	14	vessel	vessel	NN
cord-283340-ksyd5l56	211	15	injury	injury	NN
cord-283340-ksyd5l56	211	16	through	through	IN
cord-283340-ksyd5l56	211	17	coagulopathy	coagulopathy	NN
cord-283340-ksyd5l56	211	18	and	and	CC
cord-283340-ksyd5l56	211	19	endothelial	endothelial	JJ
cord-283340-ksyd5l56	211	20	dysfunction	dysfunction	NN
cord-283340-ksyd5l56	211	21	.	.	.
cord-283340-ksyd5l56	212	1	Thus	thus	RB
cord-283340-ksyd5l56	212	2	,	,	,
cord-283340-ksyd5l56	212	3	the	the	DT
cord-283340-ksyd5l56	212	4	authors	author	NNS
cord-283340-ksyd5l56	212	5	emphasized	emphasize	VBD
cord-283340-ksyd5l56	212	6	the	the	DT
cord-283340-ksyd5l56	212	7	role	role	NN
cord-283340-ksyd5l56	212	8	of	of	IN
cord-283340-ksyd5l56	212	9	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	212	10	in	in	IN
cord-283340-ksyd5l56	212	11	vasculopathy	vasculopathy	NNP
cord-283340-ksyd5l56	212	12	caused	cause	VBN
cord-283340-ksyd5l56	212	13	by	by	IN
cord-283340-ksyd5l56	212	14	Related	relate	VBN
cord-283340-ksyd5l56	212	15	to	to	IN
cord-283340-ksyd5l56	212	16	this	this	DT
cord-283340-ksyd5l56	212	17	topic	topic	NN
cord-283340-ksyd5l56	212	18	,	,	,
cord-283340-ksyd5l56	212	19	Zhang	Zhang	NNP
cord-283340-ksyd5l56	212	20	et	et	NNP
cord-283340-ksyd5l56	212	21	al	al	NNP
cord-283340-ksyd5l56	212	22	.	.	.
cord-283340-ksyd5l56	213	1	60	60	CD
cord-283340-ksyd5l56	213	2	reported	report	VBD
cord-283340-ksyd5l56	213	3	that	that	IN
cord-283340-ksyd5l56	213	4	in	in	IN
cord-283340-ksyd5l56	213	5	a	a	DT
cord-283340-ksyd5l56	213	6	retrospective	retrospective	JJ
cord-283340-ksyd5l56	213	7	study	study	NN
cord-283340-ksyd5l56	213	8	of	of	IN
cord-283340-ksyd5l56	213	9	13,981	13,981	CD
cord-283340-ksyd5l56	213	10	patients	patient	NNS
cord-283340-ksyd5l56	213	11	,	,	,
cord-283340-ksyd5l56	213	12	statin	statin	NN
cord-283340-ksyd5l56	213	13	therapy	therapy	NN
cord-283340-ksyd5l56	213	14	(	(	-LRB-
cord-283340-ksyd5l56	213	15	the	the	DT
cord-283340-ksyd5l56	213	16	main	main	JJ
cord-283340-ksyd5l56	213	17	treatment	treatment	NN
cord-283340-ksyd5l56	213	18	for	for	IN
cord-283340-ksyd5l56	213	19	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	213	20	)	)	-RRB-
cord-283340-ksyd5l56	213	21	significantly	significantly	RB
cord-283340-ksyd5l56	213	22	reduced	reduce	VBD
cord-283340-ksyd5l56	213	23	the	the	DT
cord-283340-ksyd5l56	213	24	severity	severity	NN
cord-283340-ksyd5l56	213	25	and	and	CC
cord-283340-ksyd5l56	213	26	mortality	mortality	NN
cord-283340-ksyd5l56	213	27	of	of	IN
cord-283340-ksyd5l56	213	28	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	213	29	.	.	.
cord-283340-ksyd5l56	214	1	In	in	IN
cord-283340-ksyd5l56	214	2	an	an	DT
cord-283340-ksyd5l56	214	3	analysis	analysis	NN
cord-283340-ksyd5l56	214	4	of	of	IN
cord-283340-ksyd5l56	214	5	all	all	DT
cord-283340-ksyd5l56	214	6	participants	participant	NNS
cord-283340-ksyd5l56	214	7	'	'	POS
cord-283340-ksyd5l56	214	8	baseline	baseline	JJ
cord-283340-ksyd5l56	214	9	characteristics	characteristic	NNS
cord-283340-ksyd5l56	214	10	,	,	,
cord-283340-ksyd5l56	214	11	subjects	subject	NNS
cord-283340-ksyd5l56	214	12	with	with	IN
cord-283340-ksyd5l56	214	13	statin	statin	NN
cord-283340-ksyd5l56	214	14	therapy	therapy	NN
cord-283340-ksyd5l56	214	15	had	have	VBD
cord-283340-ksyd5l56	214	16	less	less	JJR
cord-283340-ksyd5l56	214	17	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	214	18	,	,	,
cord-283340-ksyd5l56	214	19	defined	define	VBN
cord-283340-ksyd5l56	214	20	as	as	IN
cord-283340-ksyd5l56	214	21	a	a	DT
cord-283340-ksyd5l56	214	22	LDL	ldl	NN
cord-283340-ksyd5l56	214	23	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	214	24	level	level	NN
cord-283340-ksyd5l56	214	25	more	more	JJR
cord-283340-ksyd5l56	214	26	than	than	IN
cord-283340-ksyd5l56	214	27	the	the	DT
cord-283340-ksyd5l56	214	28	upper	upper	JJ
cord-283340-ksyd5l56	214	29	limit	limit	NN
cord-283340-ksyd5l56	214	30	of	of	IN
cord-283340-ksyd5l56	214	31	the	the	DT
cord-283340-ksyd5l56	214	32	normal	normal	JJ
cord-283340-ksyd5l56	214	33	range	range	NN
cord-283340-ksyd5l56	214	34	according	accord	VBG
cord-283340-ksyd5l56	214	35	to	to	IN
cord-283340-ksyd5l56	214	36	the	the	DT
cord-283340-ksyd5l56	214	37	criteria	criterion	NNS
cord-283340-ksyd5l56	214	38	at	at	IN
cord-283340-ksyd5l56	214	39	each	each	DT
cord-283340-ksyd5l56	214	40	hospital	hospital	NN
cord-283340-ksyd5l56	214	41	,	,	,
cord-283340-ksyd5l56	214	42	and	and	CC
cord-283340-ksyd5l56	214	43	even	even	RB
cord-283340-ksyd5l56	214	44	after	after	IN
cord-283340-ksyd5l56	214	45	propensity	propensity	NN
cord-283340-ksyd5l56	214	46	score	score	NN
cord-283340-ksyd5l56	214	47	matching	matching	NN
cord-283340-ksyd5l56	214	48	,	,	,
cord-283340-ksyd5l56	214	49	there	there	EX
cord-283340-ksyd5l56	214	50	was	be	VBD
cord-283340-ksyd5l56	214	51	a	a	DT
cord-283340-ksyd5l56	214	52	slight	slight	JJ
cord-283340-ksyd5l56	214	53	statistical	statistical	JJ
cord-283340-ksyd5l56	214	54	difference	difference	NN
cord-283340-ksyd5l56	214	55	between	between	IN
cord-283340-ksyd5l56	214	56	the	the	DT
cord-283340-ksyd5l56	214	57	two	two	CD
cord-283340-ksyd5l56	214	58	groups	group	NNS
cord-283340-ksyd5l56	214	59	.	.	.
cord-283340-ksyd5l56	215	1	However	however	RB
cord-283340-ksyd5l56	215	2	,	,	,
cord-283340-ksyd5l56	215	3	even	even	RB
cord-283340-ksyd5l56	215	4	after	after	IN
cord-283340-ksyd5l56	215	5	correcting	correct	VBG
cord-283340-ksyd5l56	215	6	for	for	IN
cord-283340-ksyd5l56	215	7	various	various	JJ
cord-283340-ksyd5l56	215	8	risk	risk	NN
cord-283340-ksyd5l56	215	9	factors	factor	NNS
cord-283340-ksyd5l56	215	10	including	include	VBG
cord-283340-ksyd5l56	215	11	LDL	ldl	NN
cord-283340-ksyd5l56	215	12	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	215	13	,	,	,
cord-283340-ksyd5l56	215	14	the	the	DT
cord-283340-ksyd5l56	215	15	mortality	mortality	NN
cord-283340-ksyd5l56	215	16	rate	rate	NN
cord-283340-ksyd5l56	215	17	within	within	IN
cord-283340-ksyd5l56	215	18	28	28	CD
cord-283340-ksyd5l56	215	19	days	day	NNS
cord-283340-ksyd5l56	215	20	was	be	VBD
cord-283340-ksyd5l56	215	21	5.2	5.2	CD
cord-283340-ksyd5l56	215	22	%	%	NN
cord-283340-ksyd5l56	215	23	and	and	CC
cord-283340-ksyd5l56	215	24	9.4	9.4	CD
cord-283340-ksyd5l56	215	25	%	%	NN
cord-283340-ksyd5l56	215	26	in	in	IN
cord-283340-ksyd5l56	215	27	the	the	DT
cord-283340-ksyd5l56	215	28	statin	statin	NN
cord-283340-ksyd5l56	215	29	and	and	CC
cord-283340-ksyd5l56	215	30	non	non	JJ
cord-283340-ksyd5l56	215	31	-	-	JJ
cord-283340-ksyd5l56	215	32	statin	statin	JJ
cord-283340-ksyd5l56	215	33	groups	group	NNS
cord-283340-ksyd5l56	215	34	,	,	,
cord-283340-ksyd5l56	215	35	respectively	respectively	RB
cord-283340-ksyd5l56	215	36	,	,	,
cord-283340-ksyd5l56	215	37	with	with	IN
cord-283340-ksyd5l56	215	38	an	an	DT
cord-283340-ksyd5l56	215	39	adjusted	adjusted	JJ
cord-283340-ksyd5l56	215	40	hazard	hazard	NN
cord-283340-ksyd5l56	215	41	ratio	ratio	NN
cord-283340-ksyd5l56	215	42	of	of	IN
cord-283340-ksyd5l56	215	43	0.58	0.58	CD
cord-283340-ksyd5l56	215	44	.	.	.
cord-283340-ksyd5l56	216	1	The	the	DT
cord-283340-ksyd5l56	216	2	possibility	possibility	NN
cord-283340-ksyd5l56	216	3	that	that	IN
cord-283340-ksyd5l56	216	4	these	these	DT
cord-283340-ksyd5l56	216	5	results	result	NNS
cord-283340-ksyd5l56	216	6	may	may	MD
cord-283340-ksyd5l56	216	7	reflect	reflect	VB
cord-283340-ksyd5l56	216	8	the	the	DT
cord-283340-ksyd5l56	216	9	pleiotropic	pleiotropic	JJ
cord-283340-ksyd5l56	216	10	effects	effect	NNS
cord-283340-ksyd5l56	216	11	of	of	IN
cord-283340-ksyd5l56	216	12	statins	statin	NNS
cord-283340-ksyd5l56	216	13	,	,	,
cord-283340-ksyd5l56	216	14	including	include	VBG
cord-283340-ksyd5l56	216	15	their	-PRON-	PRP$
cord-283340-ksyd5l56	216	16	anti	anti	JJ
cord-283340-ksyd5l56	216	17	-	-	JJ
cord-283340-ksyd5l56	216	18	inflammatory	inflammatory	JJ
cord-283340-ksyd5l56	216	19	and	and	CC
cord-283340-ksyd5l56	216	20	antioxidant	antioxidant	JJ
cord-283340-ksyd5l56	216	21	effects	effect	NNS
cord-283340-ksyd5l56	216	22	,	,	,
cord-283340-ksyd5l56	216	23	rather	rather	RB
cord-283340-ksyd5l56	216	24	than	than	IN
cord-283340-ksyd5l56	216	25	their	-PRON-	PRP$
cord-283340-ksyd5l56	216	26	LDL	LDL	NNP
cord-283340-ksyd5l56	216	27	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	216	28	-	-	HYPH
cord-283340-ksyd5l56	216	29	lowering	lower	VBG
cord-283340-ksyd5l56	216	30	effect	effect	NN
cord-283340-ksyd5l56	216	31	itself	-PRON-	PRP
cord-283340-ksyd5l56	216	32	,	,	,
cord-283340-ksyd5l56	216	33	has	have	VBZ
cord-283340-ksyd5l56	216	34	attracted	attract	VBN
cord-283340-ksyd5l56	216	35	attention	attention	NN
cord-283340-ksyd5l56	216	36	.	.	.
cord-283340-ksyd5l56	217	1	In	in	IN
cord-283340-ksyd5l56	217	2	particular	particular	JJ
cord-283340-ksyd5l56	217	3	,	,	,
cord-283340-ksyd5l56	217	4	protease	protease	JJ
cord-283340-ksyd5l56	217	5	inhibitor	inhibitor	NN
cord-283340-ksyd5l56	217	6	-	-	HYPH
cord-283340-ksyd5l56	217	7	based	base	VBN
cord-283340-ksyd5l56	217	8	antiretroviral	antiretroviral	JJ
cord-283340-ksyd5l56	217	9	and	and	CC
cord-283340-ksyd5l56	217	10	immunosuppressive	immunosuppressive	JJ
cord-283340-ksyd5l56	217	11	drugs	drug	NNS
cord-283340-ksyd5l56	217	12	are	be	VBP
cord-283340-ksyd5l56	217	13	used	use	VBN
cord-283340-ksyd5l56	217	14	to	to	TO
cord-283340-ksyd5l56	217	15	treat	treat	VB
cord-283340-ksyd5l56	217	16	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	217	17	,	,	,
cord-283340-ksyd5l56	217	18	61	61	CD
cord-283340-ksyd5l56	217	19	and	and	CC
cord-283340-ksyd5l56	217	20	these	these	DT
cord-283340-ksyd5l56	217	21	drugs	drug	NNS
cord-283340-ksyd5l56	217	22	may	may	MD
cord-283340-ksyd5l56	217	23	exacerbate	exacerbate	VB
cord-283340-ksyd5l56	217	24	hyperlipidemia	hyperlipidemia	NN
cord-283340-ksyd5l56	217	25	,	,	,
cord-283340-ksyd5l56	217	26	so	so	IN
cord-283340-ksyd5l56	217	27	statins	statin	NNS
cord-283340-ksyd5l56	217	28	may	may	MD
cord-283340-ksyd5l56	217	29	be	be	VB
cord-283340-ksyd5l56	217	30	particularly	particularly	RB
cord-283340-ksyd5l56	217	31	effective	effective	JJ
cord-283340-ksyd5l56	217	32	in	in	IN
cord-283340-ksyd5l56	217	33	patients	patient	NNS
cord-283340-ksyd5l56	217	34	receiving	receive	VBG
cord-283340-ksyd5l56	217	35	these	these	DT
cord-283340-ksyd5l56	217	36	medications	medication	NNS
cord-283340-ksyd5l56	217	37	.	.	.
cord-283340-ksyd5l56	218	1	62	62	CD
cord-283340-ksyd5l56	219	1	Furthermore	furthermore	RB
cord-283340-ksyd5l56	219	2	,	,	,
cord-283340-ksyd5l56	219	3	in	in	IN
cord-283340-ksyd5l56	219	4	a	a	DT
cord-283340-ksyd5l56	219	5	study	study	NN
cord-283340-ksyd5l56	219	6	in	in	IN
cord-283340-ksyd5l56	219	7	which	which	WDT
cord-283340-ksyd5l56	219	8	proteomic	proteomic	JJ
cord-283340-ksyd5l56	219	9	analysis	analysis	NN
cord-283340-ksyd5l56	219	10	was	be	VBD
cord-283340-ksyd5l56	219	11	performed	perform	VBN
cord-283340-ksyd5l56	219	12	on	on	IN
cord-283340-ksyd5l56	219	13	various	various	JJ
cord-283340-ksyd5l56	219	14	tissues	tissue	NNS
cord-283340-ksyd5l56	219	15	obtained	obtain	VBN
cord-283340-ksyd5l56	219	16	from	from	IN
cord-283340-ksyd5l56	219	17	autopsy	autopsy	JJ
cord-283340-ksyd5l56	219	18	samples	sample	NNS
cord-283340-ksyd5l56	219	19	of	of	IN
cord-283340-ksyd5l56	219	20	patients	patient	NNS
cord-283340-ksyd5l56	219	21	who	who	WP
cord-283340-ksyd5l56	219	22	died	die	VBD
cord-283340-ksyd5l56	219	23	from	from	IN
cord-283340-ksyd5l56	219	24	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	219	25	,	,	,
cord-283340-ksyd5l56	219	26	63	63	CD
cord-283340-ksyd5l56	219	27	Niemann	Niemann	NNP
cord-283340-ksyd5l56	219	28	-	-	HYPH
cord-283340-ksyd5l56	219	29	Pick	Pick	NNP
cord-283340-ksyd5l56	219	30	C1	C1	NNP
cord-283340-ksyd5l56	219	31	(	(	-LRB-
cord-283340-ksyd5l56	219	32	NPC1	NPC1	NNP
cord-283340-ksyd5l56	219	33	)	)	-RRB-
cord-283340-ksyd5l56	219	34	was	be	VBD
cord-283340-ksyd5l56	219	35	significantly	significantly	RB
cord-283340-ksyd5l56	219	36	upregulated	upregulate	VBN
cord-283340-ksyd5l56	219	37	in	in	IN
cord-283340-ksyd5l56	219	38	most	most	JJS
cord-283340-ksyd5l56	219	39	organs	organ	NNS
cord-283340-ksyd5l56	219	40	,	,	,
cord-283340-ksyd5l56	219	41	including	include	VBG
cord-283340-ksyd5l56	219	42	the	the	DT
cord-283340-ksyd5l56	219	43	lung	lung	NN
cord-283340-ksyd5l56	219	44	,	,	,
cord-283340-ksyd5l56	219	45	spleen	spleen	NNS
cord-283340-ksyd5l56	219	46	,	,	,
cord-283340-ksyd5l56	219	47	and	and	CC
cord-283340-ksyd5l56	219	48	heart	heart	NN
cord-283340-ksyd5l56	219	49	.	.	.
cord-283340-ksyd5l56	220	1	Considering	consider	VBG
cord-283340-ksyd5l56	220	2	that	that	IN
cord-283340-ksyd5l56	220	3	lipids	lipid	NNS
cord-283340-ksyd5l56	220	4	and	and	CC
cord-283340-ksyd5l56	220	5	lipid	lipid	NN
cord-283340-ksyd5l56	220	6	metabolism	metabolism	NN
cord-283340-ksyd5l56	220	7	play	play	VBP
cord-283340-ksyd5l56	220	8	an	an	DT
cord-283340-ksyd5l56	220	9	important	important	JJ
cord-283340-ksyd5l56	220	10	role	role	NN
cord-283340-ksyd5l56	220	11	in	in	IN
cord-283340-ksyd5l56	220	12	the	the	DT
cord-283340-ksyd5l56	220	13	process	process	NN
cord-283340-ksyd5l56	220	14	of	of	IN
cord-283340-ksyd5l56	220	15	viral	viral	JJ
cord-283340-ksyd5l56	220	16	replication	replication	NN
cord-283340-ksyd5l56	220	17	,	,	,
cord-283340-ksyd5l56	220	18	64	64	CD
cord-283340-ksyd5l56	220	19	NPC1	NPC1	NNP
cord-283340-ksyd5l56	220	20	may	may	MD
cord-283340-ksyd5l56	220	21	be	be	VB
cord-283340-ksyd5l56	220	22	a	a	DT
cord-283340-ksyd5l56	220	23	potential	potential	JJ
cord-283340-ksyd5l56	220	24	drug	drug	NN
cord-283340-ksyd5l56	220	25	target	target	NN
cord-283340-ksyd5l56	220	26	for	for	IN
cord-283340-ksyd5l56	220	27	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	220	28	.	.	.
cord-283340-ksyd5l56	221	1	Prospective	prospective	JJ
cord-283340-ksyd5l56	221	2	randomized	randomized	JJ
cord-283340-ksyd5l56	221	3	clinical	clinical	JJ
cord-283340-ksyd5l56	221	4	studies	study	NNS
cord-283340-ksyd5l56	221	5	are	be	VBP
cord-283340-ksyd5l56	221	6	needed	need	VBN
cord-283340-ksyd5l56	221	7	to	to	TO
cord-283340-ksyd5l56	221	8	obtain	obtain	VB
cord-283340-ksyd5l56	221	9	an	an	DT
cord-283340-ksyd5l56	221	10	accurate	accurate	JJ
cord-283340-ksyd5l56	221	11	answer	answer	NN
cord-283340-ksyd5l56	221	12	.	.	.
cord-283340-ksyd5l56	222	1	An	an	DT
cord-283340-ksyd5l56	222	2	important	important	JJ
cord-283340-ksyd5l56	222	3	limitation	limitation	NN
cord-283340-ksyd5l56	222	4	of	of	IN
cord-283340-ksyd5l56	222	5	this	this	DT
cord-283340-ksyd5l56	222	6	overview	overview	NN
cord-283340-ksyd5l56	222	7	is	be	VBZ
cord-283340-ksyd5l56	222	8	that	that	IN
cord-283340-ksyd5l56	222	9	the	the	DT
cord-283340-ksyd5l56	222	10	number	number	NN
cord-283340-ksyd5l56	222	11	of	of	IN
cord-283340-ksyd5l56	222	12	studies	study	NNS
cord-283340-ksyd5l56	222	13	included	include	VBN
cord-283340-ksyd5l56	222	14	-	-	:
cord-283340-ksyd5l56	222	15	reflecting	reflect	VBG
cord-283340-ksyd5l56	222	16	the	the	DT
cord-283340-ksyd5l56	222	17	number	number	NN
cord-283340-ksyd5l56	222	18	of	of	IN
cord-283340-ksyd5l56	222	19	reviews	review	NNS
cord-283340-ksyd5l56	222	20	that	that	WDT
cord-283340-ksyd5l56	222	21	included	include	VBD
cord-283340-ksyd5l56	222	22	data	datum	NNS
cord-283340-ksyd5l56	222	23	regarding	regard	VBG
cord-283340-ksyd5l56	222	24	the	the	DT
cord-283340-ksyd5l56	222	25	association	association	NN
cord-283340-ksyd5l56	222	26	between	between	IN
cord-283340-ksyd5l56	222	27	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	222	28	and	and	CC
cord-283340-ksyd5l56	222	29	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	222	30	infection	infection	NN
cord-283340-ksyd5l56	222	31	-	-	,
cord-283340-ksyd5l56	222	32	was	be	VBD
cord-283340-ksyd5l56	222	33	limited	limit	VBN
cord-283340-ksyd5l56	222	34	,	,	,
cord-283340-ksyd5l56	222	35	precluding	preclude	VBG
cord-283340-ksyd5l56	222	36	a	a	DT
cord-283340-ksyd5l56	222	37	stringent	stringent	JJ
cord-283340-ksyd5l56	222	38	analysis	analysis	NN
cord-283340-ksyd5l56	222	39	of	of	IN
cord-283340-ksyd5l56	222	40	this	this	DT
cord-283340-ksyd5l56	222	41	end	end	NN
cord-283340-ksyd5l56	222	42	point	point	NN
cord-283340-ksyd5l56	222	43	.	.	.
cord-283340-ksyd5l56	223	1	Moreover	moreover	RB
cord-283340-ksyd5l56	223	2	,	,	,
cord-283340-ksyd5l56	223	3	the	the	DT
cord-283340-ksyd5l56	223	4	methodological	methodological	JJ
cord-283340-ksyd5l56	223	5	quality	quality	NN
cord-283340-ksyd5l56	223	6	assessment	assessment	NN
cord-283340-ksyd5l56	223	7	showed	show	VBD
cord-283340-ksyd5l56	223	8	that	that	IN
cord-283340-ksyd5l56	223	9	both	both	DT
cord-283340-ksyd5l56	223	10	reviews	review	NNS
cord-283340-ksyd5l56	223	11	had	have	VBD
cord-283340-ksyd5l56	223	12	multiple	multiple	JJ
cord-283340-ksyd5l56	223	13	critical	critical	JJ
cord-283340-ksyd5l56	223	14	flaws	flaw	NNS
cord-283340-ksyd5l56	223	15	,	,	,
cord-283340-ksyd5l56	223	16	making	make	VBG
cord-283340-ksyd5l56	223	17	the	the	DT
cord-283340-ksyd5l56	223	18	current	current	JJ
cord-283340-ksyd5l56	223	19	umbrella	umbrella	NN
cord-283340-ksyd5l56	223	20	review	review	NN
cord-283340-ksyd5l56	223	21	limited	limit	VBN
cord-283340-ksyd5l56	223	22	.	.	.
cord-283340-ksyd5l56	224	1	The	the	DT
cord-283340-ksyd5l56	224	2	situation	situation	NN
cord-283340-ksyd5l56	224	3	regarding	regard	VBG
cord-283340-ksyd5l56	224	4	the	the	DT
cord-283340-ksyd5l56	224	5	COVID-19	covid-19	CD
cord-283340-ksyd5l56	224	6	pandemic	pandemic	NN
cord-283340-ksyd5l56	224	7	is	be	VBZ
cord-283340-ksyd5l56	224	8	changing	change	VBG
cord-283340-ksyd5l56	224	9	so	so	RB
cord-283340-ksyd5l56	224	10	rapidly	rapidly	RB
cord-283340-ksyd5l56	224	11	,	,	,
cord-283340-ksyd5l56	224	12	with	with	IN
cord-283340-ksyd5l56	224	13	such	such	JJ
cord-283340-ksyd5l56	224	14	serious	serious	JJ
cord-283340-ksyd5l56	224	15	consequences	consequence	NNS
cord-283340-ksyd5l56	224	16	,	,	,
cord-283340-ksyd5l56	224	17	that	that	IN
cord-283340-ksyd5l56	224	18	numerous	numerous	JJ
cord-283340-ksyd5l56	224	19	reports	report	NNS
cord-283340-ksyd5l56	224	20	are	be	VBP
cord-283340-ksyd5l56	224	21	published	publish	VBN
cord-283340-ksyd5l56	224	22	without	without	IN
cord-283340-ksyd5l56	224	23	a	a	DT
cord-283340-ksyd5l56	224	24	sufficient	sufficient	JJ
cord-283340-ksyd5l56	224	25	evaluation	evaluation	NN
cord-283340-ksyd5l56	224	26	of	of	IN
cord-283340-ksyd5l56	224	27	the	the	DT
cord-283340-ksyd5l56	224	28	data	data	NN
cord-283340-ksyd5l56	224	29	quality	quality	NN
cord-283340-ksyd5l56	224	30	.	.	.
cord-283340-ksyd5l56	225	1	This	this	DT
cord-283340-ksyd5l56	225	2	may	may	MD
cord-283340-ksyd5l56	225	3	explain	explain	VB
cord-283340-ksyd5l56	225	4	the	the	DT
cord-283340-ksyd5l56	225	5	low	low	JJ
cord-283340-ksyd5l56	225	6	methodological	methodological	JJ
cord-283340-ksyd5l56	225	7	quality	quality	NN
cord-283340-ksyd5l56	225	8	of	of	IN
cord-283340-ksyd5l56	225	9	the	the	DT
cord-283340-ksyd5l56	225	10	reviews	review	NNS
cord-283340-ksyd5l56	225	11	included	include	VBN
cord-283340-ksyd5l56	225	12	in	in	IN
cord-283340-ksyd5l56	225	13	the	the	DT
cord-283340-ksyd5l56	225	14	present	present	JJ
cord-283340-ksyd5l56	225	15	study	study	NN
cord-283340-ksyd5l56	225	16	.	.	.
cord-283340-ksyd5l56	226	1	Consequently	consequently	RB
cord-283340-ksyd5l56	226	2	,	,	,
cord-283340-ksyd5l56	226	3	we	-PRON-	PRP
cord-283340-ksyd5l56	226	4	conducted	conduct	VBD
cord-283340-ksyd5l56	226	5	this	this	DT
cord-283340-ksyd5l56	226	6	overview	overview	NN
cord-283340-ksyd5l56	226	7	as	as	IN
cord-283340-ksyd5l56	226	8	a	a	DT
cord-283340-ksyd5l56	226	9	narrative	narrative	NN
cord-283340-ksyd5l56	226	10	synthesis	synthesis	NN
cord-283340-ksyd5l56	226	11	of	of	IN
cord-283340-ksyd5l56	226	12	the	the	DT
cord-283340-ksyd5l56	226	13	evidence	evidence	NN
cord-283340-ksyd5l56	226	14	.	.	.
cord-283340-ksyd5l56	227	1	In	in	IN
cord-283340-ksyd5l56	227	2	addition	addition	NN
cord-283340-ksyd5l56	227	3	,	,	,
cord-283340-ksyd5l56	227	4	we	-PRON-	PRP
cord-283340-ksyd5l56	227	5	only	only	RB
cord-283340-ksyd5l56	227	6	analyzed	analyze	VBD
cord-283340-ksyd5l56	227	7	articles	article	NNS
cord-283340-ksyd5l56	227	8	in	in	IN
cord-283340-ksyd5l56	227	9	English	English	NNP
cord-283340-ksyd5l56	227	10	.	.	.
cord-283340-ksyd5l56	228	1	If	if	IN
cord-283340-ksyd5l56	228	2	the	the	DT
cord-283340-ksyd5l56	228	3	search	search	NN
cord-283340-ksyd5l56	228	4	had	have	VBD
cord-283340-ksyd5l56	228	5	been	be	VBN
cord-283340-ksyd5l56	228	6	done	do	VBN
cord-283340-ksyd5l56	228	7	in	in	IN
cord-283340-ksyd5l56	228	8	other	other	JJ
cord-283340-ksyd5l56	228	9	languages	language	NNS
cord-283340-ksyd5l56	228	10	,	,	,
cord-283340-ksyd5l56	228	11	more	more	JJR
cord-283340-ksyd5l56	228	12	studies	study	NNS
cord-283340-ksyd5l56	228	13	could	could	MD
cord-283340-ksyd5l56	228	14	have	have	VB
cord-283340-ksyd5l56	228	15	been	be	VBN
cord-283340-ksyd5l56	228	16	included	include	VBN
cord-283340-ksyd5l56	228	17	.	.	.
cord-283340-ksyd5l56	229	1	Despite	despite	IN
cord-283340-ksyd5l56	229	2	these	these	DT
cord-283340-ksyd5l56	229	3	limitations	limitation	NNS
cord-283340-ksyd5l56	229	4	,	,	,
cord-283340-ksyd5l56	229	5	however	however	RB
cord-283340-ksyd5l56	229	6	,	,	,
cord-283340-ksyd5l56	229	7	this	this	DT
cord-283340-ksyd5l56	229	8	is	be	VBZ
cord-283340-ksyd5l56	229	9	the	the	DT
cord-283340-ksyd5l56	229	10	first	first	JJ
cord-283340-ksyd5l56	229	11	umbrella	umbrella	NN
cord-283340-ksyd5l56	229	12	review	review	NN
cord-283340-ksyd5l56	229	13	investigating	investigate	VBG
cord-283340-ksyd5l56	229	14	the	the	DT
cord-283340-ksyd5l56	229	15	association	association	NN
cord-283340-ksyd5l56	229	16	between	between	IN
cord-283340-ksyd5l56	229	17	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	229	18	and	and	CC
cord-283340-ksyd5l56	229	19	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	229	20	infection	infection	NN
cord-283340-ksyd5l56	229	21	.	.	.
cord-283340-ksyd5l56	230	1	Furthermore	furthermore	RB
cord-283340-ksyd5l56	230	2	,	,	,
cord-283340-ksyd5l56	230	3	we	-PRON-	PRP
cord-283340-ksyd5l56	230	4	applied	apply	VBD
cord-283340-ksyd5l56	230	5	a	a	DT
cord-283340-ksyd5l56	230	6	rigorous	rigorous	JJ
cord-283340-ksyd5l56	230	7	methodology	methodology	NN
cord-283340-ksyd5l56	230	8	to	to	TO
cord-283340-ksyd5l56	230	9	conduct	conduct	VB
cord-283340-ksyd5l56	230	10	an	an	DT
cord-283340-ksyd5l56	230	11	umbrella	umbrella	NN
cord-283340-ksyd5l56	230	12	review	review	NN
cord-283340-ksyd5l56	230	13	of	of	IN
cord-283340-ksyd5l56	230	14	systematic	systematic	JJ
cord-283340-ksyd5l56	230	15	reviews	review	NNS
cord-283340-ksyd5l56	230	16	.	.	.
cord-283340-ksyd5l56	231	1	Hence	hence	RB
cord-283340-ksyd5l56	231	2	,	,	,
cord-283340-ksyd5l56	231	3	the	the	DT
cord-283340-ksyd5l56	231	4	evidence	evidence	NN
cord-283340-ksyd5l56	231	5	from	from	IN
cord-283340-ksyd5l56	231	6	this	this	DT
cord-283340-ksyd5l56	231	7	study	study	NN
cord-283340-ksyd5l56	231	8	is	be	VBZ
cord-283340-ksyd5l56	231	9	important	important	JJ
cord-283340-ksyd5l56	231	10	from	from	IN
cord-283340-ksyd5l56	231	11	the	the	DT
cord-283340-ksyd5l56	231	12	perspective	perspective	NN
cord-283340-ksyd5l56	231	13	of	of	IN
cord-283340-ksyd5l56	231	14	aggressive	aggressive	JJ
cord-283340-ksyd5l56	231	15	treatment	treatment	NN
cord-283340-ksyd5l56	231	16	and	and	CC
cord-283340-ksyd5l56	231	17	disease	disease	NN
cord-283340-ksyd5l56	231	18	prevention	prevention	NN
cord-283340-ksyd5l56	231	19	.	.	.
cord-283340-ksyd5l56	232	1	In	in	IN
cord-283340-ksyd5l56	232	2	conclusion	conclusion	NN
cord-283340-ksyd5l56	232	3	,	,	,
cord-283340-ksyd5l56	232	4	we	-PRON-	PRP
cord-283340-ksyd5l56	232	5	conducted	conduct	VBD
cord-283340-ksyd5l56	232	6	an	an	DT
cord-283340-ksyd5l56	232	7	umbrella	umbrella	NN
cord-283340-ksyd5l56	232	8	review	review	NN
cord-283340-ksyd5l56	232	9	to	to	TO
cord-283340-ksyd5l56	232	10	identify	identify	VB
cord-283340-ksyd5l56	232	11	the	the	DT
cord-283340-ksyd5l56	232	12	findings	finding	NNS
cord-283340-ksyd5l56	232	13	and	and	CC
cord-283340-ksyd5l56	232	14	contents	content	NNS
cord-283340-ksyd5l56	232	15	of	of	IN
cord-283340-ksyd5l56	232	16	systematic	systematic	JJ
cord-283340-ksyd5l56	232	17	reviews	review	NNS
cord-283340-ksyd5l56	233	1	and/or	and/or	CC
cord-283340-ksyd5l56	233	2	meta	meta	NNP
cord-283340-ksyd5l56	233	3	-	-	HYPH
cord-283340-ksyd5l56	233	4	analyses	analysis	NNS
cord-283340-ksyd5l56	233	5	of	of	IN
cord-283340-ksyd5l56	233	6	the	the	DT
cord-283340-ksyd5l56	233	7	relationship	relationship	NN
cord-283340-ksyd5l56	233	8	between	between	IN
cord-283340-ksyd5l56	233	9	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	233	10	and	and	CC
cord-283340-ksyd5l56	233	11	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	233	12	infection	infection	NN
cord-283340-ksyd5l56	233	13	severity	severity	NN
cord-283340-ksyd5l56	233	14	.	.	.
cord-283340-ksyd5l56	234	1	According	accord	VBG
cord-283340-ksyd5l56	234	2	to	to	IN
cord-283340-ksyd5l56	234	3	the	the	DT
cord-283340-ksyd5l56	234	4	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	234	5	2	2	CD
cord-283340-ksyd5l56	234	6	criteria	criterion	NNS
cord-283340-ksyd5l56	234	7	and	and	CC
cord-283340-ksyd5l56	234	8	GRADE	grade	NN
cord-283340-ksyd5l56	234	9	system	system	NN
cord-283340-ksyd5l56	234	10	,	,	,
cord-283340-ksyd5l56	234	11	the	the	DT
cord-283340-ksyd5l56	234	12	studies	study	NNS
cord-283340-ksyd5l56	234	13	did	do	VBD
cord-283340-ksyd5l56	234	14	not	not	RB
cord-283340-ksyd5l56	234	15	show	show	VB
cord-283340-ksyd5l56	234	16	high	high	JJ
cord-283340-ksyd5l56	234	17	quality	quality	NN
cord-283340-ksyd5l56	234	18	,	,	,
cord-283340-ksyd5l56	234	19	and	and	CC
cord-283340-ksyd5l56	234	20	the	the	DT
cord-283340-ksyd5l56	234	21	primary	primary	JJ
cord-283340-ksyd5l56	234	22	evidence	evidence	NN
cord-283340-ksyd5l56	234	23	quality	quality	NN
cord-283340-ksyd5l56	234	24	of	of	IN
cord-283340-ksyd5l56	234	25	both	both	CC
cord-283340-ksyd5l56	234	26	the	the	DT
cord-283340-ksyd5l56	234	27	observational	observational	JJ
cord-283340-ksyd5l56	234	28	studies	study	NNS
cord-283340-ksyd5l56	234	29	and	and	CC
cord-283340-ksyd5l56	234	30	the	the	DT
cord-283340-ksyd5l56	234	31	systematic	systematic	JJ
cord-283340-ksyd5l56	234	32	reviews	review	NNS
cord-283340-ksyd5l56	234	33	was	be	VBD
cord-283340-ksyd5l56	234	34	considered	consider	VBN
cord-283340-ksyd5l56	234	35	low	low	JJ
cord-283340-ksyd5l56	234	36	.	.	.
cord-283340-ksyd5l56	235	1	Although	although	IN
cord-283340-ksyd5l56	235	2	it	-PRON-	PRP
cord-283340-ksyd5l56	235	3	is	be	VBZ
cord-283340-ksyd5l56	235	4	difficult	difficult	JJ
cord-283340-ksyd5l56	235	5	to	to	TO
cord-283340-ksyd5l56	235	6	draw	draw	VB
cord-283340-ksyd5l56	235	7	a	a	DT
cord-283340-ksyd5l56	235	8	definitive	definitive	JJ
cord-283340-ksyd5l56	235	9	conclusion	conclusion	NN
cord-283340-ksyd5l56	235	10	,	,	,
cord-283340-ksyd5l56	235	11	patients	patient	NNS
cord-283340-ksyd5l56	235	12	with	with	IN
cord-283340-ksyd5l56	235	13	a	a	DT
cord-283340-ksyd5l56	235	14	history	history	NN
cord-283340-ksyd5l56	235	15	of	of	IN
cord-283340-ksyd5l56	235	16	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	235	17	are	be	VBP
cord-283340-ksyd5l56	235	18	likely	likely	JJ
cord-283340-ksyd5l56	235	19	to	to	TO
cord-283340-ksyd5l56	235	20	be	be	VB
cord-283340-ksyd5l56	235	21	at	at	IN
cord-283340-ksyd5l56	235	22	risk	risk	NN
cord-283340-ksyd5l56	235	23	for	for	IN
cord-283340-ksyd5l56	235	24	severe	severe	JJ
cord-283340-ksyd5l56	235	25	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	235	26	infections	infection	NNS
cord-283340-ksyd5l56	235	27	,	,	,
cord-283340-ksyd5l56	235	28	but	but	CC
cord-283340-ksyd5l56	235	29	the	the	DT
cord-283340-ksyd5l56	235	30	contrary	contrary	JJ
cord-283340-ksyd5l56	235	31	finding	finding	NN
cord-283340-ksyd5l56	235	32	was	be	VBD
cord-283340-ksyd5l56	235	33	shown	show	VBN
cord-283340-ksyd5l56	235	34	for	for	IN
cord-283340-ksyd5l56	235	35	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	235	36	levels	level	NNS
cord-283340-ksyd5l56	235	37	at	at	IN
cord-283340-ksyd5l56	235	38	hospitalization	hospitalization	NN
cord-283340-ksyd5l56	235	39	.	.	.
cord-283340-ksyd5l56	236	1	These	these	DT
cord-283340-ksyd5l56	236	2	findings	finding	NNS
cord-283340-ksyd5l56	236	3	suggest	suggest	VBP
cord-283340-ksyd5l56	236	4	that	that	IN
cord-283340-ksyd5l56	236	5	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	236	6	may	may	MD
cord-283340-ksyd5l56	236	7	potentially	potentially	RB
cord-283340-ksyd5l56	236	8	play	play	VB
cord-283340-ksyd5l56	236	9	a	a	DT
cord-283340-ksyd5l56	236	10	role	role	NN
cord-283340-ksyd5l56	236	11	in	in	IN
cord-283340-ksyd5l56	236	12	the	the	DT
cord-283340-ksyd5l56	236	13	severity	severity	NN
cord-283340-ksyd5l56	236	14	of	of	IN
cord-283340-ksyd5l56	236	15	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	236	16	infection	infection	NN
cord-283340-ksyd5l56	236	17	.	.	.
cord-283340-ksyd5l56	237	1	These	these	DT
cord-283340-ksyd5l56	237	2	results	result	NNS
cord-283340-ksyd5l56	237	3	provide	provide	VBP
cord-283340-ksyd5l56	237	4	clinically	clinically	RB
cord-283340-ksyd5l56	237	5	valuable	valuable	JJ
cord-283340-ksyd5l56	237	6	evidence	evidence	NN
cord-283340-ksyd5l56	237	7	in	in	IN
cord-283340-ksyd5l56	237	8	this	this	DT
cord-283340-ksyd5l56	237	9	pandemic	pandemic	NN
cord-283340-ksyd5l56	237	10	situation	situation	NN
cord-283340-ksyd5l56	237	11	because	because	IN
cord-283340-ksyd5l56	237	12	existing	exist	VBG
cord-283340-ksyd5l56	237	13	research	research	NN
cord-283340-ksyd5l56	237	14	on	on	IN
cord-283340-ksyd5l56	237	15	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	237	16	and	and	CC
cord-283340-ksyd5l56	237	17	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	237	18	is	be	VBZ
cord-283340-ksyd5l56	237	19	limited	limit	VBN
cord-283340-ksyd5l56	237	20	.	.	.
cord-283340-ksyd5l56	238	1	More	more	RBR
cord-283340-ksyd5l56	238	2	adequately	adequately	RB
cord-283340-ksyd5l56	238	3	powered	powered	JJ
cord-283340-ksyd5l56	238	4	studies	study	NNS
cord-283340-ksyd5l56	238	5	are	be	VBP
cord-283340-ksyd5l56	238	6	needed	need	VBN
cord-283340-ksyd5l56	238	7	to	to	TO
cord-283340-ksyd5l56	238	8	obtain	obtain	VB
cord-283340-ksyd5l56	238	9	reliable	reliable	JJ
cord-283340-ksyd5l56	238	10	results	result	NNS
cord-283340-ksyd5l56	238	11	on	on	IN
cord-283340-ksyd5l56	238	12	this	this	DT
cord-283340-ksyd5l56	238	13	issue	issue	NN
cord-283340-ksyd5l56	238	14	.	.	.
cord-283340-ksyd5l56	239	1	It	-PRON-	PRP
cord-283340-ksyd5l56	239	2	is	be	VBZ
cord-283340-ksyd5l56	239	3	very	very	RB
cord-283340-ksyd5l56	239	4	important	important	JJ
cord-283340-ksyd5l56	239	5	to	to	TO
cord-283340-ksyd5l56	239	6	ensure	ensure	VB
cord-283340-ksyd5l56	239	7	that	that	IN
cord-283340-ksyd5l56	239	8	future	future	JJ
cord-283340-ksyd5l56	239	9	research	research	NN
cord-283340-ksyd5l56	239	10	is	be	VBZ
cord-283340-ksyd5l56	239	11	well	well	RB
cord-283340-ksyd5l56	239	12	-	-	HYPH
cord-283340-ksyd5l56	239	13	designed	design	VBN
cord-283340-ksyd5l56	239	14	,	,	,
cord-283340-ksyd5l56	239	15	since	since	IN
cord-283340-ksyd5l56	239	16	conflicting	conflict	VBG
cord-283340-ksyd5l56	239	17	results	result	NNS
cord-283340-ksyd5l56	239	18	may	may	MD
cord-283340-ksyd5l56	239	19	occur	occur	VB
cord-283340-ksyd5l56	239	20	depending	depend	VBG
cord-283340-ksyd5l56	239	21	on	on	IN
cord-283340-ksyd5l56	239	22	when	when	WRB
cord-283340-ksyd5l56	239	23	dyslipidemia	dyslipidemia	NN
cord-283340-ksyd5l56	239	24	is	be	VBZ
cord-283340-ksyd5l56	239	25	defined	define	VBN
cord-283340-ksyd5l56	239	26	or	or	CC
cord-283340-ksyd5l56	239	27	laboratory	laboratory	NN
cord-283340-ksyd5l56	239	28	tests	test	NNS
cord-283340-ksyd5l56	239	29	are	be	VBP
cord-283340-ksyd5l56	239	30	performed	perform	VBN
cord-283340-ksyd5l56	239	31	.	.	.
cord-283340-ksyd5l56	240	1	Characteristics	characteristic	NNS
cord-283340-ksyd5l56	240	2	of	of	IN
cord-283340-ksyd5l56	240	3	persons	person	NNS
cord-283340-ksyd5l56	240	4	who	who	WP
cord-283340-ksyd5l56	240	5	died	die	VBD
cord-283340-ksyd5l56	240	6	with	with	IN
cord-283340-ksyd5l56	240	7	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	240	8	-United	-unite	VBN
cord-283340-ksyd5l56	240	9	States	States	NNPS
cord-283340-ksyd5l56	240	10	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	240	11	and	and	CC
cord-283340-ksyd5l56	240	12	COPD	COPD	NNP
cord-283340-ksyd5l56	240	13	Asthma	Asthma	NNP
cord-283340-ksyd5l56	240	14	and	and	CC
cord-283340-ksyd5l56	240	15	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	240	16	:	:	:
cord-283340-ksyd5l56	240	17	review	review	NN
cord-283340-ksyd5l56	240	18	of	of	IN
cord-283340-ksyd5l56	240	19	evidence	evidence	NN
cord-283340-ksyd5l56	240	20	on	on	IN
cord-283340-ksyd5l56	240	21	risks	risk	NNS
cord-283340-ksyd5l56	240	22	and	and	CC
cord-283340-ksyd5l56	240	23	management	management	NN
cord-283340-ksyd5l56	240	24	considerations	consideration	NNS
cord-283340-ksyd5l56	240	25	Association	Association	NNP
cord-283340-ksyd5l56	240	26	of	of	IN
cord-283340-ksyd5l56	240	27	cardiac	cardiac	JJ
cord-283340-ksyd5l56	240	28	injury	injury	NN
cord-283340-ksyd5l56	240	29	with	with	IN
cord-283340-ksyd5l56	240	30	mortality	mortality	NN
cord-283340-ksyd5l56	240	31	in	in	IN
cord-283340-ksyd5l56	240	32	hospitalized	hospitalize	VBN
cord-283340-ksyd5l56	240	33	patients	patient	NNS
cord-283340-ksyd5l56	240	34	with	with	IN
cord-283340-ksyd5l56	240	35	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	240	36	in	in	IN
cord-283340-ksyd5l56	240	37	Wuhan	Wuhan	NNP
cord-283340-ksyd5l56	240	38	,	,	,
cord-283340-ksyd5l56	240	39	China	China	NNP
cord-283340-ksyd5l56	240	40	Clinical	clinical	JJ
cord-283340-ksyd5l56	240	41	characteristics	characteristic	NNS
cord-283340-ksyd5l56	240	42	and	and	CC
cord-283340-ksyd5l56	240	43	risk	risk	NN
cord-283340-ksyd5l56	240	44	factors	factor	NNS
cord-283340-ksyd5l56	240	45	for	for	IN
cord-283340-ksyd5l56	240	46	mortality	mortality	NN
cord-283340-ksyd5l56	240	47	of	of	IN
cord-283340-ksyd5l56	240	48	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	240	49	patients	patient	NNS
cord-283340-ksyd5l56	240	50	with	with	IN
cord-283340-ksyd5l56	240	51	diabetes	diabete	NNS
cord-283340-ksyd5l56	240	52	in	in	IN
cord-283340-ksyd5l56	240	53	Wuhan	Wuhan	NNP
cord-283340-ksyd5l56	240	54	,	,	,
cord-283340-ksyd5l56	240	55	China	China	NNP
cord-283340-ksyd5l56	240	56	:	:	:
cord-283340-ksyd5l56	240	57	a	a	DT
cord-283340-ksyd5l56	240	58	two	two	CD
cord-283340-ksyd5l56	240	59	-	-	HYPH
cord-283340-ksyd5l56	240	60	center	center	NN
cord-283340-ksyd5l56	240	61	,	,	,
cord-283340-ksyd5l56	240	62	retrospective	retrospective	NNP
cord-283340-ksyd5l56	240	63	study	study	NNP
cord-283340-ksyd5l56	240	64	Association	Association	NNP
cord-283340-ksyd5l56	240	65	of	of	IN
cord-283340-ksyd5l56	240	66	hypertension	hypertension	NN
cord-283340-ksyd5l56	240	67	and	and	CC
cord-283340-ksyd5l56	240	68	antihypertensive	antihypertensive	JJ
cord-283340-ksyd5l56	240	69	treatment	treatment	NN
cord-283340-ksyd5l56	240	70	with	with	IN
cord-283340-ksyd5l56	240	71	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	240	72	mortality	mortality	NN
cord-283340-ksyd5l56	240	73	:	:	:
cord-283340-ksyd5l56	240	74	a	a	DT
cord-283340-ksyd5l56	240	75	retrospective	retrospective	JJ
cord-283340-ksyd5l56	240	76	observational	observational	JJ
cord-283340-ksyd5l56	240	77	study	study	NN
cord-283340-ksyd5l56	240	78	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	240	79	and	and	CC
cord-283340-ksyd5l56	240	80	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	240	81	disease	disease	NN
cord-283340-ksyd5l56	240	82	Associations	association	NNS
cord-283340-ksyd5l56	240	83	of	of	IN
cord-283340-ksyd5l56	240	84	type	type	NN
cord-283340-ksyd5l56	240	85	1	1	CD
cord-283340-ksyd5l56	240	86	and	and	CC
cord-283340-ksyd5l56	240	87	type	type	NN
cord-283340-ksyd5l56	240	88	2	2	CD
cord-283340-ksyd5l56	240	89	diabetes	diabetes	NN
cord-283340-ksyd5l56	240	90	with	with	IN
cord-283340-ksyd5l56	240	91	COVID-19-related	covid-19-related	JJ
cord-283340-ksyd5l56	240	92	mortality	mortality	NN
cord-283340-ksyd5l56	240	93	in	in	IN
cord-283340-ksyd5l56	240	94	England	England	NNP
cord-283340-ksyd5l56	240	95	:	:	:
cord-283340-ksyd5l56	240	96	a	a	DT
cord-283340-ksyd5l56	240	97	whole	whole	JJ
cord-283340-ksyd5l56	240	98	-	-	HYPH
cord-283340-ksyd5l56	240	99	population	population	NN
cord-283340-ksyd5l56	240	100	study	study	NN
cord-283340-ksyd5l56	240	101	Is	be	VBZ
cord-283340-ksyd5l56	240	102	diabetes	diabetes	NN
cord-283340-ksyd5l56	240	103	mellitus	mellitus	NN
cord-283340-ksyd5l56	240	104	associated	associate	VBN
cord-283340-ksyd5l56	240	105	with	with	IN
cord-283340-ksyd5l56	240	106	mortality	mortality	NN
cord-283340-ksyd5l56	240	107	and	and	CC
cord-283340-ksyd5l56	240	108	severity	severity	NN
cord-283340-ksyd5l56	240	109	of	of	IN
cord-283340-ksyd5l56	240	110	COVID-19	covid-19	NN
cord-283340-ksyd5l56	240	111	?	?	.
cord-283340-ksyd5l56	241	1	A	a	DT
cord-283340-ksyd5l56	241	2	meta	meta	JJ
cord-283340-ksyd5l56	241	3	-	-	HYPH
cord-283340-ksyd5l56	241	4	analysis	analysis	NNP
cord-283340-ksyd5l56	241	5	Association	Association	NNP
cord-283340-ksyd5l56	241	6	of	of	IN
cord-283340-ksyd5l56	241	7	hypertension	hypertension	NN
cord-283340-ksyd5l56	241	8	with	with	IN
cord-283340-ksyd5l56	241	9	the	the	DT
cord-283340-ksyd5l56	241	10	severity	severity	NN
cord-283340-ksyd5l56	241	11	and	and	CC
cord-283340-ksyd5l56	241	12	fatality	fatality	NN
cord-283340-ksyd5l56	241	13	of	of	IN
cord-283340-ksyd5l56	241	14	SARS	SARS	NNP
cord-283340-ksyd5l56	241	15	-	-	HYPH
cord-283340-ksyd5l56	241	16	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	241	17	infection	infection	NN
cord-283340-ksyd5l56	242	1	:	:	:
cord-283340-ksyd5l56	242	2	a	a	DT
cord-283340-ksyd5l56	242	3	meta	meta	NNP
cord-283340-ksyd5l56	242	4	-	-	HYPH
cord-283340-ksyd5l56	242	5	analysis	analysis	NN
cord-283340-ksyd5l56	242	6	Declined	decline	VBD
cord-283340-ksyd5l56	242	7	serum	serum	JJ
cord-283340-ksyd5l56	242	8	high	high	JJ
cord-283340-ksyd5l56	242	9	density	density	NN
cord-283340-ksyd5l56	242	10	lipoprotein	lipoprotein	NN
cord-283340-ksyd5l56	242	11	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	242	12	is	be	VBZ
cord-283340-ksyd5l56	242	13	associated	associate	VBN
cord-283340-ksyd5l56	242	14	with	with	IN
cord-283340-ksyd5l56	242	15	the	the	DT
cord-283340-ksyd5l56	242	16	severity	severity	NN
cord-283340-ksyd5l56	242	17	of	of	IN
cord-283340-ksyd5l56	242	18	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	242	19	infection	infection	NN
cord-283340-ksyd5l56	242	20	Low	low	JJ
cord-283340-ksyd5l56	242	21	high	high	JJ
cord-283340-ksyd5l56	242	22	-	-	HYPH
cord-283340-ksyd5l56	242	23	density	density	NN
cord-283340-ksyd5l56	242	24	lipoprotein	lipoprotein	NN
cord-283340-ksyd5l56	242	25	level	level	NN
cord-283340-ksyd5l56	242	26	is	be	VBZ
cord-283340-ksyd5l56	242	27	correlated	correlate	VBN
cord-283340-ksyd5l56	242	28	with	with	IN
cord-283340-ksyd5l56	242	29	the	the	DT
cord-283340-ksyd5l56	242	30	severity	severity	NN
cord-283340-ksyd5l56	242	31	of	of	IN
cord-283340-ksyd5l56	242	32	COVID-19	covid-19	CD
cord-283340-ksyd5l56	242	33	patients	patient	NNS
cord-283340-ksyd5l56	242	34	:	:	:
cord-283340-ksyd5l56	242	35	an	an	DT
cord-283340-ksyd5l56	242	36	observational	observational	JJ
cord-283340-ksyd5l56	242	37	study	study	NN
cord-283340-ksyd5l56	242	38	Summarizing	summarize	VBG
cord-283340-ksyd5l56	242	39	systematic	systematic	JJ
cord-283340-ksyd5l56	242	40	reviews	review	NNS
cord-283340-ksyd5l56	242	41	:	:	:
cord-283340-ksyd5l56	242	42	methodological	methodological	JJ
cord-283340-ksyd5l56	242	43	development	development	NN
cord-283340-ksyd5l56	242	44	,	,	,
cord-283340-ksyd5l56	242	45	conduct	conduct	NN
cord-283340-ksyd5l56	242	46	and	and	CC
cord-283340-ksyd5l56	242	47	reporting	reporting	NN
cord-283340-ksyd5l56	242	48	of	of	IN
cord-283340-ksyd5l56	242	49	an	an	DT
cord-283340-ksyd5l56	242	50	umbrella	umbrella	NN
cord-283340-ksyd5l56	242	51	review	review	NN
cord-283340-ksyd5l56	242	52	approach	approach	NN
cord-283340-ksyd5l56	242	53	Cochrane	Cochrane	NNP
cord-283340-ksyd5l56	242	54	Handbook	Handbook	NNP
cord-283340-ksyd5l56	242	55	for	for	IN
cord-283340-ksyd5l56	242	56	Systematic	Systematic	NNP
cord-283340-ksyd5l56	242	57	Reviews	Reviews	NNPS
cord-283340-ksyd5l56	242	58	of	of	IN
cord-283340-ksyd5l56	242	59	Interventions	Interventions	NNPS
cord-283340-ksyd5l56	242	60	:	:	:
cord-283340-ksyd5l56	242	61	Cochrane	Cochrane	NNP
cord-283340-ksyd5l56	242	62	Book	Book	NNP
cord-283340-ksyd5l56	242	63	Series	Series	NNP
cord-283340-ksyd5l56	242	64	Methodology	Methodology	NNP
cord-283340-ksyd5l56	242	65	in	in	IN
cord-283340-ksyd5l56	242	66	conducting	conduct	VBG
cord-283340-ksyd5l56	242	67	a	a	DT
cord-283340-ksyd5l56	242	68	systematic	systematic	JJ
cord-283340-ksyd5l56	242	69	review	review	NN
cord-283340-ksyd5l56	242	70	of	of	IN
cord-283340-ksyd5l56	242	71	systematic	systematic	JJ
cord-283340-ksyd5l56	242	72	reviews	review	NNS
cord-283340-ksyd5l56	242	73	of	of	IN
cord-283340-ksyd5l56	242	74	healthcare	healthcare	NN
cord-283340-ksyd5l56	242	75	interventions	intervention	NNS
cord-283340-ksyd5l56	242	76	Using	use	VBG
cord-283340-ksyd5l56	242	77	existing	exist	VBG
cord-283340-ksyd5l56	242	78	systematic	systematic	JJ
cord-283340-ksyd5l56	242	79	reviews	review	NNS
cord-283340-ksyd5l56	242	80	in	in	IN
cord-283340-ksyd5l56	242	81	complex	complex	JJ
cord-283340-ksyd5l56	242	82	systematic	systematic	JJ
cord-283340-ksyd5l56	242	83	reviews	review	NNS
cord-283340-ksyd5l56	243	1	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	243	2	2	2	CD
cord-283340-ksyd5l56	243	3	:	:	:
cord-283340-ksyd5l56	243	4	a	a	DT
cord-283340-ksyd5l56	243	5	critical	critical	JJ
cord-283340-ksyd5l56	243	6	appraisal	appraisal	NN
cord-283340-ksyd5l56	243	7	tool	tool	NN
cord-283340-ksyd5l56	243	8	for	for	IN
cord-283340-ksyd5l56	243	9	systematic	systematic	JJ
cord-283340-ksyd5l56	243	10	reviews	review	NNS
cord-283340-ksyd5l56	243	11	that	that	WDT
cord-283340-ksyd5l56	243	12	include	include	VBP
cord-283340-ksyd5l56	243	13	randomised	randomised	JJ
cord-283340-ksyd5l56	243	14	or	or	CC
cord-283340-ksyd5l56	243	15	non	non	JJ
cord-283340-ksyd5l56	243	16	-	-	JJ
cord-283340-ksyd5l56	243	17	randomised	randomised	JJ
cord-283340-ksyd5l56	243	18	studies	study	NNS
cord-283340-ksyd5l56	243	19	of	of	IN
cord-283340-ksyd5l56	243	20	healthcare	healthcare	NN
cord-283340-ksyd5l56	243	21	interventions	intervention	NNS
cord-283340-ksyd5l56	243	22	,	,	,
cord-283340-ksyd5l56	243	23	or	or	CC
cord-283340-ksyd5l56	243	24	both	both	DT
cord-283340-ksyd5l56	243	25	Reaching	reach	VBG
cord-283340-ksyd5l56	243	26	for	for	IN
cord-283340-ksyd5l56	243	27	the	the	DT
cord-283340-ksyd5l56	243	28	stars	star	NNS
cord-283340-ksyd5l56	243	29	-rating	-rate	VBG
cord-283340-ksyd5l56	244	1	the	the	DT
cord-283340-ksyd5l56	244	2	quality	quality	NN
cord-283340-ksyd5l56	244	3	of	of	IN
cord-283340-ksyd5l56	244	4	systematic	systematic	JJ
cord-283340-ksyd5l56	244	5	reviews	review	NNS
cord-283340-ksyd5l56	244	6	with	with	IN
cord-283340-ksyd5l56	244	7	the	the	DT
cord-283340-ksyd5l56	244	8	Assessment	Assessment	NNP
cord-283340-ksyd5l56	244	9	of	of	IN
cord-283340-ksyd5l56	244	10	Multiple	Multiple	NNP
cord-283340-ksyd5l56	244	11	Systematic	Systematic	NNP
cord-283340-ksyd5l56	244	12	Reviews	Reviews	NNPS
cord-283340-ksyd5l56	244	13	(	(	-LRB-
cord-283340-ksyd5l56	244	14	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	244	15	)	)	-RRB-
cord-283340-ksyd5l56	245	1	2	2	LS
cord-283340-ksyd5l56	246	1	AMSTAR	AMSTAR	NNP
cord-283340-ksyd5l56	246	2	is	be	VBZ
cord-283340-ksyd5l56	246	3	a	a	DT
cord-283340-ksyd5l56	246	4	reliable	reliable	JJ
cord-283340-ksyd5l56	246	5	and	and	CC
cord-283340-ksyd5l56	246	6	valid	valid	JJ
cord-283340-ksyd5l56	246	7	measurement	measurement	NN
cord-283340-ksyd5l56	246	8	tool	tool	NN
cord-283340-ksyd5l56	246	9	to	to	TO
cord-283340-ksyd5l56	246	10	assess	assess	VB
cord-283340-ksyd5l56	246	11	the	the	DT
cord-283340-ksyd5l56	246	12	methodological	methodological	JJ
cord-283340-ksyd5l56	246	13	quality	quality	NN
cord-283340-ksyd5l56	246	14	of	of	IN
cord-283340-ksyd5l56	246	15	systematic	systematic	JJ
cord-283340-ksyd5l56	246	16	reviews	review	NNS
cord-283340-ksyd5l56	246	17	GRADE	grade	NN
cord-283340-ksyd5l56	246	18	guidelines	guideline	NNS
cord-283340-ksyd5l56	246	19	:	:	:
cord-283340-ksyd5l56	247	1	1	1	LS
cord-283340-ksyd5l56	247	2	.	.	.
cord-283340-ksyd5l56	248	1	Introduction	introduction	NN
cord-283340-ksyd5l56	248	2	-	-	HYPH
cord-283340-ksyd5l56	248	3	GRADE	grade	NN
cord-283340-ksyd5l56	248	4	evidence	evidence	NN
cord-283340-ksyd5l56	248	5	profiles	profile	NNS
cord-283340-ksyd5l56	248	6	and	and	CC
cord-283340-ksyd5l56	248	7	summary	summary	NN
cord-283340-ksyd5l56	248	8	of	of	IN
cord-283340-ksyd5l56	248	9	findings	finding	NNS
cord-283340-ksyd5l56	248	10	tables	table	NNS
cord-283340-ksyd5l56	248	11	Impact	Impact	NNP
cord-283340-ksyd5l56	248	12	of	of	IN
cord-283340-ksyd5l56	248	13	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	248	14	on	on	IN
cord-283340-ksyd5l56	248	15	neurological	neurological	JJ
cord-283340-ksyd5l56	248	16	manifestations	manifestation	NNS
cord-283340-ksyd5l56	248	17	:	:	:
cord-283340-ksyd5l56	249	1	an	an	DT
cord-283340-ksyd5l56	249	2	overview	overview	NN
cord-283340-ksyd5l56	249	3	of	of	IN
cord-283340-ksyd5l56	249	4	stroke	stroke	NN
cord-283340-ksyd5l56	249	5	presentation	presentation	NN
cord-283340-ksyd5l56	249	6	in	in	IN
cord-283340-ksyd5l56	249	7	pandemic	pandemic	NN
cord-283340-ksyd5l56	249	8	Diabetes	diabetes	NN
cord-283340-ksyd5l56	249	9	mellitus	mellitus	NN
cord-283340-ksyd5l56	249	10	is	be	VBZ
cord-283340-ksyd5l56	249	11	associated	associate	VBN
cord-283340-ksyd5l56	249	12	with	with	IN
cord-283340-ksyd5l56	249	13	increased	increase	VBN
cord-283340-ksyd5l56	249	14	mortality	mortality	NN
cord-283340-ksyd5l56	249	15	and	and	CC
cord-283340-ksyd5l56	249	16	severity	severity	NN
cord-283340-ksyd5l56	249	17	of	of	IN
cord-283340-ksyd5l56	249	18	disease	disease	NN
cord-283340-ksyd5l56	249	19	in	in	IN
cord-283340-ksyd5l56	249	20	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	249	21	pneumonia	pneumonia	NN
cord-283340-ksyd5l56	249	22	-A	-A	.
cord-283340-ksyd5l56	249	23	systematic	systematic	JJ
cord-283340-ksyd5l56	249	24	review	review	NN
cord-283340-ksyd5l56	249	25	,	,	,
cord-283340-ksyd5l56	249	26	meta	meta	NNP
cord-283340-ksyd5l56	249	27	-	-	HYPH
cord-283340-ksyd5l56	249	28	analysis	analysis	NNP
cord-283340-ksyd5l56	249	29	,	,	,
cord-283340-ksyd5l56	249	30	and	and	CC
cord-283340-ksyd5l56	249	31	meta	meta	JJ
cord-283340-ksyd5l56	249	32	-	-	HYPH
cord-283340-ksyd5l56	249	33	regression	regression	JJ
cord-283340-ksyd5l56	249	34	Meta	Meta	NNP
cord-283340-ksyd5l56	249	35	-	-	HYPH
cord-283340-ksyd5l56	249	36	analysis	analysis	NN
cord-283340-ksyd5l56	249	37	investigating	investigate	VBG
cord-283340-ksyd5l56	249	38	the	the	DT
cord-283340-ksyd5l56	249	39	relationship	relationship	NN
cord-283340-ksyd5l56	249	40	between	between	IN
cord-283340-ksyd5l56	249	41	clinical	clinical	JJ
cord-283340-ksyd5l56	249	42	features	feature	NNS
cord-283340-ksyd5l56	249	43	,	,	,
cord-283340-ksyd5l56	249	44	outcomes	outcome	NNS
cord-283340-ksyd5l56	249	45	,	,	,
cord-283340-ksyd5l56	249	46	and	and	CC
cord-283340-ksyd5l56	249	47	severity	severity	NN
cord-283340-ksyd5l56	249	48	of	of	IN
cord-283340-ksyd5l56	249	49	severe	severe	JJ
cord-283340-ksyd5l56	249	50	acute	acute	JJ
cord-283340-ksyd5l56	249	51	respiratory	respiratory	JJ
cord-283340-ksyd5l56	249	52	syndrome	syndrome	NN
cord-283340-ksyd5l56	249	53	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	249	54	2	2	CD
cord-283340-ksyd5l56	249	55	(	(	-LRB-
cord-283340-ksyd5l56	249	56	SARS	SARS	NNP
cord-283340-ksyd5l56	249	57	-	-	HYPH
cord-283340-ksyd5l56	249	58	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	249	59	)	)	-RRB-
cord-283340-ksyd5l56	250	1	pneumonia	pneumonia	NNP
cord-283340-ksyd5l56	250	2	Sanchis	Sanchis	NNP
cord-283340-ksyd5l56	250	3	-	-	HYPH
cord-283340-ksyd5l56	250	4	Gomar	Gomar	NNP
cord-283340-ksyd5l56	250	5	F.	F.	NNP
cord-283340-ksyd5l56	250	6	Physical	physical	JJ
cord-283340-ksyd5l56	250	7	inactivity	inactivity	NN
cord-283340-ksyd5l56	250	8	and	and	CC
cord-283340-ksyd5l56	250	9	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	250	10	disease	disease	NN
cord-283340-ksyd5l56	250	11	at	at	IN
cord-283340-ksyd5l56	250	12	the	the	DT
cord-283340-ksyd5l56	250	13	time	time	NN
cord-283340-ksyd5l56	250	14	of	of	IN
cord-283340-ksyd5l56	250	15	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	250	16	disease	disease	NN
cord-283340-ksyd5l56	250	17	2019	2019	CD
cord-283340-ksyd5l56	250	18	(	(	-LRB-
cord-283340-ksyd5l56	250	19	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	250	20	)	)	-RRB-
cord-283340-ksyd5l56	250	21	COVID-19	covid-19	VBP
cord-283340-ksyd5l56	250	22	among	among	IN
cord-283340-ksyd5l56	250	23	people	people	NNS
cord-283340-ksyd5l56	250	24	living	live	VBG
cord-283340-ksyd5l56	250	25	with	with	IN
cord-283340-ksyd5l56	250	26	HIV	HIV	NNP
cord-283340-ksyd5l56	250	27	:	:	:
cord-283340-ksyd5l56	250	28	a	a	DT
cord-283340-ksyd5l56	250	29	systematic	systematic	JJ
cord-283340-ksyd5l56	250	30	review	review	NN
cord-283340-ksyd5l56	250	31	Prognosis	prognosis	NN
cord-283340-ksyd5l56	250	32	of	of	IN
cord-283340-ksyd5l56	250	33	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	250	34	in	in	IN
cord-283340-ksyd5l56	250	35	patients	patient	NNS
cord-283340-ksyd5l56	250	36	with	with	IN
cord-283340-ksyd5l56	250	37	liver	liver	NN
cord-283340-ksyd5l56	250	38	and	and	CC
cord-283340-ksyd5l56	250	39	kidney	kidney	NN
cord-283340-ksyd5l56	250	40	diseases	disease	NNS
cord-283340-ksyd5l56	250	41	:	:	:
cord-283340-ksyd5l56	250	42	an	an	DT
cord-283340-ksyd5l56	250	43	early	early	JJ
cord-283340-ksyd5l56	250	44	systematic	systematic	JJ
cord-283340-ksyd5l56	250	45	review	review	NN
cord-283340-ksyd5l56	250	46	and	and	CC
cord-283340-ksyd5l56	250	47	meta	meta	NNP
cord-283340-ksyd5l56	250	48	-	-	HYPH
cord-283340-ksyd5l56	250	49	analysis	analysis	NNP
cord-283340-ksyd5l56	250	50	Editor	Editor	NNP
cord-283340-ksyd5l56	250	51	's	's	POS
cord-283340-ksyd5l56	250	52	presentation	presentation	NN
cord-283340-ksyd5l56	250	53	:	:	:
cord-283340-ksyd5l56	250	54	staying	stay	VBG
cord-283340-ksyd5l56	250	55	healthy	healthy	JJ
cord-283340-ksyd5l56	250	56	and	and	CC
cord-283340-ksyd5l56	250	57	fighting	fight	VBG
cord-283340-ksyd5l56	250	58	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	250	59	disease	disease	NN
cord-283340-ksyd5l56	250	60	at	at	IN
cord-283340-ksyd5l56	250	61	the	the	DT
cord-283340-ksyd5l56	250	62	time	time	NN
cord-283340-ksyd5l56	250	63	of	of	IN
cord-283340-ksyd5l56	250	64	COVID	COVID	NNP
cord-283340-ksyd5l56	250	65	Impact	Impact	NNP
cord-283340-ksyd5l56	250	66	of	of	IN
cord-283340-ksyd5l56	250	67	cerebrovascular	cerebrovascular	JJ
cord-283340-ksyd5l56	250	68	and	and	CC
cord-283340-ksyd5l56	250	69	cardiovascular	cardiovascular	JJ
cord-283340-ksyd5l56	250	70	diseases	disease	NNS
cord-283340-ksyd5l56	250	71	on	on	IN
cord-283340-ksyd5l56	250	72	mortality	mortality	NN
cord-283340-ksyd5l56	250	73	and	and	CC
cord-283340-ksyd5l56	250	74	severity	severity	NN
cord-283340-ksyd5l56	250	75	of	of	IN
cord-283340-ksyd5l56	250	76	COVID-19-systematic	COVID-19-systematic	NNP
cord-283340-ksyd5l56	250	77	review	review	NN
cord-283340-ksyd5l56	250	78	,	,	,
cord-283340-ksyd5l56	250	79	meta	meta	NNP
cord-283340-ksyd5l56	250	80	-	-	HYPH
cord-283340-ksyd5l56	250	81	analysis	analysis	NNP
cord-283340-ksyd5l56	250	82	,	,	,
cord-283340-ksyd5l56	250	83	and	and	CC
cord-283340-ksyd5l56	250	84	meta	meta	JJ
cord-283340-ksyd5l56	250	85	-	-	HYPH
cord-283340-ksyd5l56	250	86	regression	regression	NN
cord-283340-ksyd5l56	251	1	Elevated	elevated	JJ
cord-283340-ksyd5l56	251	2	N	n	CD
cord-283340-ksyd5l56	251	3	-	-	HYPH
cord-283340-ksyd5l56	251	4	terminal	terminal	NN
cord-283340-ksyd5l56	251	5	pro	pro	JJ
cord-283340-ksyd5l56	251	6	-	-	JJ
cord-283340-ksyd5l56	251	7	brain	brain	JJ
cord-283340-ksyd5l56	251	8	natriuretic	natriuretic	JJ
cord-283340-ksyd5l56	251	9	peptide	peptide	NN
cord-283340-ksyd5l56	251	10	is	be	VBZ
cord-283340-ksyd5l56	251	11	associated	associate	VBN
cord-283340-ksyd5l56	251	12	with	with	IN
cord-283340-ksyd5l56	251	13	increased	increase	VBN
cord-283340-ksyd5l56	251	14	mortality	mortality	NN
cord-283340-ksyd5l56	251	15	in	in	IN
cord-283340-ksyd5l56	251	16	patients	patient	NNS
cord-283340-ksyd5l56	251	17	with	with	IN
cord-283340-ksyd5l56	251	18	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	251	19	:	:	:
cord-283340-ksyd5l56	251	20	systematic	systematic	JJ
cord-283340-ksyd5l56	251	21	review	review	NN
cord-283340-ksyd5l56	251	22	and	and	CC
cord-283340-ksyd5l56	251	23	meta	meta	NNP
cord-283340-ksyd5l56	251	24	-	-	HYPH
cord-283340-ksyd5l56	251	25	analysis	analysis	NN
cord-283340-ksyd5l56	252	1	Covid-19	Covid-19	NNP
cord-283340-ksyd5l56	252	2	and	and	CC
cord-283340-ksyd5l56	252	3	heart	heart	NN
cord-283340-ksyd5l56	252	4	:	:	:
cord-283340-ksyd5l56	252	5	from	from	IN
cord-283340-ksyd5l56	252	6	clinical	clinical	JJ
cord-283340-ksyd5l56	252	7	features	feature	NNS
cord-283340-ksyd5l56	252	8	to	to	IN
cord-283340-ksyd5l56	252	9	pharmacological	pharmacological	JJ
cord-283340-ksyd5l56	252	10	implications	implication	NNS
cord-283340-ksyd5l56	252	11	D	d	NN
cord-283340-ksyd5l56	252	12	-	-	HYPH
cord-283340-ksyd5l56	252	13	dimer	dimer	NN
cord-283340-ksyd5l56	252	14	as	as	IN
cord-283340-ksyd5l56	252	15	an	an	DT
cord-283340-ksyd5l56	252	16	indicator	indicator	NN
cord-283340-ksyd5l56	252	17	of	of	IN
cord-283340-ksyd5l56	252	18	prognosis	prognosis	NN
cord-283340-ksyd5l56	252	19	in	in	IN
cord-283340-ksyd5l56	252	20	SARS	SARS	NNP
cord-283340-ksyd5l56	252	21	-	-	HYPH
cord-283340-ksyd5l56	252	22	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	252	23	infection	infection	NN
cord-283340-ksyd5l56	252	24	:	:	:
cord-283340-ksyd5l56	252	25	a	a	DT
cord-283340-ksyd5l56	252	26	systematic	systematic	JJ
cord-283340-ksyd5l56	252	27	review	review	NN
cord-283340-ksyd5l56	252	28	Prediction	prediction	NN
cord-283340-ksyd5l56	252	29	models	model	NNS
cord-283340-ksyd5l56	252	30	for	for	IN
cord-283340-ksyd5l56	252	31	diagnosis	diagnosis	NN
cord-283340-ksyd5l56	252	32	and	and	CC
cord-283340-ksyd5l56	252	33	prognosis	prognosis	NN
cord-283340-ksyd5l56	252	34	of	of	IN
cord-283340-ksyd5l56	252	35	covid-19	covid-19	CD
cord-283340-ksyd5l56	252	36	infection	infection	NN
cord-283340-ksyd5l56	252	37	:	:	:
cord-283340-ksyd5l56	252	38	systematic	systematic	JJ
cord-283340-ksyd5l56	252	39	review	review	NN
cord-283340-ksyd5l56	252	40	and	and	CC
cord-283340-ksyd5l56	252	41	critical	critical	JJ
cord-283340-ksyd5l56	252	42	appraisal	appraisal	NN
cord-283340-ksyd5l56	252	43	Risk	risk	NN
cord-283340-ksyd5l56	252	44	factors	factor	NNS
cord-283340-ksyd5l56	252	45	of	of	IN
cord-283340-ksyd5l56	252	46	critical	critical	JJ
cord-283340-ksyd5l56	252	47	&	&	CC
cord-283340-ksyd5l56	252	48	mortal	mortal	JJ
cord-283340-ksyd5l56	252	49	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	252	50	cases	case	NNS
cord-283340-ksyd5l56	252	51	:	:	:
cord-283340-ksyd5l56	252	52	a	a	DT
cord-283340-ksyd5l56	252	53	systematic	systematic	JJ
cord-283340-ksyd5l56	252	54	literature	literature	NN
cord-283340-ksyd5l56	252	55	review	review	NN
cord-283340-ksyd5l56	252	56	and	and	CC
cord-283340-ksyd5l56	252	57	meta	meta	NNP
cord-283340-ksyd5l56	252	58	-	-	HYPH
cord-283340-ksyd5l56	252	59	analysis	analysis	NN
cord-283340-ksyd5l56	252	60	Lipoprotein(a	Lipoprotein(a	NNP
cord-283340-ksyd5l56	252	61	)	)	-RRB-
cord-283340-ksyd5l56	252	62	and	and	CC
cord-283340-ksyd5l56	252	63	its	-PRON-	PRP$
cord-283340-ksyd5l56	252	64	potential	potential	JJ
cord-283340-ksyd5l56	252	65	association	association	NN
cord-283340-ksyd5l56	252	66	with	with	IN
cord-283340-ksyd5l56	252	67	thrombosis	thrombosis	NN
cord-283340-ksyd5l56	252	68	and	and	CC
cord-283340-ksyd5l56	252	69	inflammation	inflammation	NN
cord-283340-ksyd5l56	252	70	in	in	IN
cord-283340-ksyd5l56	252	71	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	252	72	:	:	:
cord-283340-ksyd5l56	252	73	a	a	DT
cord-283340-ksyd5l56	252	74	testable	testable	JJ
cord-283340-ksyd5l56	252	75	hypothesis	hypothesis	NN
cord-283340-ksyd5l56	252	76	Obesity	obesity	NN
cord-283340-ksyd5l56	252	77	as	as	IN
cord-283340-ksyd5l56	252	78	a	a	DT
cord-283340-ksyd5l56	252	79	predictor	predictor	NN
cord-283340-ksyd5l56	252	80	for	for	IN
cord-283340-ksyd5l56	252	81	a	a	DT
cord-283340-ksyd5l56	252	82	poor	poor	JJ
cord-283340-ksyd5l56	252	83	prognosis	prognosis	NN
cord-283340-ksyd5l56	252	84	of	of	IN
cord-283340-ksyd5l56	252	85	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	252	86	:	:	:
cord-283340-ksyd5l56	252	87	a	a	DT
cord-283340-ksyd5l56	252	88	systematic	systematic	JJ
cord-283340-ksyd5l56	252	89	review	review	NN
cord-283340-ksyd5l56	252	90	Dyslipidemia	Dyslipidemia	NNP
cord-283340-ksyd5l56	252	91	is	be	VBZ
cord-283340-ksyd5l56	252	92	associated	associate	VBN
cord-283340-ksyd5l56	252	93	with	with	IN
cord-283340-ksyd5l56	252	94	severe	severe	JJ
cord-283340-ksyd5l56	252	95	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	252	96	disease	disease	NN
cord-283340-ksyd5l56	252	97	2019	2019	CD
cord-283340-ksyd5l56	252	98	(	(	-LRB-
cord-283340-ksyd5l56	252	99	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	252	100	)	)	-RRB-
cord-283340-ksyd5l56	252	101	infection	infection	NN
cord-283340-ksyd5l56	252	102	Association	Association	NNP
cord-283340-ksyd5l56	252	103	of	of	IN
cord-283340-ksyd5l56	252	104	hypertension	hypertension	NN
cord-283340-ksyd5l56	252	105	,	,	,
cord-283340-ksyd5l56	252	106	diabetes	diabetes	NN
cord-283340-ksyd5l56	252	107	,	,	,
cord-283340-ksyd5l56	252	108	stroke	stroke	NN
cord-283340-ksyd5l56	252	109	,	,	,
cord-283340-ksyd5l56	252	110	cancer	cancer	NN
cord-283340-ksyd5l56	252	111	,	,	,
cord-283340-ksyd5l56	252	112	kidney	kidney	NN
cord-283340-ksyd5l56	252	113	disease	disease	NN
cord-283340-ksyd5l56	252	114	,	,	,
cord-283340-ksyd5l56	252	115	and	and	CC
cord-283340-ksyd5l56	252	116	high	high	JJ
cord-283340-ksyd5l56	252	117	-	-	HYPH
cord-283340-ksyd5l56	252	118	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	252	119	with	with	IN
cord-283340-ksyd5l56	252	120	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	252	121	disease	disease	NN
cord-283340-ksyd5l56	252	122	severity	severity	NN
cord-283340-ksyd5l56	252	123	and	and	CC
cord-283340-ksyd5l56	252	124	fatality	fatality	NN
cord-283340-ksyd5l56	252	125	:	:	:
cord-283340-ksyd5l56	253	1	a	a	DT
cord-283340-ksyd5l56	253	2	systematic	systematic	JJ
cord-283340-ksyd5l56	253	3	review	review	NN
cord-283340-ksyd5l56	253	4	Low	low	JJ
cord-283340-ksyd5l56	253	5	serum	serum	NN
cord-283340-ksyd5l56	253	6	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	253	7	level	level	NN
cord-283340-ksyd5l56	253	8	among	among	IN
cord-283340-ksyd5l56	253	9	patients	patient	NNS
cord-283340-ksyd5l56	253	10	with	with	IN
cord-283340-ksyd5l56	253	11	COVID-19	covid-19	JJ
cord-283340-ksyd5l56	253	12	infection	infection	NN
cord-283340-ksyd5l56	253	13	in	in	IN
cord-283340-ksyd5l56	253	14	Wenzhou	Wenzhou	NNP
cord-283340-ksyd5l56	253	15	Metabolic	metabolic	JJ
cord-283340-ksyd5l56	253	16	disturbances	disturbance	NNS
cord-283340-ksyd5l56	253	17	and	and	CC
cord-283340-ksyd5l56	253	18	inflammatory	inflammatory	JJ
cord-283340-ksyd5l56	253	19	dysfunction	dysfunction	NN
cord-283340-ksyd5l56	253	20	predict	predict	VBP
cord-283340-ksyd5l56	253	21	severity	severity	NN
cord-283340-ksyd5l56	253	22	of	of	IN
cord-283340-ksyd5l56	253	23	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	253	24	disease	disease	NN
cord-283340-ksyd5l56	253	25	2019	2019	CD
cord-283340-ksyd5l56	253	26	(	(	-LRB-
cord-283340-ksyd5l56	253	27	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	253	28	)	)	-RRB-
cord-283340-ksyd5l56	253	29	:	:	:
cord-283340-ksyd5l56	253	30	a	a	DT
cord-283340-ksyd5l56	253	31	retrospective	retrospective	JJ
cord-283340-ksyd5l56	253	32	study	study	NN
cord-283340-ksyd5l56	253	33	Cholesterol	cholesterol	NN
cord-283340-ksyd5l56	253	34	metabolism	metabolism	NN
cord-283340-ksyd5l56	253	35	--	--	:
cord-283340-ksyd5l56	253	36	Impacts	impact	NNS
cord-283340-ksyd5l56	253	37	on	on	IN
cord-283340-ksyd5l56	253	38	SARS	SARS	NNP
cord-283340-ksyd5l56	253	39	-	-	HYPH
cord-283340-ksyd5l56	253	40	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	253	41	infection	infection	NN
cord-283340-ksyd5l56	253	42	prognosis	prognosis	NN
cord-283340-ksyd5l56	253	43	.	.	.
cord-283340-ksyd5l56	254	1	medRxiv	medRxiv	NNS
cord-283340-ksyd5l56	254	2	Membrane	Membrane	NNP
cord-283340-ksyd5l56	254	3	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	254	4	modulates	modulate	VBZ
cord-283340-ksyd5l56	254	5	oligomeric	oligomeric	JJ
cord-283340-ksyd5l56	254	6	status	status	NN
cord-283340-ksyd5l56	254	7	and	and	CC
cord-283340-ksyd5l56	254	8	peptide	peptide	NN
cord-283340-ksyd5l56	254	9	-	-	HYPH
cord-283340-ksyd5l56	254	10	membrane	membrane	NN
cord-283340-ksyd5l56	254	11	interaction	interaction	NN
cord-283340-ksyd5l56	254	12	of	of	IN
cord-283340-ksyd5l56	254	13	severe	severe	JJ
cord-283340-ksyd5l56	254	14	acute	acute	JJ
cord-283340-ksyd5l56	254	15	respiratory	respiratory	JJ
cord-283340-ksyd5l56	254	16	syndrome	syndrome	NN
cord-283340-ksyd5l56	254	17	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	254	18	fusion	fusion	NN
cord-283340-ksyd5l56	254	19	peptide	peptide	NN
cord-283340-ksyd5l56	254	20	Importance	importance	NN
cord-283340-ksyd5l56	254	21	of	of	IN
cord-283340-ksyd5l56	254	22	cholesterol	cholesterol	NN
cord-283340-ksyd5l56	254	23	for	for	IN
cord-283340-ksyd5l56	254	24	infection	infection	NN
cord-283340-ksyd5l56	254	25	of	of	IN
cord-283340-ksyd5l56	254	26	cells	cell	NNS
cord-283340-ksyd5l56	254	27	by	by	IN
cord-283340-ksyd5l56	254	28	transmissible	transmissible	JJ
cord-283340-ksyd5l56	254	29	gastroenteritis	gastroenteritis	NN
cord-283340-ksyd5l56	254	30	virus	virus	NN
cord-283340-ksyd5l56	254	31	Factors	factor	NNS
cord-283340-ksyd5l56	254	32	associated	associate	VBN
cord-283340-ksyd5l56	254	33	with	with	IN
cord-283340-ksyd5l56	254	34	hospital	hospital	NN
cord-283340-ksyd5l56	254	35	admission	admission	NN
cord-283340-ksyd5l56	254	36	and	and	CC
cord-283340-ksyd5l56	254	37	critical	critical	JJ
cord-283340-ksyd5l56	254	38	illness	illness	NN
cord-283340-ksyd5l56	254	39	among	among	IN
cord-283340-ksyd5l56	254	40	5279	5279	CD
cord-283340-ksyd5l56	254	41	people	people	NNS
cord-283340-ksyd5l56	254	42	with	with	IN
cord-283340-ksyd5l56	254	43	coronavirus	coronavirus	NN
cord-283340-ksyd5l56	254	44	disease	disease	NN
cord-283340-ksyd5l56	254	45	Changes	change	NNS
cord-283340-ksyd5l56	254	46	in	in	IN
cord-283340-ksyd5l56	254	47	lipid	lipid	NN
cord-283340-ksyd5l56	254	48	metabolism	metabolism	NN
cord-283340-ksyd5l56	254	49	in	in	IN
cord-283340-ksyd5l56	254	50	patients	patient	NNS
cord-283340-ksyd5l56	254	51	with	with	IN
cord-283340-ksyd5l56	254	52	severe	severe	JJ
cord-283340-ksyd5l56	254	53	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	254	54	Risk	Risk	NNP
cord-283340-ksyd5l56	254	55	factors	factor	NNS
cord-283340-ksyd5l56	254	56	for	for	IN
cord-283340-ksyd5l56	254	57	disease	disease	NN
cord-283340-ksyd5l56	254	58	progression	progression	NN
cord-283340-ksyd5l56	254	59	in	in	IN
cord-283340-ksyd5l56	254	60	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	254	61	patients	patient	NNS
cord-283340-ksyd5l56	254	62	Clinical	clinical	JJ
cord-283340-ksyd5l56	254	63	characteristics	characteristic	NNS
cord-283340-ksyd5l56	254	64	of	of	IN
cord-283340-ksyd5l56	254	65	145	145	CD
cord-283340-ksyd5l56	254	66	patients	patient	NNS
cord-283340-ksyd5l56	254	67	with	with	IN
cord-283340-ksyd5l56	254	68	corona	corona	NN
cord-283340-ksyd5l56	254	69	virus	virus	NN
cord-283340-ksyd5l56	254	70	disease	disease	NNP
cord-283340-ksyd5l56	254	71	2019	2019	CD
cord-283340-ksyd5l56	255	1	(	(	-LRB-
cord-283340-ksyd5l56	255	2	COVID-19	covid-19	VB
cord-283340-ksyd5l56	255	3	High	high	JJ
cord-283340-ksyd5l56	255	4	prevalence	prevalence	NN
cord-283340-ksyd5l56	255	5	of	of	IN
cord-283340-ksyd5l56	255	6	obesity	obesity	NN
cord-283340-ksyd5l56	255	7	in	in	IN
cord-283340-ksyd5l56	255	8	severe	severe	JJ
cord-283340-ksyd5l56	255	9	acute	acute	JJ
cord-283340-ksyd5l56	255	10	respiratory	respiratory	JJ
cord-283340-ksyd5l56	255	11	syndrome	syndrome	NN
cord-283340-ksyd5l56	255	12	coronavirus-2	coronavirus-2	NN
cord-283340-ksyd5l56	256	1	(	(	-LRB-
cord-283340-ksyd5l56	256	2	SARS	SARS	NNP
cord-283340-ksyd5l56	256	3	-	-	HYPH
cord-283340-ksyd5l56	256	4	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	256	5	)	)	-RRB-
cord-283340-ksyd5l56	257	1	requiring	require	VBG
cord-283340-ksyd5l56	257	2	invasive	invasive	JJ
cord-283340-ksyd5l56	257	3	mechanical	mechanical	JJ
cord-283340-ksyd5l56	257	4	ventilation	ventilation	NN
cord-283340-ksyd5l56	257	5	Temporal	temporal	JJ
cord-283340-ksyd5l56	257	6	profiles	profile	NNS
cord-283340-ksyd5l56	257	7	of	of	IN
cord-283340-ksyd5l56	257	8	viral	viral	JJ
cord-283340-ksyd5l56	257	9	load	load	NN
cord-283340-ksyd5l56	257	10	in	in	IN
cord-283340-ksyd5l56	257	11	posterior	posterior	JJ
cord-283340-ksyd5l56	257	12	oropharyngeal	oropharyngeal	JJ
cord-283340-ksyd5l56	257	13	saliva	saliva	NN
cord-283340-ksyd5l56	257	14	samples	sample	NNS
cord-283340-ksyd5l56	257	15	and	and	CC
cord-283340-ksyd5l56	257	16	serum	serum	NN
cord-283340-ksyd5l56	257	17	antibody	antibody	NN
cord-283340-ksyd5l56	257	18	responses	response	NNS
cord-283340-ksyd5l56	257	19	during	during	IN
cord-283340-ksyd5l56	257	20	infection	infection	NN
cord-283340-ksyd5l56	257	21	by	by	IN
cord-283340-ksyd5l56	257	22	SARS	SARS	NNP
cord-283340-ksyd5l56	257	23	-	-	HYPH
cord-283340-ksyd5l56	257	24	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	257	25	:	:	:
cord-283340-ksyd5l56	257	26	an	an	DT
cord-283340-ksyd5l56	257	27	observational	observational	JJ
cord-283340-ksyd5l56	257	28	cohort	cohort	NN
cord-283340-ksyd5l56	257	29	study	study	NN
cord-283340-ksyd5l56	257	30	A	a	DT
cord-283340-ksyd5l56	257	31	Novel	Novel	NNP
cord-283340-ksyd5l56	257	32	scoring	scoring	NN
cord-283340-ksyd5l56	257	33	system	system	NN
cord-283340-ksyd5l56	257	34	for	for	IN
cord-283340-ksyd5l56	257	35	prediction	prediction	NN
cord-283340-ksyd5l56	257	36	of	of	IN
cord-283340-ksyd5l56	257	37	disease	disease	NN
cord-283340-ksyd5l56	257	38	severity	severity	NN
cord-283340-ksyd5l56	257	39	in	in	IN
cord-283340-ksyd5l56	257	40	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	257	41	Clinical	clinical	JJ
cord-283340-ksyd5l56	257	42	characteristics	characteristic	NNS
cord-283340-ksyd5l56	257	43	of	of	IN
cord-283340-ksyd5l56	257	44	140	140	CD
cord-283340-ksyd5l56	257	45	patients	patient	NNS
cord-283340-ksyd5l56	257	46	infected	infect	VBN
cord-283340-ksyd5l56	257	47	with	with	IN
cord-283340-ksyd5l56	257	48	SARS	SARS	NNP
cord-283340-ksyd5l56	257	49	-	-	HYPH
cord-283340-ksyd5l56	257	50	CoV-2	CoV-2	NNP
cord-283340-ksyd5l56	257	51	in	in	IN
cord-283340-ksyd5l56	257	52	Wuhan	Wuhan	NNP
cord-283340-ksyd5l56	257	53	Cytokine	Cytokine	NNP
cord-283340-ksyd5l56	257	54	storm	storm	NN
cord-283340-ksyd5l56	257	55	in	in	IN
cord-283340-ksyd5l56	257	56	COVID-19	covid-19	NN
cord-283340-ksyd5l56	257	57	:	:	:
cord-283340-ksyd5l56	257	58	pathogenesis	pathogenesis	NN
cord-283340-ksyd5l56	257	59	and	and	CC
cord-283340-ksyd5l56	257	60	overview	overview	NN
cord-283340-ksyd5l56	257	61	of	of	IN
cord-283340-ksyd5l56	257	62	anti	anti	JJ
cord-283340-ksyd5l56	257	63	-	-	JJ
cord-283340-ksyd5l56	257	64	inflammatory	inflammatory	JJ
cord-283340-ksyd5l56	257	65	agents	agent	NNS
cord-283340-ksyd5l56	257	66	used	use	VBN
cord-283340-ksyd5l56	257	67	in	in	IN
cord-283340-ksyd5l56	257	68	treatment	treatment	NN
cord-283340-ksyd5l56	257	69	Cholesterol	cholesterol	NN
cord-283340-ksyd5l56	257	70	,	,	,
cord-283340-ksyd5l56	257	71	inflammation	inflammation	NN
cord-283340-ksyd5l56	257	72	and	and	CC
cord-283340-ksyd5l56	257	73	innate	innate	JJ
cord-283340-ksyd5l56	257	74	immunity	immunity	NN
cord-283340-ksyd5l56	257	75	The	the	DT
cord-283340-ksyd5l56	257	76	innate	innate	JJ
cord-283340-ksyd5l56	257	77	immune	immune	JJ
cord-283340-ksyd5l56	257	78	system	system	NN
cord-283340-ksyd5l56	257	79	:	:	:
cord-283340-ksyd5l56	257	80	fighting	fighting	NN
cord-283340-ksyd5l56	257	81	on	on	IN
cord-283340-ksyd5l56	257	82	the	the	DT
cord-283340-ksyd5l56	257	83	front	front	JJ
cord-283340-ksyd5l56	257	84	lines	line	NNS
cord-283340-ksyd5l56	257	85	or	or	CC
cord-283340-ksyd5l56	257	86	fanning	fan	VBG
cord-283340-ksyd5l56	257	87	the	the	DT
cord-283340-ksyd5l56	257	88	flames	flame	NNS
cord-283340-ksyd5l56	257	89	of	of	IN
cord-283340-ksyd5l56	257	90	COVID-19	covid-19	NN
cord-283340-ksyd5l56	257	91	?	?	.
cord-283340-ksyd5l56	258	1	Role	role	NN
cord-283340-ksyd5l56	258	2	of	of	IN
cord-283340-ksyd5l56	258	3	lipotoxicity	lipotoxicity	NN
cord-283340-ksyd5l56	258	4	in	in	IN
cord-283340-ksyd5l56	258	5	endothelial	endothelial	JJ
cord-283340-ksyd5l56	258	6	dysfunction	dysfunction	NN
cord-283340-ksyd5l56	259	1	In	in	IN
cord-283340-ksyd5l56	259	2	-	-	HYPH
cord-283340-ksyd5l56	259	3	Hospital	hospital	NN
cord-283340-ksyd5l56	259	4	Use	Use	NNP
cord-283340-ksyd5l56	259	5	of	of	IN
cord-283340-ksyd5l56	259	6	Statins	Statins	NNPS
cord-283340-ksyd5l56	259	7	Is	be	VBZ
cord-283340-ksyd5l56	259	8	Associated	associate	VBN
cord-283340-ksyd5l56	259	9	with	with	IN
cord-283340-ksyd5l56	259	10	a	a	DT
cord-283340-ksyd5l56	259	11	Reduced	reduce	VBN
cord-283340-ksyd5l56	259	12	Risk	risk	NN
cord-283340-ksyd5l56	259	13	of	of	IN
cord-283340-ksyd5l56	259	14	Mortality	mortality	NN
cord-283340-ksyd5l56	259	15	among	among	IN
cord-283340-ksyd5l56	259	16	Individuals	individual	NNS
cord-283340-ksyd5l56	259	17	with	with	IN
cord-283340-ksyd5l56	259	18	COVID-19	COVID-19	.
cord-283340-ksyd5l56	259	19	The	the	DT
cord-283340-ksyd5l56	259	20	role	role	NN
cord-283340-ksyd5l56	259	21	of	of	IN
cord-283340-ksyd5l56	259	22	statins	statin	NNS
cord-283340-ksyd5l56	259	23	in	in	IN
cord-283340-ksyd5l56	259	24	the	the	DT
cord-283340-ksyd5l56	259	25	setting	setting	NN
cord-283340-ksyd5l56	259	26	of	of	IN
cord-283340-ksyd5l56	259	27	HIV	HIV	NNP
cord-283340-ksyd5l56	259	28	infection	infection	NN
cord-283340-ksyd5l56	259	29	Statin	Statin	NNP
cord-283340-ksyd5l56	259	30	therapy	therapy	NN
cord-283340-ksyd5l56	259	31	in	in	IN
cord-283340-ksyd5l56	259	32	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	259	33	infection	infection	NN
cord-283340-ksyd5l56	259	34	Multi	multi	JJ
cord-283340-ksyd5l56	259	35	-	-	JJ
cord-283340-ksyd5l56	259	36	organ	organ	JJ
cord-283340-ksyd5l56	259	37	proteomic	proteomic	JJ
cord-283340-ksyd5l56	259	38	landscape	landscape	NN
cord-283340-ksyd5l56	259	39	of	of	IN
cord-283340-ksyd5l56	259	40	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	259	41	autopsies	autopsy	NNS
cord-283340-ksyd5l56	259	42	.	.	.
cord-283340-ksyd5l56	260	1	medRxiv	medRxiv	NNS
cord-283340-ksyd5l56	260	2	The	the	DT
cord-283340-ksyd5l56	260	3	role	role	NN
cord-283340-ksyd5l56	260	4	of	of	IN
cord-283340-ksyd5l56	260	5	lipid	lipid	NN
cord-283340-ksyd5l56	260	6	metabolism	metabolism	NN
cord-283340-ksyd5l56	260	7	in	in	IN
cord-283340-ksyd5l56	260	8	COVID-19	COVID-19	NNP
cord-283340-ksyd5l56	260	9	virus	virus	NN
cord-283340-ksyd5l56	260	10	infection	infection	NN
cord-283340-ksyd5l56	260	11	and	and	CC
cord-283340-ksyd5l56	260	12	as	as	IN
cord-283340-ksyd5l56	260	13	a	a	DT
cord-283340-ksyd5l56	260	14	drug	drug	NN
cord-283340-ksyd5l56	260	15	target	target	NN